







A COMPREHENSIVE ANALYSIS OF CANCER-RELATED FATIGUE IN EARLY BREAST 












A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in 
fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of 













         Approved By: 
         Claudio L. Battaglini 
         Erik D. Hanson 
         Zachary Y. Kerr 
         Kirsten A. Nyrop 












































Chad William Wagoner 














Chad William Wagoner: A Comprehensive Analysis of Cancer-Related Fatigue in Early Breast 
Cancer Survivors: A Community-Based Exercise Perspective 
(Under the direction of Dr. Claudio L. Battaglini) 
 
PURPOSE: The purpose of this investigation was to gain a better overall understanding 
of cancer-related fatigue (CRF) in early-breast cancer survivors (EBCS) within a community-
based exercise setting by evaluating baseline CRF severity, CRF change after exercise, and 
identifying potential correlates of CRF. PARTICIPANTS: 33 EBCS (54  11 years) within one 
year of completing primary chemotherapy or radiation and 21 sedentary age-matched controls 
(CON) (54  8 years) were enrolled. METHODS: Pre/post intervention measurements for each 
group included the PROMIS Fatigue 7a, cardiorespiratory fitness (VO2peak), lower/upper body 
strength, quality of life, depression/anxiety, pain, sleep quality, self-efficacy for fatigue 
management, physical function, and self-reported physical activity/outcome exercise 
expectations. Both groups participated in a 16-week aerobic/resistance exercise intervention, 
exercising under supervision 3 days/week for 1 hour each day. Exercise adherence and 
compliance was tracked. RESULTS: At baseline, CRF scores were not statistically different 
between groups (EBCS: 16.9  5.75; CON: 14.2  3.4, p=0.121). Lower CRF in EBCS was 
associated with better quality of life (adj R2 = 0.447; p<0.001), mental health (adj R2 = 0.414; 
p<0.001), outcome expectations for exercise (adj R2 = 0.208; p<0.001), and less depression (adj 
R2 = 0.360; p<0.001) at baseline. Post-exercise, CRF improved in EBCS (-2.6, Cohen’s D = 
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0.51) but not in CON (0.0, Cohen’s D = 0.02). Post-exercise, improved CRF in EBCS was also 
associated with better overall self-reported quality of life (adj R2 = 0.364; p<0.001), less 
depression (adj R2 = 0.223; p<0.01), higher self-efficacy for fatigue self-management (adj R2 = 
0.433; p<0.01), higher outcome expectations for exercise (adj R2 = 0.227; p<0.01), and better 
balance (adj R2 = 0.136; p<0.05). CONCLUSIONS: EBCS enrolled in community-based 
exercise programs report mild fatigue levels at baseline that are similar to CON. Despite this 
similarity, EBCS’ fatigue was significantly associated with multiple psychosocial outcomes at 
baseline whereas CON was not. Community-based exercise is beneficial for alleviating CRF in 
EBCS, with improvements primarily associated with psychosocial and functional outcomes. 
Further research in larger samples is needed to validate the impact of community-based exercise 
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CHAPTER 1: INTRODUCTION 
Background  
There were an estimated 276,480 breast cancer diagnoses in the United States in 2020, 
making it the leading cancer diagnosis in women (Siegel, Miller, & Jemal, 2020). Advancements 
in anti-cancer therapies (surgery, radiation, chemotherapy) have resulted in improved mortality 
rates, with five- and 10-year survival rates close to 90% and 83% respectively for women with 
early stage tumors (Stage I-III) (“Cancer Facts & Figures,” 2019). Of concern is that anti-cancer 
therapies can cause treatment related side effects including pain, anxiety, depression, nausea, 
sleep disturbances, cachexia, diminished functional/aerobic capacity, and cancer-related fatigue 
(CRF), ranging from mild to severe (Nyrop et al., 2019; Schmitz et al., 2010).  
 CRF is the most common patient reported side effect, as 60-90% of women with breast 
cancer report this symptom during treatment and ~20-50% report it lasting after treatment 
completion for up to 10 years (Berger et al., 2010; Bower et al., 2006; Matias et al., 2019; 
Richardson, Ream, & Wilson-Barnett, 1998). The National Comprehensive Cancer Network 
(NCCN) defines CRF as “A distressing, persistent, subjective sense of physical, emotional, 
and/or cognitive tiredness or exhaustion related to cancer and/or cancer treatment that is not 
proportional to recent activity and significantly interferes with usual functioning” (Berger et al., 
2010). A defining characteristic of CRF that distinguishes it from acute fatigue (i.e., exercise-
induced) is that it is persistent and is not alleviated by rest (Cella, Peterman, Passik, Jacobsen, & 
Breitbart, 1998; Jean-Pierre et al., 2007). CRF is also characterized as a multi-factorial symptom 
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that can limit one’s ability to complete instrumental activities of daily living (IADLs), which can 
ultimately impair quality of life (QOL) (Berger et al., 2010). Multi-factorial components of CRF 
include clinical characteristics such as treatment type and disease stage (Abrahams et al., 2016; 
Vardy et al., 2016), physical activity / overall functionality (Kessels, Husson, & van der Feltz-
Cornelis, 2018; Kneis et al., 2016), demographics such as body mass index (BMI) and age 
(Inglis et al., 2020), and psychosocial factors such as anxiety and depression (Jones et al., 2016). 
Evidence pertaining to physiological factors involved in CRF is inconsistent and is an area that 
requires further research.   
 Current evidence around the impact of exercise and physical activity for CRF 
management is promising. Exercise, specifically aerobic exercise (AE) or aerobic + resistance 
exercise (AE+RE), has been shown to be an effective treatment for alleviating CRF in cancer 
survivors, even when compared to pharmaceutical and psychological treatments (Kessels et al., 
2018; Mustian et al., 2017; Serdà I Ferrer et al., 2018). Cancer survivors that remain and/or 
become more physically active after anti-cancer therapy tend to experience milder CRF severity 
(Matias et al., 2019). In light of growing evidence that exercise can effectively manage and 
alleviate CRF across the cancer continuum, governing bodies such as the American College of 
Sports Medicine (ACSM) have published specific exercise and physical activity guidelines for 
all cancer types (Campbell et al., 2019). These guidelines are designed to not only reduce CRF, 
but also provide a comprehensive cancer rehabilitation framework for health/medical 
professionals to help guide patients towards an active lifestyle throughout the cancer continuum.  
Community-Based Exercise 
 Most of the published evidence supporting the positive influence of exercise on CRF in 
cancer survivors has been conducted in laboratory/clinic-based settings through randomized 
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controlled trials (RCTs) (Kessels et al., 2018; Mustian et al., 2017). The extent to which the 
positive effects of exercise participation on CRF translate outside of these settings has yet to be 
established. Now that exercise is well recognized as safe and effective in providing substantial 
benefits for cancer survivors (Battaglini et al., 2014; Hanson, Wagoner, Anderson, & Battaglini, 
2016; Kirkham, Bland, Sayyari, Campbell, & Davis, 2016), it is timely and important that the 
field of exercise oncology begin to scale-up and translate exercise interventions to more 
“practical” venues such as community-based settings. This is of particular importance as the 
growing number of breast cancer survivors suggests the need for exercise opportunities on a 
more broad and accessible scale.  
 Community-based exercise programs are designed to provide rehabilitation exercise 
opportunities to cancer survivors in the surrounding area at little to no cost. Examples of 
community-based programs include the Livestrong program associated with the YMCA, the 
Rocky Mountain Cancer Rehab Institute at the University of Northern Colorado, and Get Real 
and Heel at the University of North Carolina at Chapel Hill. These programs may offer AE+RE 
sessions in group formats, typically two to three days/week to assist in meeting the ACSM 
guidelines. The overall goal of community-based exercise programs is the same as 
laboratory/clinic-based settings: improve physical fitness, improve overall functionality, relieve 
the burden of treatment-related side effects, and ultimately improve QOL. However, compared to 
laboratory/clinic-based settings, community-based programs tend to be more flexible in the 
individual participant’s progression of the exercise regimen. They also provide an opportunity 
for the development of social networks among patients, allowing patients to feel a sense of 
inclusiveness with their peers who have likely undergone similar experiences. This has been 
shown to help mitigate some of the psychological anguish that is often experienced throughout 
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the cancer continuum in early breast cancer survivors (Spector, Battaglini, Alsobrooks, Owen, & 
Groff, 2012).   
 Although research regarding the impact of community-based exercise programs on the 
well-being of cancer patients is preliminary, these types of programs appear effective and 
promising. Improvements in muscular strength, balance, physical fitness and function, 
physical/emotional well-being, and body composition have all been reported in response to 
community-based exercise programs for cancer patients (Foley, Barnes, & Hasson, 2015; Grote, 
Modeste, Sealy, Dehom, & Tarleton, 2017; Knobf, Thompson, Fennie, & Erdos, 2014; Nock et 
al., 2013). Not surprisingly, these types of programs also appear effective in their ability to 
enhance the overall QOL of participating cancer survivors (Covington, Hidde, Pergolotti, & 
Leach, 2019; Foley, Hasson, & Kendall, 2018).  
With regard to CRF, the effectiveness of community-based exercise programs is mixed, 
with some suggesting effectiveness (Battaglini et al., 2006; De Jesus et al., 2017; Kirkham et al., 
2016; Leach, Danyluk, Nishimura, & Culos-Reed, 2016; Musanti, Chao, & Collins, 2019; 
Rajotte et al., 2012; Santa Mina et al., 2017) and some showing no improvement (Irwin et al., 
2017; Leach, Danyluk, Nishimura, & Culos-Reed, 2015; Loughney, Cahill, O’Malley, 
McCaffrey, & Furlong, 2019; Nock et al., 2015; Schumacher & McNiel, 2018). Many factors 
may explain these varying results including cancer type, cancer continuum (during or after 
treatment), treatment type, baseline fatigue levels, fatigue measurement, exercise regimen, and 
exercise adherence/compliance. Ultimately, the extent to which the positive impact of exercise 
on CRF translates to community-based exercise settings remains to be established. It is important 
to address this question in light of the (1) high prevalence of CRF among breast cancer survivors, 
(2) rising numbers of breast cancer survivors due to improved anti-cancer therapies, and (3) the 
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promotion of exercise as component of cancer care, which will drive the need for more 
accessible cancer exercise/rehabilitation services.  Exploring whether the positive results from 
lab/clinic-based exercise interventions on CRF translate to community-based settings and 
whether any modifications need to be made for “real world” implementation will provide a better 
overall understanding of how/why CRF develops and subsequently improves in response to 
exercise. 
 
Etiology of Cancer-Related Fatigue 
Previous research among various cancer types has shown that CRF is multi-factorial and 
associated with clinical/treatment characteristics (Nyrop et al., 2019; Thong et al., 2018) , 
psychosocial factors (Charalambous & Kouta, 2016; Iwase et al., 2015; Minton, Alexander, & 
Stone, 2012), physical activity/functional status (Kessels et al., 2018; Romero et al., 2018), and 
demographics (Huang, Zhang, Kang, Song, & Zhao, 2010; Winters-Stone, Bennett, Nail, & 
Schwartz, 2008). But, a deeper understanding of the etiology of CRF remains limited. In 
particular, the physiological mechanisms that underpin CRF are poorly understood or examined 
because it is largely measured using validated but still subjective patient-reported questionnaires 
(Minton & Stone, 2009). Proposed physiological mechanisms underlying CRF are categorized as 
manifesting from central and peripheral mechanisms (O’Higgins, Brady, O’Connor, Walsh, & 
Reilly, 2018).  
Most studies have focused on central physiological mechanisms. Specifically, 
inflammation via pro-inflammatory cytokine release resulting from both the cancer itself and its 
treatment has been linked to CRF (Bower & Lamkin, 2013). Hypo-pituitary adrenal (HPA)-axis 
dysfunction characterized by dysregulated cortisol release has been associated with CRF, as well 
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(Bower et al., 2005). In contrast, very little has been done to explore possible peripheral 
physiological mechanisms of CRF. Proposed peripheral mechanisms of CRF are often depicted 
as irregularities in the production of adenosine triphosphate (ATP → our energy currency) and 
impaired contractile properties within skeletal muscle (O’Higgins et al., 2018), both of which can 
be evaluated non-invasively through the measurement of cardiorespiratory fitness (or peak 
oxygen uptake → VO2peak) and muscular strength, respectively.   
There is preliminary evidence that lower VO2peak and muscular strength are associated 
with greater CRF severity (Adams et al., 2018; Courneya et al., 2003; Cantarero-Villanueva et 
al., 2011; Kalter et al., 2016; Kirkham et al., 2020; Morishita et al., 2018; Neefjes et al., 2017; 
Rajotte et al., 2012; Segal et al., 2009; Winters-Stone et al., 2008). Reductions in VO2peak are 
well documented across the cancer continuum in women with EBC (Jones et al., 2012) and are 
likely compounded by a decrease in physical activity due to treatment related side-effects. An 
individual’s VO2peak represents the ability to transport, consume, and utilize oxygen efficiently, 
which in turn powers aerobic metabolic pathways that produce ATP (i.e., energy). When this 
process becomes impaired, aerobic energy production capabilities decrease, which could play a 
role in feeling fatigue (i.e., tiredness, exhaustion, lack of energy). Likewise, muscular strength 
has been shown to both predict CRF and reduce CRF after an exercise intervention in EBC 
survivors; however, this evidence is not consistent and highlights the need for further 
investigation (Battaglini et al., 2006; Serra, Ryan, Ortmeyer, Addison, & Goldberg, 2018; 
Winters-Stone et al., 2008). This potential link between CRF and peripheral physiological 
outcomes warrant further exploration both independently and in conjunction with other known 
contributors of CRF to truly capture its multi-factorial nature. 
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Purpose of the Study  
 There are several well-established concepts in regard to exercise and cancer care. First, 
we know that exercise is considered safe and effective for improving both physical and 
psychological outcomes before and after anti-cancer therapy for EBC survivors (Battaglini et al., 
2014; Campbell et al., 2019; Hanson et al., 2016). Additionally, it has been proposed that 
exercise should be included as a part of standard cancer care (Schmitz et al., 2019). This would 
require medical and health professionals to provide accessible and scalable 
exercise/rehabilitation programs for patients with a variety of cancer types, disease stages, and 
other individual characteristics. To meet this demand, these programs will need to be 
community-based and/or embedded within medical health and wellness centers, making them 
both low-cost and readily accessible.   
Furthermore, we know that CRF is the top patient-reported treatment-related side effect 
among all cancer types and can persist for years after completion of anti-cancer therapy (Bower 
et al., 2006; Matias et al., 2019). We also know that CRF is debilitating, making it a major 
contributor in diminishing patients’ overall QOL and limiting their ability to complete IADLs 
throughout a day (Berger et al., 2010). And, it has been shown that exercise is superior for 
alleviating CRF both during and after anti-cancer treatment compared to other treatment options 
such as psychological interventions and pharmaceuticals (Mustian et al., 2017).  
Community-based exercise settings often involve cancer patients volunteering to 
participate as a result of their own motivation to become physically active. On the other hand, 
fatigue in itself can be a barrier for exercise participation in cancer patients (Cheifetz, Dorsay, & 
MacDermid, 2015) and may discourage them to consider community-based exercise. By 
investigating the baseline fatigue severity and its potential determinants in patients volunteering 
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for a community-based exercise program, we can gain a better understanding of the “type” of 
fatigued patient that may want to join a community-based exercise program. This information 
will allow community-based programs to tailor their messaging about the benefits of exercise on 
CRF and design exercise interventions to address different levels of CRF severity.     
Within the context of multi-factorial CRF, we also need to determine the physiological 
mechanisms that may be influencing CRF, both independently and in conjunction with other 
factors. By exploring possible physiological mechanisms of CRF both at baseline (pre-
intervention) and in response to exercise (post-intervention), this will provide insights into the 
extent to which changes in CRF are driven by a particular physiological outcome. This 
information, in turn, could lead to better tailored exercise interventions to combat CRF. Previous 
literature exploring the physiological etiology of CRF have not measured or considered a variety 
of factors that are known to influence fatigue. Also, it is important to know how and to what 
extent CRF is also driven by a patients’ physiology, functionality, and psychology.   
 This study is designed to gain a more complete understanding of CRF in a sample of 
EBC survivors within a year of completing anti-cancer therapy enrolled in a community-based 
exercise program. Specifically, we explore the following in EBC survivors as compared to non-
cancer controls: (1) baseline CRF severity level and multiple factors associated with baseline 
CRF, (2) pre-post impact of active participation in a community-based exercise program on 
managing/improving CRF, and (3) the association of pre-post intervention changes in CRF with 
factors influencing baseline CRF levels.  
Definition of Terms  
Anti-Cancer Therapy: surgery, chemotherapy, and radiation therapy  
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Breast Cancer Survivors: Women diagnosed with Stage I-III invasive breast cancer who are 
within one year of completing primary anti-cancer therapy.  
Healthy Sedentary Controls: Women without a cancer diagnosis who have participated in less 
than 2 days of physical activity for the previous 6 months.  
Community-Based Exercise: An exercise program for early breast cancer survivors conducted at 
a central facility (Get REAL and HEEL) 3 days/week, 1 hour/day consisting of aerobic and 
resistance training. 
  
Research Aims and Hypotheses  
 The purposes of this study were addressed by three Research Aims. Aim #1 is to develop 
a multi-factorial fatigue severity profile in EBC survivors in comparison to healthy controls. This 
Aim is addressed in Chapter IV. Aim #2 is to evaluate the impact of active participation in a 
community-based exercise program on CRF in EBC survivors and compared to healthy controls. 
This Aim is addressed in Chapter V. Aim #3 is to explore the associations of pre-post intervention 
changes in CRF with factors associated with pre-intervention CRF. This Aim is addressed in 
Chapter V.  
 
Research Aims  
Research Aim #1: To develop a baseline multi-factorial fatigue severity profile of early breast 
cancer (EBC) survivors enrolled in a community-based exercise program.  
Research Question 1.1: What is the baseline severity level of CRF in EBC survivors and 
healthy controls volunteering to participate in community-based exercise?  
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Hypothesis 1.1a: CRF severity level in EBC survivors will differ when compared 
to healthy controls similarly enrolled in a community-based exercise program.   
Research Question 1.2: What is the association between CRF and clinical/demographic 
characteristics in EBC survivors and healthy controls prior to community-based exercise 
participation?  
Hypothesis 1.2a: A significant association will be observed between body mass 
index (BMI) and CRF.  
Hypothesis 1.2b: A significant association will be observed between total body 
weight and CRF.  
Hypothesis 1.2c: A significant association will be observed between CRF and 
different anti-cancer therapy regimens (i.e., chemotherapy, radiation, 
chemotherapy + radiation, and surgery).   
Hypothesis 1.2d: A significant association will be observed between participant 
age and CRF. 
Research Question 1.3: What is the association between CRF and physical activity status 
/ physical function characteristics in EBC survivors and healthy controls prior to 
community-based exercise participation?  
Hypothesis 1.3a: A significant association will be observed between self-reported 
moderate to vigorous physical activity / continuous walking and CRF.  
Hypothesis 1.3b: A significant association will be observed between outcome 
expectations for exercise (OEE) and CRF.   
Hypothesis 1.3c: A significant association will be observed between objectively 
assessed dynamic balance and CRF.   
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Hypothesis 1.3d: A significant association will be observed between a six-minute 
walk test (6MWT) and CRF.  
Hypothesis 1.3e: A significant association will be observed between the ability to 
complete instrumental activities of daily living (IADL) and CRF.    
Research Question 1.4: What is the association between CRF and psychosocial outcomes 
in EBC survivors and healthy controls prior to community-based exercise participation? 
Hypothesis 1.4a: A significant association will be observed between overall 
quality of life (QOL) and CRF.   
Hypothesis 1.4b: A significant association will be observed between self-reported 
depression and CRF.   
Hypothesis 1.4c: A significant association will be observed between self-reported 
anxiety and CRF.  
Hypothesis 1.4d: A significant association will be observed between self-reported 
pain and CRF.  
Hypothesis 1.4e: A significant association will be observed between sleep quality 
and CRF.   
Hypothesis 1.4f: A significant association will be observed between perceived 
self-efficacy for fatigue self-management (PSEFSM) and CRF.   
Research Question 1.5: What is the association between CRF and physiological outcomes 
in EBC survivors and healthy controls prior to community-based exercise participation? 
Hypothesis 1.5a: A significant association will be observed between 
cardiorespiratory fitness (VO2peak) and CRF.   
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Hypothesis 1.5b: A significant association will be observed between total-body 
muscular strength (upper and lower body) and CRF.   
 
Research Aim #2: To determine the impact of community-based exercise participation 
(adherence and compliance) on CRF in EBC survivors compared to healthy controls.  
Research Question 2.1: Does CRF improve after community-based exercise participation 
in EBC survivors compared to healthy controls?  
Hypothesis 2.1a: A significant change will be observed in CRF immediately after 
participation in a community-based exercise program compared to baseline.  
Hypothesis 2.1b: A significant change will be observed in CRF six months after 
participation in a community-based exercise program compared to immediately 
post participation.  
Hypothesis 2.1b: A significant change will be observed in CRF six months after 
participation in a community-based exercise program compared to baseline.  
Research Question 2.2: What is the association between changes in CRF and active 
participation (adherence and compliance) in community-based exercise for EBC 
survivors compared to healthy controls?   
Hypothesis 2.2a: A significant association will be observed between changes in 
CRF from baseline to immediately post intervention and adherence / compliance 
rates.  
Hypothesis 2.2b: A significant association will be observed between changes in 
CRF from immediately post intervention to six months post intervention and 
adherence / compliance rates.  
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Hypothesis 2.2c: A significant association will be observed between changes in 
CRF from baseline to six months post intervention and adherence / compliance 
rates.  
Research Question 2.3: Do demographic characteristics, physical activity/functional 
outcomes, psychosocial outcomes, and physiological outcomes as identified in Aim 1 
improve after community-based exercise participation for EBC survivors compared to 
healthy controls?  
Hypothesis 2.3a: A significant change will be observed in BMI and total body 
weight immediately after participation in a community-based exercise program 
compared to baseline. 
Hypothesis 2.3b: A significant change will be observed in self-reported physical 
activity, OEE, dynamic balance, and 6MWT immediately after participation in a 
community-based exercise program compared to baseline. 
Hypothesis 2.3c: A significant change will be observed in QOL, depression, 
anxiety, pain, sleep quality, and PSEFSM immediately after participation in a 
community-based exercise program compared to baseline. 
Hypothesis 2.3d: A significant change will be observed in VO2peak and total body 
muscular strength immediately after participation in a community-based exercise 





Research Aim #3: To examine the association of pre-post intervention changes in CRF with 
changes in demographic, physical activity/functional, psychosocial, and physiological 
outcomes in EBC survivors compared healthy controls. 
Research Question 3.1: What is the association between CRF and demographic 
characteristics in EBC survivors and healthy controls post community-based exercise 
participation?  
Hypothesis 3.1a: There will be a significant association between BMI and total 
body weight with CRF post community-based exercise participation. 
Hypothesis 3.1b: There will be a significant association between changes in BMI 
and total body weight with changes in CRF post community-based exercise 
participation.   
Hypothesis 3.1c: There will be a significant association between age and CRF 
post community-based exercise participation. 
Hypothesis 3.1b: There will be a significant association between treatment type 
and CRF post community-based exercise participation.  
Research Question 3.2: What is the association between CRF and physical activity / 
functional outcomes in EBC survivors compared to healthy controls post community-
based exercise participation? 
Hypothesis 3.2a: There will be a significant association between self-reported 
physical activity, activities of daily living, OEE, dynamic balance, and 6MWT 
with CRF post community-based exercise participation. 
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Hypothesis 3.2b: There will be a significant association between changes in self-
reported physical activity, activities of daily living, OEE, dynamic balance, and 
6MWT with changes in CRF post community-based exercise participation. 
Research Question 3.3: What is the association between CRF and psychosocial outcomes 
in EBC survivors compared to healthy controls post community-based exercise 
participation? 
Hypothesis 3.3a: There will be a significant association between QOL, 
depression, anxiety, pain, sleep quality, and PSEFSM with CRF post community-
based exercise participation. 
Hypothesis 3.3b: There will be a significant association between changes in QOL, 
depression, anxiety, pain, sleep quality, and PSEFSM with changes in CRF post 
community-based exercise participation. 
Research Question 3.4: What is the association between CRF and physiological outcomes 
in EBC survivors compared to healthy controls post community-based exercise 
participation? 
Hypothesis 3.4a: There will be a significant association between VO2peak and total 
body muscular strength with CRF post community-based exercise participation. 
Hypothesis 3.4b: There will be a significant association between changes in 
VO2peak and total body muscular strength with changes in CRF post community-









CHAPTER II: REVIEW OF LITERATURE 
I. Introduction 
 The purposes of this study were to 1) develop a fatigue severity profile of CRF in EBC 
survivors prior to participating in a community-based exercise program, 2) determine the impact 
of a community-based exercise program on alleviating CRF in EBC survivors, and 3) report on a 
preliminary investigation designed to identify potential physiological, psychological, and 
functional determinants of CRF in EBC survivors. The following literature review begins with a 
general discussion about cancer and breast cancer specific prevalence in the United States as well 
as a general discussion of the pathophysiological development of cancer and the protective role 
of exercise. The review then shifts focus to discussing CRF by addressing its different 
definitions, its impact of on the QOL of cancer patients, and the different validated 
questionnaires in which it is measured. Section IV of the review will focus on the impact of 
exercise on CRF. This section will range in topics as it provides information the impact of non-
traditional exercise, aerobic exercise, resistance exercise, aerobic + resistance exercise, and 
community-based exercise programs on their ability to mitigate CRF. Section V will focus on the 
multi-factorial nature of CRF as it discusses the various factors that have been hypothesized to 
be related to CRF up until now. Lastly, the literature review concludes with a brief discussion 
synthesizing what we know currently know and how this project will provide valuable insight in 




II. Cancer Overview and the Protective Role of Exercise  
Cancer Prevalence and Development  
Second to cardiovascular disease, cancer is a leading cause of death in the United States 
with an estimated 1.7 million new diagnoses and an estimated 609,000 deaths with the majority 
occurring in older individuals (> 55 years) (“Cancer Facts & Figures,” 2019). Many cancers can 
be prevented by undergoing behavior modification (smoking cessation, increasing physical 
activity, reducing alcohol consumption) and participating in annual screenings for certain cancers 
such as colorectal, cervical cancer, and mammograms for breast cancer, all of which can detect 
lesions that are not considered cancerous. In addition to physical health issues, a cancer diagnosis 
also comes with its own financial burdens. It is estimated that close to $80.2 billion in expenses 
accrues from direct medical costs (“Medical Expenditure Panel Survey,” 2019). Overall survival 
rates of cancer have improved, which can be attributed to better targeted therapies as well as 
improved surveillance methods.   
Cancer is characterized as uncontrolled proliferation and spread of abnormal cells. This 
dysregulation in the cell cycle has been thought to be brought about and enhanced by multiple 
pathobiological mechanisms, also known as the “Hallmarks of Cancer” (Hanahan & Weinberg, 
2011). The Hallmarks describe the multistep process of cellular irregularities that must occur in 
order for a malignant phenotype to develop. It includes the following biological processes: 
Sustained Proliferative Signaling, Evasion of Growth Suppressors; Evasion of Apoptosis, 
Limitless Proliferative Capacity, Sustained Angiogenesis, Tissue Invasion and Metastasis, 
Deregulation of Cellular Energetics, Avoidance of Immune Destruction, Genome Instability, and 
Tumor Promoting Inflammation. A general overview of each will be provided for the purposes 
of this literature review.  
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Hallmarks of Cancer  
Sustained Proliferative Signaling 
 Oncogenes are mutations that arise in one or both alleles of a given gene. They gain 
function of a protein that contributes to cancer development by inducing excessive cell 
proliferation. This type of cell proliferation can be accomplished by multiple cellular 
mechanisms. Once produced, cancer cells have the ability generate growth factor ligands or 
stimulate normal cells within the tumor stroma to produce growth factor ligands, which can in 
turn increase cell proliferation (Bhowmick, Neilson, & Moses, 2004; Cheng, Chytil, Moses, Joly, 
& Shyr, 2008). Additionally, oncogenes work to disrupt negative feedback mechanisms that play 
crucial roles in regulating the cell cycle (Hanahan & Weinberg, 2011). Without feedback control, 
cell division becomes unregulated leading to sustained proliferative signaling. 
 
Evasion of Growth Suppressors  
 Tumor suppressor genes that help to regulate cell proliferation become inactivated via 
point mutations and regional chromosomal deletion. When this occurs, cell proliferation can 
occur uncontrollably. The p53 gene is a powerful tumor suppressor as it helps to regulate the cell 
cycle, and it has the ability trigger apoptosis (cell death). When p53 becomes mutated, its ability 
to carry out these important regulatory roles becomes inhibited resulting in uncontrolled cell 







Evasion of Apoptosis  
  Programmed cell death (apoptosis) is the body’s natural defense against the development 
of cancer, and its impairment leads to tumorigenesis (Lowe, Cepero, & Evan, 2004). Activation 
of oncogenes, mutations in tumor suppressors such as p53 described above, and impairment of 
signaling pathways leads to a dysregulation of apoptosis (Wong, 2011).  As a result, a crucial 
defense against cancer becomes inactivated, allowing for cell proliferation and tumorigenesis as 
the cancerous cells cannot be killed.  
 
Limitless Proliferative Capacity  
 Normal cells have only a certain capacity to proliferate. Once this capacity is met, cell 
senescence and/or apoptosis occurs in the absence of telomerase expression. This limited 
proliferative capacity is attributed to chromosomal telomere shortening. With each cell cycle, 
chromosomal telomere length will shorten, reaching a point where telomeres can no longer 
protect the chromosome and cell senescence and/or apoptosis takes place. In cancer cells, 
inactivation of tumor suppressors such as p53 and retinoblastoma (RB) can significantly extend 
replicative lifespans. Additionally, the uncontrolled activation of telomerase can lead to 
immortalized proliferative capacity as it adds to the telomere length and is associated with 
evasion of apoptosis and cell senescence. As a result, cells will continue to proliferate, 
contributing the malignant progression.  
 
Sustained Angiogenesis  
 Though cancerous, malignant tumors function much like normal tissues in the human 
body in that they require nutrients, oxygen, and the ability to rid metabolic waste (i.e., carbon 
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dioxide). In order to do so, tumors develop the ability to induce and sustain angiogenesis, 
allowing it to thrive and grow. In malignant tumors, pro-angiogenic factors, such as vascular 
endothelial growth factor (VEGF), are activated and induce the growth of blood vessels. The 
vasculature that develops within the tumor is abnormal compared to normal tissue, causing parts 
of the tumor to become hypoxic. Due to the abnormal vasculature, tumors will metabolically 
adapt (discussed in deregulation of cellular energetics) to the hypoxic environment. Tumors 
further sustain angiogenesis by becoming resistant to anti-angiogenic therapy, which allows it to 
obtain the blood flow that it requires. 
   
Tissue Invasion and Metastasis  
 Tissue invasion and metastasis are a result of increased migration of cancer cells. 
Increased migration, a crucial step in metastasis, is a consequence of both changes in structural 
proteins and signal enzymes that alters interactions in the extra-cellular matrix. This process is 
characterized by the initial developing tumor undergoing an invasion of the tissue it was formed 
in. Associated cancer cells can enter circulation and be taken up by other organ sites where 
micrometastasis and metastatic colonization can occur, which results in the development of 
macroscopic metastases in other organs (Valastyan & Weinberg, 2011).  
  
Deregulation of Cellular Energetics  
 For normal cells, energy metabolism involves both the production of adenosine 
triphosphate (ATP) via oxidative and non-oxidative metabolic pathways by predominantly 
metabolizing glucose and lipids. These pathways involve glycolysis in the cytosol and oxidative 
phosphorylation in the mitochondria (Krebs Cycle, Electron Transport Chain, etc.). In normal 
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cells under resting conditions, pyruvate formed from glycolysis would be taken to the 
mitochondria for further production of ATP (being converted to Acetyl-CoA and entered into the 
Krebs Cycle). Interestingly, a characteristic of a cancer is that even in the presence of oxygen, 
tumor cells favor glycolysis, termed the “Warburg Effect”. Comparatively to normal cells, 
tumor/cancer cells favoring glycolysis is less efficient for the production of ATP. Cancer cells 
attempt to “make-up” for this inefficiency by up-regulating GLUT-transport proteins (i.e., 
GLUT1).  This favoring of glycolysis is also beneficial for cancerous tumors as they are 
relatively hypoxic (as described above), resulting in little oxygen availability for the production 
of ATP. Despite the inefficiency, the deregulation of metabolism that occurs in cancer cells helps 
to fuel cell growth and division. 
  
Avoidance of Immune Destruction  
 Cancer develops at a higher frequency in immunocompromised mice, revealing that the 
immune system does indeed work to suppress cancer development (Shankaran et al., 2001). 
When a cancer antigen presents itself, lymph nodes will activate the release of T-cells which are 
then circulated to tumor sites. T-cells are then infiltrated into the tumor and work to kill cancer 
cells. Interestingly, only after the initial attack on cancer cells from T-cells does the cancer begin 
to adapt to avoid immune destruction. After the elimination of cancer cells, a “equilibrium” is 
reached, which signals to the immune system to no longer attack as it senses it has killed all 
cancer cells. In reality, cancer cells (minimal number of cells) that the immune system failed to 
kill remain in the tumor. The malignant cells that remain can begin to have an 
immunosuppressive cytokine response, suppressing T-cell activation and exhausting the T-cells 
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that had been designated to kill said cells. This results in the continued cell proliferation of 
cancer cells.   
 
Breast Cancer Prevalence and Overview   
Prevalence regarding breast cancer follow a similar trend to the general cancer statistics. 
From 2006 to 2015, breast cancer incidence increased by 0.4%, with close to 268,600 new cases 
expected to occur in 2019 and about 42,000 deaths, making it the most commonly diagnosed 
cancer in females (“Cancer Facts & Figures,” 2019). Of importance, mortality rates from breast 
cancer have declined by almost 40% from 1989 (33% mortality rate) to 2016 (20% mortality 
rate) (“Cancer Facts & Figures,” 2019). Knowing more patients are surviving from breast cancer, 
as expected, five (90%) and 10 (83%) year survival rates have increased as well (“Cancer Facts 
& Figures,” 2019). Despite the improved survival rates, many breast cancer survivors (BCS) still 
continue to experience treatment-related side effects ranging from pain, nausea, anxiety, 
depression, cachexia, and cancer-related fatigue (CRF), all of which have been suggested to be 
alleviated with physical activity (Nyrop et al., 2019; Schmitz et al., 2010). Though all are their 
separate entity, many of these side effects work together to impair the patient’s quality of life 
(QOL) and decrease physical activity levels, which can lead to further complications even as the 
cancer has fully receded. 
 Breast cancer development has been linked to risk factors such as age, race, obesity, 
genetics (BRCA 1 & 2), and radiation exposure (Kelsey, 1979; McPherson, Steel, & Dixon, 
2000). It is characterized as uncontrolled cell proliferation in the milk producing ducts (invasive 
ductal carcinoma) or the glandular tissue (lobules – invasive lobular carcinoma) of the breast 
tissue. As the cancer cells are produced, palpable masses on the breast emerge, forming tumors 
 23 
 
that are then staged. Tumors that are confined to breast tissue fall within the stages of 0-III.  
Metastatic breast cancer (Stage IV) occurs when breast cancer cells invade surrounding tissues 
and even leave the breast tissue, forming tumors in other parts the body (lungs, liver, brain, etc.). 
This particular stage of breast cancer is considered to have the most diminishing prognosis.  
 
Breast Cancer Staging 
A breast cancer diagnosis can be determined through imaging involving mammograms, 
ultrasound scans, and biopsies. These imaging techniques provide information on tumor size and 
subsequent lymph node involvement as well as cellular composition. In turn, oncologists are able 
to stage the tumor. Staging requires assigning a number of 0-IV. Generally, the larger the tumor 
and subsequent invasion of surrounding lymph nodes and tissues, the greater the tumor stage.  
 Stage 0 breast cancer involves ductal and lobular carcinoma. Both carcinomas are non-
invasive and are considered in-situ. Stage I indicates that cancer cells are present and that the 
cancer cells are contained in the region where the original cells began to develop. Stage II is still 
contained in the breast. However, there is evidence that the disease has begun to grow and 
spread. Stage III breast cancer is diagnosed when there is definite lymph node involvement. 
Stage IV is considered metastatic breast cancer as at this point, the cancer has spread to other 
organs in the body (brain, bone, lungs, etc.). This final stage of breast cancer is considered 
incurable.   
    
Membrane Receptors and Genetic Predisposition  
Both healthy and cancer cells possess surface receptors that are activated by specific 
hormones and cytokines. These receptors activate pathways within the cell that allow the cell to 
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survive and proliferate. In the context of cancer cells, receptor positive tumors possess many 
sites for a specific receptor. When stimulated, the excessive cell proliferation leads to further 
tumor progression. To combat this, cancer treatments have been developed that can inhibit the 
lock and key mechanism for specific receptors, prohibiting signal pathways that allow the cell to 
survive, ultimately resulting in cell death (apoptosis).  
 Specific to breast cancer, human epidermal growth factor receptor 2 (HER2) (a cell 
surface protein), estrogen (ER), and progesterone (PR) are commonly overexpressed hormone 
receptors that are able to activate pathways in breast cancer cells that allow for cell survival and 
proliferation. Better treatment prognostic value is given to tumors that are characterized as 
hormone receptor positive (HR+). These tumors are either ER+, PR+, or both. For tumors that 
are HR-, treatment options are limited due to the lack of hormone receptors. This can increase 
the chances of treatment resistance and in some cases, metastasis. HR+ tumors occur in about 
70% of all breast cancer diagnoses and are more common in post-menopausal women (Bentzon, 
During, Rasmussen, Mouridsen, & Kroman, 2008). Tumors that are HER2+ (overexpression of 
HER2 cell surface proteins) are able to activate signaling pathways that are able to induce 
proliferation and cell survival. Overall, close to the 30% of breast cancer tumors express HER2+ 
and tend to possess a more aggressive phenotype, resulting in a greater challenge to treat 
(Zeglinski, Ludke, Jassal, & Singal, 2011).    
Genetic mutations that greatly increase risk for breast cancer are those that come in the 
form of BRCA1 and BRCA2. Similar to other common tumor suppressor gene mutations (such 
as p53), their genetic mutation impedes the ability of the gene to control cellular growth and 
proliferation, leading to the development of breast cancer. Females that have inherited the 
genetic mutations incur a lifetime risk of breast cancer development at around 50-85% (King, 
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Marks, & Mandell, 2003). Other genetic mutations that can either regulate or interact with 
BRCA1 and BRCA2 mutations to increase the risk of breast cancer development include 
CHEK2, BRIP1, ATM, and PALB2 (Shiovitz & Korde, 2015). Those with family history of 
BRCA1 and 2 mutations can be genetically tested to check for genetic predisposition for breast 
cancer.  
 
Breast Cancer Treatment  
Treatment options for breast cancer diagnoses include the following: surgery, 
chemotherapy, radiation, hormonal therapy, and targeted therapies. Due to improved detection 
strategies and improvements in systemic therapies, overall survival rates have increased 
significantly for breast cancer patients (Patnaik, Byers, DiGuiseppi, Dabelea, & Denberg, 2011). 
The decision to utilize one treatment option over the other, a combination of different treatments, 
and/or the timing for implementing different treatments is dependent on tumor characteristics 
that dictate its staging. Generally, timing of treatment is categorized based on if it took place 
prior to (neoadjuvant) or after (adjuvant) surgical resection. The goal of both is to ultimately rid 
the body of cancer cells. However, neoadjuvant therapy has a goal to primarily shrink the tumor 
prior to surgery whereas adjuvant therapy primarily works to destroy cancer cells that migrated 
from the tumor site. Additionally, therapeutic options for breast cancer can be categorized as 
local therapies (surgery and radiation) and systemic therapies (chemotherapy, targeted therapy, 
and hormonal therapy). 
Surgery, a local therapy, is implemented to remove a tumor from the surrounding breast 
tissue. Occasionally, surgery might be the only treatment that is required for breast cancer. More 
often, surgical removal of the tumor and surrounding lymph nodes assists in evaluation tumor 
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grade/staging and cancer cell migration, providing information for further treatment 
options/decisions. Surgical options include mastectomies and lumpectomies. A full mastectomy 
involves removing the entire tumor as well as the entirety of the affected breast. Lumpectomies 
only remove the tumor and marginal healthy breast tissue, leaving the majority of breast intact.   
Radiation treatment utilizes high energy rays to kill cancer cells which results in stoppage 
in the formation of new cancer cells. It is always completed in the adjuvant setting (after surgery) 
and sometimes after chemotherapy. Radiation treatment can be completed in the form of external 
beam radiotherapy (radiation directed at the tumor from outside the body), particle therapy 
(carbon ions and protons are used to directly impact the tumor, preserving surrounding tissue), 
brachytherapy (small radioactive particles are placed next to the tumor), and radioisotopes 
(ingestion of radioisotopes that are unstable and produce high energy rays).  It is common to 
have the whole breast irradiated, but localized radiation is being developed to better target 
specific areas on the breast that might possess cancer cells that have not spread to the lymph 
nodes.   
Chemotherapy, one form of systemic therapy, is given orally (pill) or intravenously and is 
the most common treatment for a variety of cancers, improving both survival and recurrence 
rates (Peto et al., 2012). Its works by circulating throughout the body to destroy undetected 
cancer cells that may have migrated from the primary tumor site. Common chemotherapy drugs 
include anthracyclines, taxanes, and carboplatin. It is common for these drugs to be given in 
“cycles”. Cycles are typically two to three weeks in length with the drug administered either 
once or multiple times (depending on the drug used) followed by a rest period to allow the 
patient to recover from treatment related side-effects. An entire chemotherapy regimen can last 
anywhere from three to six months on average.   
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Hormonal therapy is another type of systemic therapy that is utilized for breast cancer 
patients that are diagnosed as HR+ (ER+ and/or PR+). A commonly used drug is Tamoxifen. 
Tamoxifen works to block the hormone estrogen or progesterone from binding with its receptor. 
This in turn helps reduce cellular proliferation and tumor progression. In women who are pre-
menopausal, aromatase inhibitors can be used to control cancer progression. Aromatase 
inhibitors inhibit the enzyme that is necessary for producing estrogen. As a result, less estrogen 
is produced, aiding in the control of HR+ tumors.   
Targeted therapies are used for treatments in primary and metastatic HER2+ tumors. 
Different from other systemic therapies (chemotherapy and hormonal therapy) that circulate 
throughout the body, targeted therapies act directly on receptors of the cancer cell to disrupt 
signal pathways that control proliferation. This results in reduced HER2+ tumor progression. 
Examples of target therapies for breast cancer that specifically target human epidermal growth 
factor receptors include trastuzumab and pertuzumab.   
 
Protective Role of Exercise Against Cancer  
To date, the majority of evidence linking exercise and physical activity with cancer 
prevention has been studied in colon cancer, breast cancer, and prostate cancer. However, it 
should be noted that evidence for other cancer sites has emerged (primarily endometrial and lung 
cancer), but the biological mechanisms preventing cancer due to exercise in these other sites is 
not as established as the three listed above. The following cancer sites have significant risk 
reduction rates of a cancer diagnosis when considering greater physical activity levels: colon 
(40-70%); breast (30-40%); prostate (10-30%); endometrial (30-40%); and lung (30-40%) 
(Friedenreich & Orenstein, 2002; Hidayat, Zhou, & Shi, 2020). When considering how exercise 
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specifically interacts with the hallmarks of cancer, the initial evidence is promising (Ruiz-Casado 
et al., 2017). However, this evidence is preliminary and primarily studied in the context of 
animal models. The following biological mechanisms linking the protective effects of exercise 
against cancer are primarily summarized from the Friedenreich and Orenstein (2002) review 
article.  
Exercise appears to reduce chances of colon cancer due to improved gut motility, a 
decrease in bile acid (those who are more active contain overall less bile acid), and decreased 
ratio of prostaglandins. Generally, physical activity reduces mucosal exposure time to 
carcinogens due to decreased transit time through the colon. Additionally, those who exercise 
experience an increase in prostaglandin F (PG-F), which inhibits colonic cell proliferation. 
Similarly, more active individuals will increase their gut motility (as described above) in the 
absence of an increase in PGE2, which promotes colonic cell proliferation. 
For breast cancer, physically active individuals will experience a decrease in their 
lifetime exposure to estrogen. Exercise delays menarche, reduces the number of ovulatory 
cycles, and reduces the overall production of estrogen from the ovaries. Additionally, being 
physically active can result in a decreased body fat percentage (BF%), further limiting fat-
produced estrogen and overall exposure. Exercise also induces the secretion of sex hormone 
binding globulin, which reduces active forms of estrogen. In regard to prostate cancer, sex 
hormone binding globulin that is secreted as a result of exercise reduces the amount of active 
testosterone. 
Besides active individuals being genetically predisposed to a cancer diagnosis, being 
physically active reduces the chances of cancer through a variety of mechanisms for all cancer 
sites. A reduction in body fat as a result of exercise may help to prevent other cancer diagnoses 
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due to less carcinogenic agents being able to be stored in visceral fat. In overweight individuals, 
these carcinogens can be released, making a cancer diagnosis more probable. Tumor immune 
defenses and antioxidant defenses improve as well. Exercise results in an increase in 
macrophages, natural killer cells, and cytokines, which improves the body’s ability to protect 
against tumor formation. Persistent exercise participation results in improved free radical defense 
systems through antioxidant properties. Lastly, exercise can reduce levels of insulin and insulin-
like growth factors (IGF-1), both of which help to promote cellular proliferation. 
More recent reports indicate that exercise may interfere with signaling pathways that help 
to promote tumor growth (Hojman, Gehl, Christensen, & Pedersen, 2018). Of particular interest 
is the Hippo-Signaling Pathway that functions to promote both organ and tumor formation. 
Specifically, through the exercise induced release in epinephrine, it is believed that this signaling 
pathway may be disrupted, assisting in the prevention of tumor growth. Furthermore, when one 
exercises, active tissues require substrates in order to make ATP. It’s believed that exercise may 
limit substrate availability to tumor microenvironments, resulting in tumor starvation as it is not 
receiving the necessary nutrients to continue cellular proliferation. Lastly, it was suggested that 
there is a link between lactate and tumor formation. Lactate is thought to suppress T-cells. 
However, with exercise training, the enzyme lactate dehydrogenase (LDH) is less active, likely 
due to exercise adaptations that favor aerobic metabolism. The reduction in overall lactate was 
suggested to improve the immune profile of the tumor, allowing for more T-cells to attack the 
presented antigen. This would link with potentially preventing a cancer hallmark (Avoidance of 
Immune Detection) as more T-cells are able to infiltrate and kill off cancer cells.  
Furthermore, Hojman et al (2018) has promoted the idea of tumor organ crosstalk, which 
primarily deals with the immunological profile of the tumor. Specifically, epinephrine secretion 
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results in the increased release of natural killer cells. More natural killer cells would result in an 
increased defense against tumor formation. Given that epinephrine secretion occurs with any 
exercise bout, it is assumed that its immunological effects could be used in cancer prevention. 
Additionally, the increase in body temperature that is often observed during exercise, which 
results in vasodilation of certain vessels, was thought to increase immune cell trafficking, 
allowing more immune cells to attack an antigen. With respect to acute vs chronic exercise 
training, it would appear that these mechanisms are shown to occur more so in response to acute 
bouts of exercise, and the cumulative impact of repeated exercise bouts may play a role in 
reducing breast cancer viability (Dethlefsen et al., 2016; Dethlefsen, Pedersen, & Hojman, 2017). 
This provides valuable evidence for continuing to promote exercise as a part of standard cancer 
care, as its protective effects can specifically impact the viability to breast cancer cells, further 




III. Cancer-Related Fatigue  
Despite the improvements in cancer therapies in their ability to cure a breast cancer 
diagnosis and/or prolong life with a diagnosis, many patients (including those diagnoses other 
than breast cancer) will experience treatment-related side effects. Severe side effects can result in 
delayed treatment or dose reductions and possibly discontinuing treatment completely in order to 
allow for adequate recovery. Side effects of treatment can include nausea, vomiting, diminished 
quality of life, increased anxiety and depression, impaired cognitive function, peripheral 
neuropathy, balance decrements, insomnia, lymphedema, increase in CRF, and development of 
various cardiotoxicities (Armenian et al., 2017; Barsevick et al., 2013; Hayes, Rye, Battistutta, & 
Newman, 2010; Kim, Barsevick, Tulman, & McDermott, 2008; Kim et al., 2008; Kneis et al., 
2016; Nyrop et al., 2019). Over time, treatment-related side effects do eventually subside. 
However, certain side effects can persist past treatment for years.  
 CRF can develop during breast cancer treatment and continue to impact patient lives after 
treatment has concluded. It is the top patient reported treatment related side effect with 15-90% 
of patients reporting some severity and duration of fatigue (Barsevick et al., 2013). CRF can 
persist from four to 10 years after treatment has been completed and is experienced by ~50% of 
breast cancer survivors (Bower et al., 2006; Ganz & Bower, 2007; Minton & Stone, 2008). It is a 
debilitating symptom that can significantly impair quality of life and the ability to carry out 
activities of daily living (ADLs) (Jones et al., 2016). Characteristics of CRF are similar to those 
experiencing chronic fatigue syndrome and “sickness behavior”, with the primary difference 
being that CRF is primarily developed through cancer-related treatment in addition to the disease 
itself. Further, CRF is associated with other patient reported treatment related side effects such as 
depression, pain, and sleep disturbance (Bower et al., 2000; Weber & O’Brien, 2017). 
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Definitions and Considerations  
 CRF can be defined in multiple ways which can influence how it is assessed, interpreted, 
and treated. The European Association of Palliative care defines CRF as “a subjective feeling of 
tiredness, weakness, or lack of energy” (Radbruch et al., 2008). The most widely accepted 
definition of CRF is that put forth by the National Comprehensive Cancer Network (NCCN): “A 
distressing, persistent, subjective sense of physical, emotional, and/or cognitive tiredness or 
exhaustion related to cancer and/or cancer treatment that is not proportional to recent activity and 
significantly interferes with usual functioning” (Berger et al., 2010). Though not included in 
either definition listed above, a defining characteristic of CRF is that it continues to persist and is 
not alleviated by rest (Cella et al., 1998; Jean-Pierre et al., 2007).  
Regardless of definition used, it is clear that CRF is a multifactorial symptom that can 
significantly impact everyday life. There is a strong connection between experiencing CRF and 
having a diminished QOL (Charalambous & Kouta, 2016; Gupta, Lis, & Grutsch, 2007). This 
relationship also exists in the context of exercise; where CRF improves in response to exercise, it 
is not uncommon to also observe subsequent improvements in patients’ health related QOL 
(Steindorf et al., 2014; Yang & Wang, 2017). Additionally, CRF is implicated as being 
unfavorable for performance status, overall functionality, and the ability of patients to complete 
independent activities of daily living (Hofman, Ryan, Figueroa-Moseley, Jean-Pierre, & 
Morrow, 2007; Morrow, 2007; Purcell et al., 2010). This in itself can limit productivity and have 
a negative influence on QOL as frustration can build due the inability to complete certain tasks, 
furthering the development of psychological distress. Being driven by psychological, 
physiological, behavioral, and disease-related factors that can ultimately result in diminishing a 
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patient’s QOL and inability to carry out ADLs, more research on this debilitating symptom is 
imperative (Barsevick et al., 2013; Jones et al., 2016). 
  CRF can be evaluated based on severity and treatment type (Piper & Cella, 2010). 
Severity of CRF can be dependent upon the measurement scale used. For instance, the NCCN 
recommends the use of a 0 to 10 scale (0 = no fatigue; 10 = worst fatigue). Within the scale, 
patients can be stratified based on severity ratings of CRF in the following manner: 0 = none; 1 
to 3 = mild CRF; 4 to 6 = moderate CRF; 7 to 10 = severe CRF (Berger et al., 2010). Cut-off 
scores are also used to interpret CRF severity. The Functional Assessment of Cancer Illness 
Therapy – Fatigue (FACIT-F) measurement runs on a scale of 0-52, (0 = worst fatigue; 52 = no 
fatigue) and a score of 30 is deemed clinically significant CRF (Cella, Lai, Chang, Peterman, & 
Slavin, 2002).  
Furthermore, baseline severity scores have been shown to be predictive of CRF severity 
across treatment timelines in that those beginning treatment with severe fatigue (i.e., score of 30 
or below on FACIT-F) tend to experience greater fatigue throughout the treatment regimen 
(Berger et al., 2010; Hofman et al., 2007; Wielgus, Berger, & Hertzog, 2009). When considering 
interventions aimed at alleviating CRF, statistical and clinically significant improvements should 
be reported to determine intervention effectiveness. Though no “gold-standard” methodology has 
been established for clinical significance in terms of changes in CRF, it is suggested population 
characteristics be considered (i.e., cancer treatment and cancer type) (Revicki, Hays, Cella, & 
Sloan, 2008).  
 CRF should also be considered in the context of treatment type. During chemotherapy, 
80-90% of patients will report having experienced some degree of CRF; however, this is 
dependent on the different chemotherapy agents, the frequency of treatment, and the prescribed 
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dosage (Nyrop et al., 2019; Richardson et al., 1998). More recently, CRF in breast cancer 
patients appears to increase across chemotherapeutic treatments, regardless of the prescribed 
regimen (Berger, Lockhart, & Agrawal, 2009). In regard to radiation therapy, around 70% of 
patients will report increasing levels of fatigue throughout treatment, which typically last 4 to 6 
weeks (Berger et al., 2010). CRF, as one can see, is not a simple patient-reported outcome. It is a 
very complex symptom, one that is difficult to define, classify, and understand. Adding to this 
complexity are the various measurement scales that are used to assess CRF, all of which either 
take a unidimensional or multidimensional approach.  
  
Measurements of Cancer-Related Fatigue  
The lack of consensus on the definition of CRF has led to the development and validation 
of a variety of different measurement scales. The measurements can be deemed either 
unidimensional or multidimensional. Unidimensional CRF scales will focus on physical fatigue 
whereas multidimensional scales will focus on 2 to 5 sub-domains of CRF (Minton & Stone, 
2009). Sub-domains of CRF often assessed in multidimensional scale include physical fatigue, 
affective fatigue, sensory fatigue, cognitive fatigue, and severity of fatigue. Unidimensional 
measurement scales are most widely used and recommended due to their established validity 
when compared to multidimensional scales. When selecting a measurement scale to assess CRF 
in a cancer population, the following issues/criteria should be considered: (1) is fatigue actually 
being experienced; (2) what time frame does the selected measure cover (i.e., 24 hours, previous 
week, etc.); (3) psychometric properties; and (4) do the domains assessed, unidimensional or 
multidimensional, adequately answer the proposed research question. Descriptions of different 
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unidimensional and multidimensional validated scales for the purposes of assessing CRF are 
provided below.  
 
Unidimensional Measurement Scales  
Brief Fatigue Inventory (BFI)  
 The BFI is used to assess the impact of CRF on daily functioning within the past 24 hours 
via a 9-item scale. Each item is rated on a 0 to 10 scale (0 = no fatigue; 10 = as bad as you can 
imagine), and a global fatigue score can be obtained by computing the average of all items. 
Psychometric properties of the BFI have been shown to be reliable in mixed cancer populations 
with the Cronbach alpha statistic ranging from 0.82 to 0.97 (Mendoza et al., 1999).  
 
European Organization for Research and Treatment of Cancer Quality of Life Questionnaire 
(EORTC QLQ C30)  
 The EORTC QLQ C30 is primarily used as a global QOL measure (all 30 items). The 
measurement does possess a fatigue subscale consisting of 3 items that has consistently been 
used as an independent measure (Aaronson et al., 1993). The fatigue subscale has been validated 
in both cancer patients receiving treatment and cancer survivors (Knobel et al., 2003; Storey et 
al., 2007). Scoring the fatigue subscale on the EORTC QLQ C30 requires the average of the 3 
items and the following additional calculations: (Average Score – 1) * 100. Higher scores are 






Functional Assessment of Cancer Illness Therapy (FACIT-F)  
The FACIT-F utilizes a unidimensional 13-item questionnaire to assess tumor specific 
fatigue, with each item on a 5-point Likert-type scale (0=not at all, 1=a little bit, 2=somewhat, 3= 
quite a bit, 4=very much) (Cella et al., 2002). The questionnaire covers a patient’s subjective 
analysis of fatigue over the previous 7 days. For analysis, each item is summed (2 are reverse 
scored) and then multiplied by 13 and then divided by the number of items answered. Significant 
fatigue is considered a score of 36 within the 0 to 52 scale (lower scores = greater fatigue). 
 
Profile of Mood States (POMS)  
 The POMS measurement contains a fatigue subscale consisting seven items. Each item is 
on a 5-point scale (0 = Not at All; 1 = A Little; 2 = Moderately; 3 = Quite a Bit; 4 = Extremely). 
The fatigue subscale ranges from 0 to 28 with higher scores indicating greater fatigue. The 
assessment has been validated for use in cancer populations and also contains a defined minimal 
clinically significant change when used before and after an intervention (Meek et al., 2000; 
Schwartz et al., 2002).  
 
Patient Reported Outcome Measurement Information System – Fatigue (PROMIS-F)  
 The PROMIS-F assesses the frequency of experienced fatigue within the past seven days 
on a 7-itme scale. Items are measured on a 5-point Likert type scale (1 = never, 5= always) and 
summed (though the last item is reverse scored) with higher scores indicating greater fatigue. 
The PROMIS-F has been validated in cancer populations as well as other chronic conditions 




Multidimensional Measurement Scales  
Chalder Fatigue Scale (CFS)  
 The CFS is an 11-item fatigue scale that is measured on a 0 to 3 Likert-type scale (0 = 
less than usual; 1 = no more than usual; 2 = more than usual; 3 = much more than usual). Scores 
range from 0 to 33 with higher scores indicating greater fatigue. The CFS has been primarily 
utilized in the general population and those suffering from chronic fatigue syndrome, which in 
turn supplies normative data when used in cancer populations (Cella & Chalder, 2010; Chalder et 
al., 1993). 
 
Fatigue Symptom Inventory (FSI)  
 The FSI is validated in mixed cancer populations but has been limited to those 
participating in active treatment or survivors (Hann, Denniston, & Baker, 2000; Hann et al., 
1998). The assessment consists of 13 separate items that are on a 11-point Likert-type scale. The 
FSI is designed to assess fatigue severity, frequency, and interference with daily functioning.  A 
global score of fatigue can be calculated by summing each item together with higher scores 
indicating greater experiences of fatigue.  
 
Revised Piper Fatigue Scale (PFS-R)  
 The revised PFS is a 22-item measurement tool assessing cancer-related fatigue on a 0 to 
10 Likert-type scale that has been validated in those with a diagnosis of breast cancer (Piper et 
al., 1998). The questionnaire is a multidimensional tool of CRF as it assesses behavioral/severity 
of fatigue (items 2-7), affective meaning of fatigue (items 8-12), sensory fatigue (items 13-17), 
and cognitive/mood influence of fatigue (items 18-23) to make up the 22-item scale. Items #1 
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and 24-27 provide a qualitative analysis of cancer-related fatigue. An overall fatigue score is 
calculated by summing each sub scale and dividing the total sum by the number of items (i.e., 22 
items). The final score will be in between 0 and 10. Fatigue severity is classified as follows: 
0=none; 1-3=mild; 4-6=moderate; 7-10=severe. 
 
Schwartz Cancer Fatigue Scale  
 The Schwartz Cancer Fatigue Scale is a 28-item assessment that is validated in 
multiple/mixed cancer populations and has an established minimal clinically significant 
difference (Meek et al., 2000; Schwartz, 1998; Schwartz et al., 2002). The assessment items are 
scored on a 1 to 5 Likert-Type scale and covers fatigue experienced over the previous 2 to 3 
days. Fatigue scores are calculated by summing all items together with higher scores indicating 
greater fatigue.  
 
Multidimensional Fatigue Inventory (MFI-20)  
 The MFI-20 is a 20-item measurement that is designed and validated in its ability to 
assess fatigue specifically for cancer patients (Smets, Garssen, Cull, & de Haes, 1996). The scale 
gauges general, physical, and mental fatigue. Each item is rated on a 7-point Likert-type scale 
with some items being reverse scored. Once calculated, a higher total score will correspond with 
greater levels of acute experiences of fatigue.  
 
Multidimensional Fatigue Symptom Inventory Short Form (MFSI-30) 
 The MFSI-30 is a 30-item scale designed to assess fatigue in cancer patients. 
Specifically, it is able to derive a general fatigue score as well as assess physical fatigue, 
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emotional fatigue, mental fatigue, and vigor. Each item is scored from 0 to 4 on a Likert-type 
scale (0 = Not at all; 1 = A little; 2 = Moderately; 3 = Quite a bit; 4 = Extremely). A total score is 
derived from the following formula: Total Score = (General Fatigue + Physical Fatigue + 
Emotional Fatigue + Mental Fatigue) – Vigor. Higher scores are an indication of more fatigue. It 
has been validated in both breast cancer patients alone and mixed cancer populations (Stein, 
Martin, Hann, & Jacobsen, 1998; Stein, Jacobsen, Blanchard, & Thors, 2004). 
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IV. The Impact of Exercise on Cancer-Related Fatigue  
The relationship between physical activity / exercise and CRF severity has been well-
researched over the years. Simply participating in physical activity (active lifestyle, walking, 
self-motivated exercise) has been shown to mitigate CRF in various cancer populations both 
during treatment and post treatment (Matias et al., 2019; Romero et al., 2018; Sarna & Conde, 
2001; Serdà I Ferrer et al., 2018). As a result of growing evidence prior to the year 2010 that 
exercise not only mitigates CRF but other treatment / disease related issues as well, the American 
College of Sports Medicine (ACSM) published exercise recommendations for cancer survivors 
in 2010 and 2019: 150 minutes of moderate intensity exercise three times a week or 75 minutes 
of vigorous intensity exercise twice a week (Campbell et al., 2019; Schmitz et al., 2010) 
Additionally, exercise programs designed specifically for cancer rehabilitation have been shown 
to significantly reduce patient cost burden (Schmitz et al., 2015; Wonders, Wise, Ondreka, & 
Gratsch, 2019).    
Due to a peak in interest on the impact of exercise in cancer populations, more evidence 
has since been put forward that exercise is a beneficial treatment in combatting CRF (Cormie, 
Zopf, Zhang, & Schmitz, 2017; Cramp & Byron-Daniel, 2012; Minton, Jo, & Jane, 2015; 
Mustian et al., 2017; Persoon et al., 2013; van Vulpen, Peeters, Velthuis, van der Wall, & May, 
2016; Witlox et al., 2018). Exercise has a substantial impact on CRF both during and after 
treatment (for up to 4 years), and is more effective than often used and more expensive 
pharmaceutical treatments (Brown et al., 2011; Hilfiker et al., 2018; Kessels et al., 2018; Mustian 
et al., 2017; Persoon et al., 2013; van Vulpen et al., 2016; Witlox et al., 2018). For the purposes 
of this review, it is also worth noting that it is well established that exercise maintains its 
effectiveness in alleviating CRF in breast cancer survivors, reporting effect sizes as large as 
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0.605 (Battaglini et al., 2014; Gebruers et al., 2018; Kessels et al., 2018; Lipsett, Barrett, Haruna, 
Mustian, & O’Donovan, 2017; Meneses-Echávez, González-Jiménez, Correa-Bautista, Valle, & 
Ramírez-Vélez, 2015). Interestingly, with ample evidence confirming the benefits of exercise on 
CRF, little is known about the underlying physiological mechanisms that contribute to the 
improvement. The following sub-sections will review literature focusing on non-traditional 
exercise interventions, traditional exercise interventions (aerobic, resistance, and combination), 
as well as community-based exercise interventions and their impacts on CRF.  
 
Non-Traditional Exercise  
Other forms of exercise (non-traditional) have demonstrated effectiveness in mitigating 
CRF, such as physical therapy-based regimens (Hutchison et al., 2019). Nia, a non-traditional 
exercise, focuses on mindfulness for the individual (body, mind, and spirit). Breast cancer 
patients receiving radiotherapy report significantly less fatigue after completion of a 12-week 
structured Nia program, with little improvement in other exercise related factors such as 
cardiorespiratory fitness (Reis, Walsh, Young-McCaughan, & Jones, 2013). Possibly the two 
most studied non-traditional exercise types studied in cancer patients is that of Tai Chi and Yoga. 
Tai Chi is a Chinese martial arts practice that focuses on meditation and self-defense, and 
alleviates CRF in breast, lung, and nasopharyngeal patients receiving cancer therapy (Larkey et 
al., 2015; Zhang, Wang, Chen, & Yuan, 2016; Zhou, Wan, Chen, Qiu, & Luo, 2018). Similarly, 
Yoga, a practice of meditation, breathing control, and flexibility, positively impacts CRF as well, 
primarily in cancer survivors (Lotzke et al., 2016; Sprod et al., 2015; Stan et al., 2016). With 
their focus on meditation and mindfulness and the lack of observed improvement in 
physiological outcomes (i.e., cardiorespiratory fitness), it’s likely that these non-traditional 
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exercise interventions predominantly target psychosocial components of CRF rather than 
physiological. Regardless, implementation of these interventions is still seen as effective and 
may be most useful for patients struggling to complete activities of higher intensities and/or 
those that suffer from cancer-related psychological distress (i.e., traditional exercise).  
 
Aerobic Exercise  
A major benefit of aerobic exercise is that of improved cardiorespiratory fitness, often 
quantified by peak oxygen consumption (VO2peak). The importance of maintaining and 
improving cardiorespiratory fitness has been highlighted due to its association with mortality 
rates in the general population. For example, it has been reported that those with higher 
cardiorespiratory fitness also live longer (Mandsager et al., 2018). Additionally, it has been 
suggested that VO2peak in breast cancer patients undergoes a certain degree of impairment 
throughout the cancer continuum and into the post-treatment setting (Jones et al., 2012). This 
might suggest that cardiorespiratory fitness may be of critical importance when considering long-
term survival from breast cancer.  
 In addition to its positive impact on cardiorespiratory fitness, aerobic exercise appears to 
have a beneficiary impact on CRF as well (Patel & Bhise, 2017). During chemotherapy treatment 
regimens, supervised aerobic exercise interventions have proven effective in alleviating CRF 
(Banzer et al., 2014; Courneya et al., 2007). In a large sample of 242 breast cancer patients 
undergoing adjuvant chemotherapy, Courneya et al reported that though not statistically 
significant, changes in fatigue, VO2peak, and QOL were trending in the positive direction in 
response to aerobic exercise and was viewed as superior when compared to the control group. 
Additionally, chemotherapy completion rates were greater for those who participated in exercise. 
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Similarly, when implementing a home-based aerobic exercise program, favorable changes in 
both VO2peak and CRF haven been observed in mixed cancer type study samples (Banzer et al., 
2014). High intensity aerobic exercise during chemotherapy has been shown to mitigate 
increases in CRF up to 12 months post-treatment in breast cancer survivors (Mijwel et al., 2019). 
Comparably, when considering radiation induced CRF, aerobic exercise has proven beneficial in 
mitigating CRF levels in both prostate cancer patients and breast cancer patients with additional 
improvements seen in cardiorespiratory fitness and QOL (Segal et al., 2009; Yang, Chen, & Li, 
2015).  
Despite the reported improvements, the direct relationship between improvements in 
cardiorespiratory fitness and CRF in response to aerobic exercise has not been thoroughly 
explored. In a sample of breast cancer survivors, aerobic training on cycle ergometers at 70 to 
75% of VO2peak was reported to improve both cardiorespiratory fitness and CRF (Courneya et al., 
2003). Upon further investigation of these changes, the same study also reported a significant 
correlation (r = -0.41) between VO2peak and CRF, indicating that those who had greater 
improvements in cardiorespiratory fitness also had the largest improvements in CRF severity.  
In light of this exploratory finding, it can be speculated that cardiorespiratory fitness 
levels may play a role in the etiology, development, and persistence of CRF often observed 
throughout the cancer continuum. This speculation can be further supplemented by reports of 
cardiorespiratory fitness levels correlating with CRF (r = -0.31) in various cancer populations 
during treatment in the absence of any exercise intervention (Dimeo et al., 1997). Furthermore, a 
recent study in a small sample of breast cancer patients showed that those not participating in 
aerobically based high intensity interval training (HIIT) not only had greater reported CRF 
levels, but also decreased mitochondrial content (citrate synthase) obtained through muscle 
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biopsy (Mijwel et al., 2018). Knowing that the mitochondria plays a critical role in ATP 
production which subsequently can correspond to greater cardiorespiratory fitness levels (i.e., 
increased mitochondrial density in response to exercise), mitochondrial dysfunction may be a 
critical step in the oxygen cascade that limits cancer patients in their ability to generate ATP, 
leaving them feeling tired, weak, and fatigued. Based on the reported results, it would appear that 
this issue could be improved through aerobic based exercise training by maintaining critical 
mitochondrial metabolic enzymes.   
 
Resistance Exercise 
A critical condition that cancer patients often experience is cachexia; and excessive loss 
of skeletal muscle mass with or without the loss of fat mass. Cachexia can limit physical function 
and exacerbate fatigue. However, exercise (i.e., resistance training) aimed at maintaining and 
building muscle mass has been proposed as a means to prevent this condition through anti-
inflammatory effects (Battaglini, Hackney, & Goodwin, 2012). Likewise, studies that have been 
completed in breast cancer patients / survivors are rare but have produced efficacious results 
regarding resistance training and its ability to combat CRF both during and after treatment when 
compared to control groups (Courneya et al., 2007).   
Literature pertaining to the effect of resistance training interventions focused on whole 
body muscle groups on CRF has predominantly been studied in prostate and head and neck 
cancer populations. Progressive resistance training over the course of 12 weeks appears effective 
in alleviating CRF while simultaneously improving muscular strength in head and neck cancer 
survivors and those undergoing radiation therapy (McNeely et al., 2008; Rogers et al., 2013). 
Prostate cancer patients receiving radiation therapy have experienced decreases in CRF with 
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improvements in muscular strength as well (Segal et al., 2009). The same study reported that 
those participating in resistance training alone elicited superior improvements in CRF when 
compared to control and aerobic training groups alone (Segal et al., 2009). For prostate patients 
receiving androgen deprivation therapy, resistance training not only improves CRF, but also 
muscular strength, muscular endurance, physical function, muscle mass, and body composition 
(Hansen, Dechet, Porucznik, & LaStayo, 2009; Hanson et al., 2013; Segal et al., 2003).    
 It’s apparent that resistance training by itself can be an effective treatment for managing 
CRF in various cancer populations. However, as with aerobic training, little has been completed 
to decipher what physiological mechanism is driving this improvement. It could be speculated 
that improvements in muscular contractile properties could play a role. Many of the studies cited 
above reported improvements in muscular strength, function, and body composition. These 
improvements could possibly be a result of the resistance training, which in turn reduces fatigue 
as the patients are able to better complete functional tasks and activities of daily living. 
Regardless, the same recommendation for future research applies as it should explore 
mechanisms driving the improvement in CRF in response to resistance training. This could result 
in better tailored interventions to target CRF both during and after cancer therapy.  
 
Combination of Aerobic and Resistance Exercise (CARE)  
Perhaps the most commonly implemented type of exercise intervention in the cancer 
setting is that of combined aerobic/resistance exercise (CARE) programs. CARE programs are 
often used as they are designed to assist patients in reaching weekly exercise recommendations 
set forth by the ACSM (Campbell et al., 2019). In doing so, patients receive the benefits of both 
aerobic and resistance training. CARE programs are both safe and effective for cancer survivors 
 46 
 
and are associated with improved treatment completion rates in breast cancer populations 
(Rajotte et al., 2012; van Waart et al., 2015). Similar to considering training effects of aerobic 
and resistance training in their own entity, CARE programs not only improve CRF, but other 
training outcomes as well. Knowing that CRF is multi-factorial, CARE programs may provide 
the greatest benefit in alleviating CRF as they are able to target multiple physiological processes 
and functional movements that may be dysregulated due to the cancer disease and related 
treatments.  
 In hematological cancers (leukemia, multiple myeloma, bone marrow transplant patients), 
lower cardiorespiratory fitness has been shown to be associated with patient reported symptom 
burden (fatigue as a subscale) and mortality rates post hematopoietic transplant (Wood et al., 
2013). CARE programs implemented during treatment or workup for transplant in these types of 
cancers have proven effective in alleviating CRF and reducing treatment complications such as 
graft vs host disease (GVHD) (Alibhai et al., 2014; Battaglini et al., 2009; Coleman et al., 2003; 
Wiskemann et al., 2011). Though not evaluated statistically, a study in acute myeloid leukemia 
(AML) patients reported improvements in both CRF and VO2peak in response to exercise, 
providing more evidence of a possible link between cardiorespiratory fitness and CRF (Battaglini 
et al., 2009). Comparable results have been described in both ovarian and non-small cell lung 
cancer, though more research is needed in these cancer types to determine feasibility of CARE 
programs (Mizrahi et al., 2015; Temel et al., 2009).  
 In samples of mixed cancer types undergoing therapy (i.e., radiation and/or 
chemotherapy), both low and high intensity CARE programs have improved fatigue as well as 
cardiorespiratory fitness, muscular strength, and physical function (Adamsen et al., 2009). 
Similar outcomes are reported when CARE interventions are shifted to a home-based setting 
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during radiation and chemotherapy treatments (Cornette et al., 2016; Mustian et al., 2009). 
Specifically related to breast cancer patients, it’s been suggested that general physical activity 
levels do not provide a large enough stimulus to reduce CRF when compared to controls 
(Husebo, Dyrstad, Mjaaland, Soreide, & Bru, 2014). However, when breast cancer patients are 
placed into a structured CARE program, improvements in CRF are reported in conjunction with 
increased caloric intake (r = -0.54) (Battaglini et al., 2008). For cancer survivors, improvements 
in CRF are accompanied by improvements in other exercise related outcomes such as physical 
function, cardiorespiratory fitness, muscular strength, body composition, and QOL (De Luca et 
al., 2016; Dimeo, Schwartz, Wesel, Voigt, & Thiel, 2008; Kampshoff et al., 2015; Spector, Deal, 
Amos, Yang, & Battaglini, 2014).  
 Taken as a whole, CARE interventions seem to be extremely effective in alleviating 
CRF. Of particular interest for the present study is the simultaneous improvement that is often 
observed on cardiorespiratory fitness (VO2peak). Cancer treatments induce oxidative stress, a 
process that involves the production of reactive oxygen species (ROS) that ultimately result in 
damaged tissues and limit oxygen uptake. This associated oxidative stress has been implicated in 
with the development of CRF and exercise has been shown to improve both. In cancer survivors 
who had undergone chemotherapy treatments, a correlation coefficient of -0.58 between the delta 
scores of CRF and antioxidant capacity was produced post-exercise intervention (Repka & 
Hayward, 2018). Furthermore, cardiorespiratory fitness has been reported as a mediator for the 
improvements observed in QOL and CRF in response exercise in cancer survivors regardless of 
cancer type (Kalter et al., 2016; Repka et al., 2014). This certainly provides evidence and 
rationale to explore this relationship further. More importantly, provided the effectiveness of 
CARE programs in their ability to improve CRF, future research should also focus on how to 
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make these types of programs more easily accessible. Ultimately, this will likely come in the 
form of community-based exercise programs that are both low-cost and easily accessible.   
 
Community-Based Exercise  
 All types of exercise training appear to be beneficial in regard to alleviating CRF in 
various cancer populations. It should be recognized that many of these exercise interventions 
took place in a supervised lab-based setting. Despite the promising evidence, the extent to which 
these lab-based interventions translate into “real-world” settings is yet to be established. Given 
the substantial amount of positive evidence for the impact of exercise not only on CRF, but on 
cancer as a whole, making exercise programs scalable into community-based settings is 
imperative. In particular as the number of cancer survivors increase, the demand for exercise as a 
rehabilitation tool will also increase.  
 Generally, community-based exercise programs are designed to be accessed by cancer 
patients in the surrounding area at little to no cost. Acting as a non-commercial gym that allows 
patients to interact with each other, they tend to foster an environment that generates social 
connections among different patients that have undergone similar psychological stressors 
commonly experienced across the cancer continuum. The goal of community-based exercise 
programs is the same as lab-based interventions in the context of promoting and maintaining 
adequate physical activity to reflect guidelines set forth by the ACSM (Campbell et al., 2019). 
Comparably, community-based programs tend to be more flexible, allowing for adaptable 
changes in progression of the training programs that are specific to patient needs. The ultimate 
goal of community-based programs is to improve patients’ QOL through exercise, and 
preliminary reviews indicate that community-based exercise programs are effective in improving 
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QOL for cancer patients who participate (Covington et al., 2019). Unfortunately, little has been 
done to study the impact on these types of programs on CRF, despite it being a top patient-
reported side effect that has a detrimental influence on QOL.  
 Based on a comprehensive search for community-based exercise programs designed 
specifically for cancer patients, 31 studies were identified as being community-based. Of these 
studies, less than half (n=13; ~42%) reported any information on the measurement of CRF, let 
alone the impact of the community-based exercise program on CRF (Battaglini et al., 2006; De 
Jesus et al., 2017; Harvie et al., 2019; Irwin et al., 2017; Kirkham et al., 2016; Leach et al., 2015, 
2016; Loughney, Cahill, O’Malley, McCaffrey, & Furlong, 2019; Musanti et al., 2019; Nock et 
al., 2015; Rajotte et al., 2012; Santa Mina et al., 2017; Schumacher & McNiel, 2018). The small 
number of studies measuring CRF as an outcome is surprising given that the number of cancer 
survivors is certainly increasing and provided the notion that CRF is both prevalent and 
debilitating, further diminishing patients’ overall QOL. This was not expected given the 
sufficient evidence in previous sections describing the beneficial impact of exercise on 
alleviating CRF. Based on this alone, it is clear that more research is needed in the community-
based setting to better understand how exercise participation in this type of setting might 
alleviate/manage CRF and how to tailor these programs to not only combat CRF but improve 
overall QOL.  
Furthermore, as these survivors are likely experiencing some degree of CRF, it was 
surprising to find that no study commented on the severity level of CRF patients were 
experiencing prior to beginning their exercise program. This has important implications given 
the variety of CRF measurements currently available (described above) that can provide different 
interpretations on CRF severity. With inconsistent interpretations and lack of acknowledgement 
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of CRF severity at baseline, little information is available for exercise professionals to begin to 
know how to address the type of fatigued patient joining their program. As CRF has been shown 
to be a barrier for exercise participation (Cheifetz et al., 2015), it’s plausible that many cancer 
patients joining these programs have low to moderate fatigue levels. If this is the case, we need 
to understand why patients experiencing greater severity of CRF hesitate to participate in these 
types of programs. Whether it is fear of exasperating their CRF, lack of fatigue self-management, 
or absence of education on the benefits of exercise participation on CRF are questions that 
remain to be answered.    
 Of the 13 studies available, community-based exercise appears promising in terms of its 
ability to alleviate CRF. When considering different modes of exercise, this trend remains 
consistent. AE alone was shown to produce a favorable impact on CRF in breast cancer patients 
participating in a 16-week program three times per week (De Jesus et al., 2017). Likewise, solely 
participating in community based RE for 12-21 weeks two times per week has produced 
improvements in CRF for both breast cancer specific samples and mixed cancer cohorts 
(Battaglini et al., 2006; Rajotte et al., 2012). The majority of community-based exercise studies 
have implemented AE+RE interventions (n=10), likely due in part to both previous and current 
exercise recommendations set forth by the ACSM for cancer survivors (Campbell et al., 2019; 
Irwin et al., 2017; Kirkham et al., 2016; Leach et al., 2015, 2016; Loughney et al., 2019; Musanti 
et al., 2019; Nock et al., 2015; Santa Mina et al., 2017; Schumacher & McNiel, 2018). Of those 
10 studies, less than half reported seeing small to significant improvements in CRF after 
participating in AE+RE interventions (Kirkham et al., 2016; Leach et al., 2016; Musanti et al., 
2019; Santa Mina et al., 2017). This finding was surprising given the extensive volume of 
literature exhibiting the influential impact of exercise on CRF.  
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Furthermore, of the studies that reported both improvements in CRF to the AE+RE 
interventions, the reported adherence rates were less than 60%, indicating suboptimal 
participation in the exercise program (Leach et al., 2016; Santa Mina et al., 2017). Comparably, 
other studies that reported very high adherence rates (70-89%) showed little to no improvement 
in CRF after participation in community-based AE+RE. This is unexpected given that simply 
being more physically active has been associated with improved CRF (Serdà I Ferrer et al., 2018; 
Witlox et al., 2018). It should also be noted that some studies did not report adherence rates, 
leaving more questions as to how accessible and feasible these community-based exercise 
programs truly were.  
When taken as a whole, these studies do reveal a small yet significant impact on CRF, 
yielding a summary effect size of 0.30 (Figure 2.1). Comparatively, this analysis reveals that 
community-based programs provide minimal to moderate alleviation of CRF when compared to 
non-community-based exercise interventions (Kessels et al., 2018; Mustian et al., 2017). It’s 
possible that the variability in different training parameters may play a role in the ability of 
currently established community-based exercise programs to alleviate CRF. Among the 13 
studies, the manner in which intensity of exercise was captured was rather inconsistent, ranging 
from RPE to percent Heart Rate Reserve (HRR) derived from CPETs. This difference could 
result in training intensities of varying levels, despite the common goal of achieving moderate to 
high intensity exercise. Program duration also varied among community-based exercise 
programs, ranging from as little as two weeks to as many as 24 weeks. Not surprisingly, 
programs that reported intervention lengths ranging from two to four weeks did not report 
improvements in CRF (Loughney et al., 2019). It’s plausible that the numerous amounts of 
currently available CRF measures play a role in different outcomes in response to community-
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based exercise as well. Despite being validated against each other, CRF measures range from 
unidimensional to multidimensional, and multidimensional CRF measures vary in which 
dimensions they choose to assess.  
Although community-based exercise programs appear to be somewhat impactful against 
CRF when considered as a group, the observed inconsistencies among studies point to a 
necessity for more research regarding the impact of community-based exercise programs on 
CRF, particularly programs that reflect guidelines put forth by the ACSM. In doing so, this will 
provide insight as to how well these guidelines translate to more practical settings outside of a 
laboratory. The review of these community-based programs also revealed that less than half of 
the currently published literature reported the impact of the program on CRF. Moreover, future 
programs should consider the multi-factorial nature of CRF when designing their community-
based training interventions. More studies should report the impact of their community-based 
programs on CRF in addition to other clinical, physical, functional, and psychological outcomes. 
This will provide practical evidence to strengthen the initiative of moving to community-based 











Figure 2.1: Pooled Effect Size of Community-Based Exercise Impact on CRF 
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V. Determinants of Cancer-Related Fatigue  
 As mentioned, CRF is multi-factorial, meaning that there are numerous variables that 
have been linked to experiencing low, moderate, or severe CRF. Generally, the various 
influencing factors can be categorized into patient demographics, clinical characteristics 
(treatment type, cancer stage, etc.), psychosocial characteristics, physical activity/functionality, 
and the understudied topic of physiological mechanisms involved in CRF. This final section of 
Chapter II explores each category more in depth, providing links from various factors that have 
been hypothesized to either be associated with greater severity of CRF or even have a direct 
causal relationship with CRF. These descriptions of each category will assist in displaying the 
true complexity and multi-factorial nature of CRF, providing rationale as to why to this day, 
despite its persistence and the multitude of research surrounding it, this patient-reported outcome 
is still not well-understood.  
   
Demographics 
 Research investigating racial disparities among breast cancer patients in terms of 
diagnoses, treatments, and mortality rates show that minorities may experience CRF to a greater 
severity as well (Carey et al., 2006). Black women are less likely to be active, have a higher 
BMI, and diagnosed with more advanced breast cancer (Carey et al., 2006; Dignam et al., 2006; 
Hair, Hayes, Tse, Bell, & Olshan, 2014; Irwin et al., 2004; Paxton et al., 2012). More research is 
clearly needed in this particular area to address that racial disparity that may be occurring among 
minority populations in the context of CRF, particularly since minority populations are under-
represented in cancer research to begin with.  
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When age is considered as a factor in CRF, studies have often shown that younger cancer 
survivors are more likely to experience greater severity of fatigue (Swen, Mann, Paxton, & Dean, 
2017; Thong et al., 2018; Tibubos et al., 2019; Winters-Stone et al., 2008). It is speculated that 
younger patients perceive CRF as being more burdensome and severe due to the physical and 
social limitations that come with it. This is in contrast to older patients who are generally not as 
physically or socially active to begin with, and therefore do not experience as much of a drastic 
decline in physical limitations (Tibubos et al., 2019). Other explanations involve younger 
patients having more responsibilities throughout a typical day such as childcare and employment 
commitments, leaving them more susceptible to experiencing CRF due to an inability to 
conserve energy (Kim et al., 2008).  
Weight gain/management, often represented as BMI, is commonly observed after primary 
treatment for breast cancer. Weight gain during cancer treatment has been attributed to the 
treatment itself, hormonal changes, change in diet, and various psychological factors impacting 
overall well-being (Goodwin et al., 1999; Levine, Raczynski, & Carpenter, 1991; Rock et al., 
1999). In the context of CRF, breast cancer patients with greater percent body fat or those that 
are classified as obese (via BMI) prior to starting treatment (chemotherapy, endocrine therapy) 
have been shown to experience greater severity of CRF both during treatment and after treatment 
completion (Andrykowski, Donovan, Laronga, & Jacobsen, 2010; Gerber et al., 2011; Huang et 
al., 2010; Inglis et al., 2020; Reinertsen et al., 2010; Winters-Stone et al., 2008). From a 
mechanistic perspective, it has been suggested that cytokine dysregulation that has been linked 
with CRF may also be attributed to gut microbiota in obese cancer patients (Inglis et al., 2020), 
however, the authors emphasize that this mechanistic explanation is purely speculation and 
requires more research. It is certainly plausible that by reducing weight/BMI, CRF would likely 
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follow suit, particularly as both tend to improve with increased physical activity and exercise 
participation. Overall, demographics alone can be utilized to help paint a picture as to which 
patients may be more susceptible to experiencing severe levels of CRF as certain characteristics 
may leave patients more susceptible to late-stage disease diagnoses and intense anti-cancer 
therapies. This can assist both clinicians in their decision making on types/dosage of anti-cancer 
therapies to utilize and exercise professionals in their design and implementation of physical 
activity interventions that help to combat CRF (i.e., establishing appropriate training parameters 
for those more prone to experience severe and prolonged CRF).     
  
Clinical Characteristics  
 Clinical characteristics such as disease stage, treatment type, and treatment regimens are 
linked with the development of CRF both during and after anti-cancer therapy (Abrahams et al., 
2016; Ganz & Bower, 2007; Minton & Stone, 2008; Vardy et al., 2016). Recent meta-analyses 
indicate that breast cancer survivors with more advanced disease stages (II or III) were more 
likely to experience severe fatigue when compared to earlier disease stages (0 or I) (Abrahams et 
al., 2016). This study also reported that patients treated with a combination of therapies (surgery, 
chemotherapy, radiation) were more likely to experience severe fatigue when compared to 
patients who only received surgery only or surgery + radiation.  
Treatment plans are related to disease stage, as more advanced breast cancer diagnoses 
require combinations of therapies that are likely more intense, bringing about more severe effects 
of CRF. Furthermore, CRF is a major toxicity when considering chemotherapy regimens that are 
currently implemented within clinical practice (Nyrop et al., 2019). It would appear that 
chemotherapy and hormonal therapy alone result in more severe prolonged fatigue as opposed to 
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radiation only, which has been reported to elicit cyclical variations in fatigue that are often 
relieved once radiation treatment is completed (Abrahams et al., 2016; Charalambous & Kouta, 
2016; Colloca, Venturino, Governato, & Checcaglini, 2016; Thong et al., 2018).    
   Clinical characteristics can assist both clinicians and exercise professionals in 
identifying patients who may be particularly susceptible to severe and prolonged fatigue after 
treatment. From an exercise / cancer-rehabilitation perspective, understanding the contributing 
role of clinical characteristics in the development of CRF would give exercise professionals an 
improved understanding of those susceptible to prolonged effects of CRF and why patient 
fatigue levels are low, moderate, or severe when initiating a training program. The resulting 
training prescriptions could then be better tailored to those who fit within a certain “clinical 
profile” for more severe and prolonged fatigue after treatment. Ultimately, this may improve the 
effectiveness in which exercise combats CRF in the post-treatment phase of the cancer 
continuum.   
 
Psychosocial Characteristics  
 Discussions around exercise-induced fatigue have included both physiological and 
psychological factors, leading to debate as to which area is the primary driver to exercise 
cessation. There is no question that fatigue involves both a psychological and physiological 
component, and the same principle applies to CRF, despite its primarily subjective nature. CRF 
can have a profound impact on mental health and vice versa. Specifically, CRF is consistently 
linked with chronic depression and anxiety stemming from cancer diagnoses and anti-cancer 
therapy (Jones et al., 2016; Minton et al., 2012; Purcell et al., 2010). Patients that experience 
both severe fatigue and depression are also susceptible to a reduced health related QOL (Jones et 
 58 
 
al., 2016; Kim et al., 2008). CRF results in reduced functionality (Hofman et al., 2007; Nyrop et 
al., 2014), which in turn may cause individuals to become depressed when they are unable to 
carry out normal activities of daily living. Likewise, it may also cause individuals to feel 
anxiety/worry that they will not be able to get back to the functional status they were at prior to 
their diagnosis / treatment. The exasperated feelings of tiredness and exhaustion (i.e., CRF) 
contribute to feelings of depression and anxiety, which lead to diminished mental health and 
overall QOL.  
 Monitoring these psychosocial characteristics can give researchers, clinicians, and health 
professionals an idea about how patients’ fatigue is progressing (Jones et al., 2016). Due to the 
subjective nature of patient-reported symptom severity, it is no surprise that fatigue and 
psychosocial factors are inter-related. Although these characteristics may not provide a 
mechanistic explanation for CRF, they still offer valuable insight as to how CRF may progress 
both during and after treatment and in response to exercise. It could be argued that in the context 
of CRF, simply monitoring various self-reported symptoms (e.g., depression, anxiety) may be 
just as important as monitoring the physiological health of survivors participating in exercise 
training programs. It would appear that the relationships between psychosocial characteristics 
and CRF have a profound influence on health related QOL; when CRF is improved, functionality 
returns, depressed and worried thoughts subside, and QOL slowly returns to normal. This is 
important to recognize as it demonstrates that improvements in CRF can result in the recovery of 
multiple psychosocial factors. Health professionals need to consider the psychological impact of 





Physical Activity / Functionality  
 CRF and physical activity participation have an inverse relationship. Individuals who are 
sedentary (move less) are more prone to experiencing greater severity of CRF when compared to 
individuals who are physically active both during and after completion of anti-cancer therapies 
(Kessels et al., 2018; Purcell et al., 2010; Serdà I Ferrer et al., 2018; van Vulpen et al., 2016; 
Winters-Stone et al., 2008). This pattern applies to physical function, pain, and balance, as well. 
Patients who report increased levels of pain and balance impairments during treatment also tend 
to report greater levels of CRF and more barriers to completing activities of daily living (Hofman 
et al., 2007; Kim et al., 2008; Kneis et al., 2016; Spratt et al., 2012). A common theme is that 
those who report experiencing CRF, increased pain, and reduced functionality/balance also tend 
to be less physically active. Simple physical activities such as walking can help to improve both 
fatigue, pain, and joint stiffness (Nyrop et al., 2014).      
 The evidence of the interrelationships among CRF severity, functionality, and pain in 
addition to influence that physical activity participation has on all three areas, provides a 
rationale for the notion of evaluating physical activity throughout the cancer continuum. This 
could identify individuals who are more prone to severe CRF and, by association, have increased 
pain and diminished functionality. This would allow for early intervention techniques that 
otherwise may not have been considered, such as promoting and educating on how to safely and 
progressively participate in physical activity. There is a need to provide adequate education 
regarding safe physical activity participation considering its relationship with CRF and the 
influence this has on both functionality and pain. Furthermore, when considering physical 
activity status in the post-treatment phase, this can provide exercise professionals an idea of a 
“starting point” for a cancer-rehabilitation program focused on combatting the effects of CRF. 
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Those who are less physically active may be experiencing greater CRF and might need to begin 
their training program in a slower progression as opposed to someone whose physical activity 
level at baseline is adequate. Provided the numerous factors that are known to be associated with 
CRF, it is unlikely the two patients experiencing a similar severity of CRF would require the 
exact same exercise prescription. Ultimately, this can result in improved exercise prescriptions 
that will be better tailored to the patient and their specific needs.   
 
Proposed Physiological Mechanisms of Cancer-Related Fatigue 
The underlying physiological mechanisms of CRF have been explored but are still poorly 
understood. This in turn has resulted in controversy as to how this patient-reported symptom 
manifests (Bower, 2014; O’Higgins et al., 2018; Ryan et al., 2007; Wang & Woodruff, 2015). 
The pathophysiological origins of CRF appear to be highly complex, multi-factorial, and interact 
with one another. Furthermore, many of the proposed hypotheses have not been confirmed in 
human studies, as most mechanisms have been tested in animal models. At present, currently 
proposed physiological mechanisms of CRF can be categorized as “Central Mechanisms” and 
“Peripheral Mechanisms” (O’Higgins et al., 2018). Central mechanisms refer to physiological 
processes that originate in the central nervous system (CNS). The CNS plays a role in controlling 
voluntary movement (i.e., muscular contractions, walking, etc.), which translates into physical 
function. Peripheral mechanisms are those that refer to fatigue occurring in the periphery (i.e., 
skeletal muscle). This can result from degraded contractile properties, inability to produce ATP, 
and accumulation of metabolites within the muscle.  
Though many of the mechanisms have been studied independently, it is important to note 
their interaction/influence with each other. When considering the development of CRF, factors 
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such as disease status, treatment, and comorbidities prior to treatment should be considered as 
each can influence physiological processes. Evaluating the underlying forces driving CRF will 
ultimately lead to improved targeted therapies to treat this symptom. Pharmaceuticals and/or 
better tailored exercise interventions that can specifically target CRF and its physiological 
deficiencies will be beneficial as fitness level has been implicated in CRF as well for cancer 
survivors (LaVoy, Fagundes, & Dantzer, 2016). A review of each proposed hypothesis, 
categorized in to central and peripheral mechanisms, is provided below.  
 
Proposed Central Mechanisms  
Cytokine Dysregulation  
Perhaps more consistently than any other physiological hypothesis, cytokine 
dysregulation/inflammation and its role in the manifestation of CRF has been studied fairly 
extensively (Bower & Lamkin, 2013; Jager, Sleijfer, & van der Rijt, 2008; Kurzrock, 2001). 
Cancer patients experiencing CRF have consistently shown to have elevated pro-inflammatory 
cytokine markers (i.e., TNF-, IL-6) when compared to non-fatigued cancer patients and healthy 
controls (Cruz et al., 2015; Meeusen & Watson, 2007). It is unclear whether the increased 
inflammation observed in cancer patients is a starting point for CRF or simply exacerbates the 
symptom. A speculative link between observed increase pro-inflammatory cytokine levels and 
experienced CRF is that of sickness behavior potentially stemming the disease itself or the 
corresponding treatment (chemotherapy or radiation). Sickness behavior is often induced when 
inflammatory facilitators act on the brain, which in turn produces feelings of lethargy, fatigue, 
and loss of appetite (Kelley et al., 2003).  
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 Throughout the entire cancer continuum, elevated pro-inflammatory cytokines have been 
observed and associated with CRF prior to treatment, during treatment, and after treatment 
(Bower, Ganz, Aziz, & Fahey, 2002; Bower et al., 2009; Collado-Hidalgo, Bower, Ganz, Cole, 
& Irwin, 2006; Orre et al., 2011; Pertl et al., 2013; Wang et al., 2012; Zhang et al., 2014). Prior 
to chemotherapy, elevated C-reactive protein (CRP) levels have been shown to predict fatigue 
severity across treatment regimens in breast cancer patients independently of known covariates 
such as depression (Pertl et al., 2013). This relationship also appears to be maintained in breast 
cancer survivors experiencing persistent CRF (Orre et al., 2011). For those undergoing treatment, 
a recent systematic review reported that increased pro-inflammatory cytokine markers were 
associated with patients who were experiencing CRF and receiving anthracycline/taxane based 
chemotherapies, postulating a link between treatment type and CRF inflammation (Eyob, Ng, 
Chan, & Chan, 2016). Additionally, both chemotherapy and radiation and the corresponding 
increase in CRF during treatment has been associated with increased levels of TNF-, IL-6, and 
IL-1 in breast, prostate, and gastrointestinal cancers (Bower et al., 2009; Wang et al., 2012; 
Zhang et al., 2014).  
Persistent CRF that is often observed once treatment is completed has also been 
associated with inflammatory biomarkers in breast cancer survivors (Bower et al., 2006; 
Collado-Hidalgo et al., 2006). Similar to the relationships observed both prior to and during 
treatment, elevated levels of CRP, TNF-, and IL-6 have been reported in breast cancer 
survivors experiencing persistent CRF more than 2 years after treatment cessation (Collado-
Hidalgo et al., 2006; Orre et al., 2011). Despite the consistent evidence, it should also be noted 
that the predictive power of cytokines with CRF severity may also differ among age groups 
(Alibhai et al., 2020). It is apparent that CRF is related to but not solely driven by inflammation. 
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Rather, there is likely interplay among multiple physiological processes that have been 
implicated in the development of CRF. 
 
Hypothalamic-Pituitary-Adrenal (HPA) Axis Disruption  
HPA axis disruption in the context of its role in the development and persistence of CRF 
revolves around the release of cortisol. The HPA axis functions to regulate the release of cortisol. 
When stimulated by a stressor, corticotrophin releasing hormone (CRH) is released from the 
hypothalamus which then results in the release of adrenocorticotropic hormone from the anterior 
pituitary leading to the release of cortisol from the adrenal cortex (Spiga, Walker, Terry, & 
Lightman, 2014). Along with other physiological effects (metabolic, cardiovascular, etc.), 
cortisol works to suppress cytokine production. When excessive and chronic inflammation is 
present, CRH is suppressed, leading to cortisol suppression and increased cytokine production in 
the hypothalamus, disrupting the regulation of the HPA axis (Neefjes, van der Vorst, Blauwhoff-
Buskermolen, & Verheul, 2013; O’Higgins et al., 2018; Ryan et al., 2007; Saligan et al., 2015; 
Wang, 2008). The increased cytokine production can then lead to pro-inflammatory effects 
described above, possibly contributing to the often observed “sickness behavior”. Additionally, 
increases in cortisol levels are linked with prolonged exposure to stress, leading to feelings of 
tiredness and fatigue (Neefjes et al., 2013; Saligan & Kim, 2012).  
 It should be noted that HPA axis disruption is still not well understood in the context of 
its etiological role of CRF or the persistence of CRF after treatment. However, hypocortisolemia 
has been reported in cancer patients both undergoing treatment and post-treatment. In a sample 
of ovarian cancer patients undergoing chemotherapy, reductions in fatigue following treatment 
were associated with “normalized” salivary cortisol levels and a more ordinary diurnal cortisol 
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pattern (Schrepf et al., 2013). The same study also reported reductions in IL-6, supplementing 
the link between HPA axis disruption and cytokine production.  
The concept of diurnal cortisol and its relationship with CRF has been investigated 
further in breast cancer populations. In a sample of breast cancer patients undergoing 
chemotherapy and/or radiotherapy, abnormal cortisol levels were associated with greater 
physical fatigue across treatment (Schmidt et al., 2016). Similarly, breast cancer survivors 
experiencing CRF have been reported to have flatter diurnal cortisol slopes and less of decline 
during evening hours compared to those who are not fatigued (Bower et al., 2005). It could be 
speculated that disrupted cortisol levels correspond to higher sensations of CRF due to its impact 
on the skeletal muscle function, metabolism, and exercise intolerance in clinical populations 
(Agapitou et al., 2013; Tzanis, Dimopoulos, Agapitou, & Nanas, 2014). However, this has not 
been established in cancer populations. Despite the reported associations between abnormal HPA 
axis activity and patients experiencing CRF, it is apparent that the exact mechanism in which 
HPA axis disruption contributes to CRF still remains unclear and requires more research.  
 
Circadian Rhythm Disruption  
Circadian rhythm can be referred to as a biological clock. Certain physiological processes 
follow oscillations in response to changes in light, stress, or environment throughout a 24-hour 
period. Examples of these types of processes include hormonal secretions, regulation of body 
temperature, sleep, and even immune system rhythm (O’Higgins et al., 2018). The disruption of 
circadian rhythms in cancer patients can be observed in abnormal diurnal cortisol patterns such 
as those described above in breast cancer patients (Bower et al., 2005; Schmidt et al., 2016; 
Schrepf et al., 2013). Cancer treatments appear to elicit the abnormal diurnal cortisol patterns 
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(flatter slopes) and greater cortisol levels during evening hours, which potentially contribute to 
disrupted circadian sleep patterns. Both altered circadian rhythms and diurnal cortisol patterns 
are related to HPA axis dysfunction, which can result in increased pro-inflammatory cytokine 
production and fatigue.  
 More recently, rest-activity patterns, an objective measure of circadian rhythms, and 
corresponding associations with fatigue severity have been explored in cancer patients. Rest-
activity patterns refer the quality of sleep/activity observed throughout the circadian period (24-
hours). It is not uncommon for cancer patients to report both CRF and sleep disorders while 
undergoing treatment (Balachandran, Faiz, Bashoura, & Manzullo, 2013). For instance, non-
small cell lung cancer patients have reported elevated sleep/activity disturbance when 
experiencing elevated levels of fatigue (Levin et al., 2005). Specific to breast cancer, worsening 
rest-activity patterns and associated wake and sleep cortisol levels during treatment have been 
linked to greater CRF severity (Sultan, Choudhary, & Parganiha, 2017; Tell, Mathews, & 
Janusek, 2014). Though a common characteristic of CRF is that it is not alleviated by rest, it 
could be argued that patients experiencing are not able to get enough rest as their sleep patterns 
are constantly disrupted. As with previously discussed hypotheses, the association between 
circadian rhythm disruption and CRF has been noted. Unfortunately, the causal mechanism 
driving abnormal circadian rhythm is still yet to be established. However, it is clear that 
circadian rhythm, the HPA axis, and pro-inflammatory cytokine production all play intertwining 






Serotonin Dysregulation  
Irregularities of serotonin levels in the brain have been implicated to impact CRF based 
on its known effects to cause drowsiness and lethargy (Meeusen & Watson, 2007). A common 
link that is often mentioned is the connection between serotonin levels and cortisol. When 
serotonin is chronically high or low, cortisol levels are thought to decrease which would allow 
for an increase in pro-inflammatory cytokine production (Jager et al., 2008). Additionally, low 
serotonin levels and the associated increase in pro-inflammatory cytokines has been linked to the 
activation of the enzyme indoleamine 2,3-dioxygenase (IDO). IDO degrades both tryptophan and 
serotonin, potentially contributing to sleep disorders often observed in cancer patients 
experiencing CRF (Kim, Miller, Stefanek, & Miller, 2015; O’Higgins et al., 2018).  
 Serotonin sensitivity and tryptophan breakdown has been evaluated in at least two 
separate cancer populations. When compared to patients not experiencing CRF, one study did 
not find any differences in serotonin sensitivity in breast cancer survivors experiencing CRF as 
determined by psychiatric interview (Alexander et al., 2010). The authors attributed the lack of 
difference to poor recruitment, small sample size, and being underpowered. In a sample of lung 
cancer patients, increased breakdown of tryptophan was associated with increased CRF severity 
(Kurz et al., 2012). Mechanistically, it’s speculated that this relationship is observed in response 
to IDO activation and its ability to degrade tryptophan via decreased serotonin and increased pro-
inflammatory cytokines. Though the connection between serotonin dysregulation, HPA-axis 
dysregulation, and increased inflammation is logical, the research regarding serotonin 





Vagal Afferent Nerve  
The vagal nerve is predominantly comprised of afferent nerves that relay messages to the 
brain regarding residual muscle tension and motor control. Vagal afferents can become activated 
in response to cancer treatment or the disease itself. This activation in response to cancer has 
been thought to result in an increased pro-inflammatory cytokine response, serotonin 
dysregulation, and ultimately sickness behavior, further connecting cytokine and HPA-axis 
dysregulation in the development of CRF (Dantzer, Heijnen, Kavelaars, Laye, & Capuron, 2014; 
Hansen, Taishi, Chen, & Krueger, 2018; O’Higgins et al., 2018). It should be noted that the 
theoretical basis for this hypothesis has primarily been investigated in animal models as few 
studies have been conducted in human populations to evaluate the vagal afferent nerve’s role in 
CRF.  
An area that has been scarcely researched but might play a role in uncovering the role of 
the vagal afferent nerve is that of vagal tone/autonomic function; often times measured in the 
context heart rate variability (HRV). The autonomic nervous system (ANS) is comprised of the 
parasympathetic nervous system (PNS - energy conserving) and the sympathetic nervous system 
(SNS - energy consuming). HRV can be assessed by addressing the activity of the PNS. Low 
HRV has been associated with increased fatigue severity in clinical populations other than 
cancer, and higher HRV has been linked to reductions in pro-inflammatory cytokine production, 
providing more evidence that fatigue has many interconnected mechanisms (Beaumont et al., 
2012; Tracey, 2009). Additionally, autonomic function impairment is a known contributor to 
cardiovascular disease in breast cancer patients (Lakoski, Jones, Krone, Stein, & Scott, 2015). To 
our knowledge, two studies have explored autonomic function in breast cancer survivors and its 
relation to fatigue. In a sample of 109 breast cancer survivors, higher levels of norepinephrine 
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(NE) and lower HRV (indicating a diminished PNS response) were associated with greater levels 
of CRF and thought to prime inflammatory responses (Fagundes et al., 2011). In an attempt to 
replicate these findings, low HRV was once again found to be associated with greater CRF in 
breast cancer survivors despite inflammatory markers not being supported as a mediator in the 
relationship (Crosswell, Lockwood, Ganz, & Bower, 2014). As with other central hypotheses 
implicated in the etiology of CRF, vagal afferent nerve / autonomic function requires more 
research to validate its mechanistic role.  
 
Proposed Peripheral Mechanisms  
Muscle Metabolism 
Taken as a whole, the proposed peripheral mechanisms speculated to contribute to CRF 
have been studied to a lesser extent. Generalized muscular fatigue in healthy populations is 
characterized by a reduction in the ability to exert force and can be attributed to skeletal muscle 
structure and function (Davis & Walsh, 2010). CRF, specifically the sub-domain of physical 
CRF, has been described by cancer patients as having a decrease in physical performance in 
conjunction with extreme tiredness, weakness, and need for rest (Glaus, Crow, & Hammond, 
1996). This can translate into the inability to utilize substrates in the periphery to generate ATP. 
Muscle metabolism and its dysfunction in the context of CRF is attributed to ATP dysregulation 
and contractile properties.  
Mitochondrial dysfunction has been linked to the prevalence of CRF in various cancer 
populations as many therapies work to disrupt mitochondrial processes in order to induce cell 
death (Chae et al., 2018; Fantin & Leder, 2006; Feng, Nguyen, Ross, & Saligan, 2018; 
Morishita, Wakasugi, et al., 2018). This can be mechanistically attributed to oxidative stress and 
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the formation of DNA double-strand breaks and deletions (Lebrecht, Kokkori, Ketelsen, Setzer, 
& Walker, 2005; Minotti, Cairo, & Monti, 1999; Minotti, Menna, Salvatorelli, Cairo, & Gianni, 
2004; Mordente, Meucci, Silvestrini, Martorana, & Giardina, 2012). An increase in reactive 
oxygen species (ROS) as a result of anti-cancer therapy can damage mitochondria, causing it to 
breakup, creating issues with metabolic processes (i.e., electron transport chain) and an inability 
to properly metabolize substrates for ATP production, ultimately resulting in cell death. As many 
cancer therapies target mitochondrial processes to limit cell proliferation and induce apoptosis, 
mitochondrial dysfunction has been shown to be associated with CRF both prior to and in 
response to various exercise interventions (Chae et al., 2018; Lyon et al., 2018; Mijwel et al., 
2018; Morishita, Wakasugi, et al., 2018). Based on the information currently available, it’s 
possible that this damage could impair muscle metabolism, limiting the production of ATP and 
contributing to feelings of tiredness and exhaustion, which in turn manifests as CRF.  
 
Contractile Properties  
Very little has been done to actually decipher what deficiencies in contractile muscles 
may contribute to CRF. Claims have been made that contractile/muscular properties related to 
CRF are more central than peripheral (Cai et al., 2014; Kisiel-Sajewicz et al., 2012). However, 
this has only been observed in a couple of studies and should be interpreted with caution as the 
methodology may not capture the true nature of CRF. During chemotherapy and/or radiation 
treatment, breast and prostate patients have been reported to have accelerated neuromuscular 
fatigue and diminished muscular strength regardless of treatment regimen (Klassen et al., 2017; 
Monga et al., 1997). Additionally, resistance training has shown to improve muscular strength 
while simultaneously reducing inflammation and CRF in a sample of breast cancer survivors, 
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once again linking back with cytokine and HPA-axis dysregulation, though this has not been 
consistently shown (Serra et al., 2018). Despite the scarcity of literature in this area, more 
research is certainly needed to elucidate the relationship between CRF and contractile properties, 
particularly since muscular strength plays a role in overall functionality, which has also been 
shown to be related to CRF.  
 
Adenosine Triphosphate (ATP) Dysregulation  
ATP dysregulation is thought to be brought about by cancer and/or its treatment 
damaging the mitochondria, limiting ATP production, increasing CRF, and diminishing 
performance for activities of daily living (ADLs) (Chae et al., 2018; Feng et al., 2018; Hsu, 
Tseng, & Lee, 2016; Morishita, Wakasugi, et al., 2018; O’Higgins et al., 2018). Additionally, 
altered metabolism in cancer patients can be characterized by increased protein metabolism, 
leading to muscle wasting syndromes such as cachexia, which could then lead to CRF. The 
mechanism behind the ATP dysregulation hypothesis has been developed more so in the context 
of pharmaceutical treatment response for CRF rather than evaluating relationships. For example, 
Nicotinamide Adenine Dinucleotide (NADH) coenzymes are produced through metabolic 
processes (oxidative phosphorylation) and can be used to produce ATP in the electron transport 
chain (ETC). Though the research is still on-going, when NADH is reduced and ingested orally, 
no adverse symptoms are observed in those experiencing chronic fatigue syndrome indicating its 
potential value as a pharmaceutical therapy for fatigue (Forsyth et al., 1999). Additionally, when 
ATP is infused intravenously, a reduction in glucose turnover is observed in lung cancer patients 
(Agteresch, Dagnelie, et al., 2000; Agteresch, Leij-Halfwerk, et al., 2000). It’s speculated that 
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the reduction in glucose turnover can assist in preventing cachexia, which could also not only 
improve CRF, but to help uncover its underlying peripheral mechanisms. 
Breast cancer patients experience as much as a 30% reduction in cardiorespiratory fitness 
across the cancer continuum (Jones et al., 2012). Cardiorespiratory fitness refers to the ability of 
the pulmonary and circulatory systems to supply blood and oxygen to working muscles during 
sustained bouts of exercise and physical activity. It has also been conceptualized as the body’s 
ability to transport and utilize oxygen to produce energy (i.e., ATP) for physical work. 
Cardiorespiratory fitness can be quantified by measuring and individual’s VO2peak and represents 
the interaction between cardiovascular, respiratory, and metabolic systems. The greater the 
VO2peak, the more efficient and the transport and consumption of oxygen at the muscle for ATP 
production.  
Not only does cardiorespiratory fitness have important implications for mortality and 
reduced cancer risk, it might also have implications for CRF (Jones et al., 2010; Kavanagh et al., 
2003; Mandsager et al., 2018; Pozuelo-Carrascosa et al., 2019). There is preliminary evidence of 
an association between cardiorespiratory fitness and CRF. For example, greater cardiorespiratory 
fitness has been associated with less CRF in cancer survivors participating in exercise 
interventions (Courneya et al., 2003; Kalter et al., 2016). And, large reductions in 
cardiorespiratory fitness during chemotherapy have been linked with greater CRF severity 
(Kirkham et al., 2020). Based on what cancer patients experience when dealing with CRF (i.e., 
tiredness, and weakness) and what cardiorespiratory fitness represents (i.e., greater 
cardiorespiratory results in greater efficiency in producing ATP), it’s imperative this relationship 
be explored, particularly since measuring VO2peak is rather non-invasive and can be improved 




 In summary, CRF is a commonly reported disease- and treatment-related symptom. 
Despite its consistent presence throughout the cancer care continuum, it remains a complex 
symptom with many questions still to be explored. This is an important point as CRF is multi-
factorial and appears to play an important role in physical activity participation, overall 
functionality, clinical/treatment decision making, normal physiological processes, mental health, 
and health related QOL, all of which may in turn exacerbate CRF. It is important to continue 
searching for new insights as to possible physiological mechanisms that may be involved in CRF 
in breast cancer survivors, but also that these physiological mechanisms must be considered 
within the underlying notion that CRF is multi-factorial there is not a “one-size fits all” 
explanation. To date, it appears that exercise is the best treatment for combatting CRF.  
As the field of cancer-rehabilitation has evolved over the years, specific questions 
pertaining to the role of community-based exercise programs in CRF management have surfaced. 
First, since CRF can negatively impact exercise participation, it is important to discern the CRF 
severity level that patients are experiencing when they enter these programs. We also need to 
understand why patients with a particular CRF severity level are choosing or not choosing to 
participate in community-based exercise programs despite the positive influence it could have. 
We must also begin to determine if the positive impact of exercise participation on CRF 
translates to community-based settings, as these settings are both easily accessible and low-cost. 










CHAPTER III: METHODOLOGY 
Experimental Design  
This was a two-arm, non-randomized, pre-post intervention study designed to better 
understand the severity and etiology of CRF within the context of a community-based exercise 
program. Study participants underwent two days of testing that were held at least 24 hours apart 
both before and after the community-based exercise intervention (Figure 3.1 – Study Schema). 
Participants then took part in a 16-week aerobic + resistance exercise community-based program, 
including supervised training three days/week for one hour each day. After the 16 weeks of 
training, participants reported back for two days of post-testing, which occurred in the same 
order as baseline testing.  
 





Participants with histologically confirmed early stage breast cancer (Stage 0-III) who had 
completed their primary treatment within 1 year were eligible to participate in the study. Primary 
treatment included surgery, chemotherapy, radiation, or any combination thereof. Participants 
could continue to be on endocrine treatment. Participants had both oncologist and cardiologist 
clearance to participate in maximal exercise testing in addition to a resting electrocardiogram 
(ECG) that was completed prior to maximal exercise testing and provided to a team cardiologist 
for review and clearance. Healthy, age-matched, sedentary females were also recruited for means 
of a comparison group (CON) and completed the same assessments as the EBC group. Healthy-
sedentary female participants could not have been consistently participating in physical activity 
more than two times/week for the previous six months. No exclusions were made based on race, 
ethnicity, or fatigue level. All participants were required to be able to read and speak English.  
Recruitment of participants took place in the Research Triangle area including Chapel 
Hill (primary), Durham, Hillsborough, and Raleigh Clinics. Participants were screened based on 
inclusion criteria described above and were provided necessary information regarding 
participation in the exercise study (time commitment, number of testing days, etc.). The study 
(NCT03760536) was approved by the Protocol Review Committee at UNC Lineberger 
Comprehensive Cancer Center and the UNC School of Medicine Institutional Review Board. All 
participants were provided with, reviewed, and signed informed consent forms prior to 







 A summary table (Table 3.1) of outcome measurements is provided with condensed 
descriptions. More detailed descriptions of each outcome can be seen below Table 3.1. 
 
Table 3.1: Summary of Outcome Measurements  




Age Age at start of program participation 
Weight  Total body weight (kg) – detecto scale  
BMI Body weight (kg) / Height (m)2 
Treatment Type  
Chemotherapy, Radiation, 





PROMIS-F – assess fatigue over 
previous week 
Quality of Life  
FACT-G – 27-item questionnaire 
PROMIS Global Health   
Self-Efficacy for Fatigue  PSEFSM – 6-item questionnaire 
Activities of Daily Living  IADL – 7-item questionnaire 
Physical Activity  
IPAQ – Moderate, vigorous, and 
continuous walking participation  
Exercise Expectations OEE – 8-item questionnaire  
Pain PROMIS-P – 8-item questionnaire  
Depression MHI-17 – Items 1-9 are summed  
Anxiety MHI-17 – Items 10-14 are summed 
Sleep Quality  ISI – 7-item questionnaire  
Functional 
Outcomes 
Walking / Functional Fitness 6-Minute Walk Test  
Balance  Neurocom Balance Sensory Organ Test  
Physiological 
Outcomes 
VO2peak  Cycle Ergometer Maximal Ramp CPET  
Total Body Muscular Strength 
 HUMAC Norm Dynamometer Isokinetic 
/ Isometric Leg Ext and Isometric Row  
Exercise 
Participation 
Adherence  Sessions attended AND completed 
Compliance  
Met RPE & 80% of prescribed duration 




Demographics and Treatment History  
Height and weight were assessed using a calibrated Detecto Weight Beam Physician 
Scale (Detecto, Webb City, MO, USA). Body mass index (BMI) was calculated via height and 
weight. Participants provided their own demographic information via questionnaire pertaining to 
age, race, education, marital status, and status of employment. Medical history and electronic 
medical records were reviewed for information regarding current medications previous diagnoses 
or health complications, breast cancer diagnosis, cancer treatment regimens (type of 
chemotherapy), cancer treatment type (chemotherapy, radiation, or chemotherapy + radiation), 
current endocrine treatment (if any), and time since cancer treatment completion.  
 
Patient-Reported Outcomes  
Cancer-Related Fatigue (CRF) 
CRF was self-reported using the Patient-Reported Outcomes Measurement Information 
System – Fatigue (PROMIS-F). The PROMIS-F assesses fatigue within the past seven days, 
using a 5-point Likert type scale (1 = never, 5= always) and summed (the last item is reverse 
scored). Higher scores indicate a greater severity of fatigue. The PROMIS-F has demonstrated 
good reliability and internal consistency (Cronbach’s alphas > 0.86) as well as acceptable 
convergent, concurrent, and criterion validity (Cessna et al., 2016).  
 
Quality of Life (QOL)  
 Overall QOL was assessed with the Functional Assessment of Cancer Therapy – General 
(FACT-G) questionnaire. The FACT-G assesses QOL by comprising different sub-domains: 
Physical, Social/Family, Emotional, and Functional Well-Being. The FACT-G is a 27-item 
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questionnaire with each item on a 5-point Likert-type scale (0 = not at all, 4 = very much). 
Overall QOL is determined by summing each sub-domain category together and higher scores 
reflect greater QOL. The FACT-G is reliable and valid in its assessment of QOL in cancer 
populations, even as far as being able to distinguish between patients in regard to cancer stage 
and performance status (Cella et al., 1993).  
For means of comparison with the CON group, the PROMIS Global Health (GH) 
questionnaire was administered to quantify physical and mental health/quality of life. The 
PROMIS-GH is a 10-item questionnaire designed to provide a generic depiction of an 
individual’s physical and mental health. Physical and mental health are reported as separate 
scores and are computed by summing specific questions on a Likert-type scale. Both scores 
range from four to 20 and greater scores indicate better overall physical and mental health.   
 
Self-Reported Physical Activity  
Simply being physically active (active lifestyle, walking, self-motivated exercise) has 
been shown to mitigate CRF both during and after cancer treatment (Witlox et al., 2018). 
Participants self-reported their current physical activity levels using the International Physical 
Activity Questionnaire (IPAQ). The IPAQ assesses the (1) average number of days of the week 
the participant engages in continuous walking and moderate to vigorous intensity exercise and 
(2) average number of minutes per day of each respective intensity of exercise. These answers 
were then by multiplied to compute an average minutes / week the patient engages in moderate 





Outcome Expectations for Exercise (OEE)  
 The OEE is an 8-item scale designed to assess the outcome expectations/benefits that are 
associated with exercise participation. Participants answer each question to the degree in which 
they agree or disagree with the statement describing a benefit of exercise. Responses range from 
“Strongly Agree” (1) to “Strongly Disagree” (5). Scores from each question are summed, and 
lower scores indicate greater outcome expectations for exercise. The OEE measurement scale 
has been deemed both reliable and valid in its ability to capture the outcome expectations from 
exercise and exercise behavior of adults, particularly older adults (Resnick, Zimmerman, Orwig, 
Furstenberg, & Magaziner, 2000).  
 
Perceived Self-Efficacy for Fatigue Self-Management – (PSEFSM)  
 The PSEFSM questionnaire is a valid and reliable 6-item scale designed to assess how 
confident an individual is in completing certain activities within the context of their own fatigue 
levels (Hoffman et al., 2011). Responses for each question range from “Not at all confident” (1) 
to “Totally confident” (10). Scores from each question are summed, and greater scores 
correspond to better overall self-efficacy in the management of fatigue levels (i.e., individuals 
feel more confident in completing certain activities within the context of their experienced 
fatigue).  
 
Instrumental Activities of Daily Living (IADLs)  
 IADL is a 7-item questionnaire designed to assess the ability of individuals to complete 
basic tasks often required in everyday life (Fillenbaum, 1981). Responses to each question 
include “Without Help” (2), “With Some Help” (1), and “Are Completely Unable” (0). Scores 
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from each from each question are added to obtain a total (Range 0-14). Greater scores indicate an 
optimal ability to complete activities of daily living without help.  
  
Pain  
 The PROMIS-Pain Interference Short Form (8a) questionnaire was used to assess the 
frequency and severity of pain in the last seven days. Each item is on a 5-point Likert Type scale: 
1 = Not at all; 5 = Very Much. Items are summed together, and higher scores indicate greater 
severity of pain interference.   
 
Depression / Anxiety  
The Mental Health Inventory – 17 (MHI-17) is a 17-item questionnaire that enquires 
about an individual’s mood over the past two weeks (Stewart, Ware, Sherbourne, & Wells, 
1992). Each item is answered with responses ranging from “All of the time” to “None of the 
time”. To obtain an overall depression score, items one through nine a summed and totaled, 
ranging from 0-43 (higher scores = more depressed). An overall anxiety score is obtained by 
summing items 10 through 14, ranging from 0-20 (higher scores = more anxious).  
 
Sleep Quality  
Sleep quality was assessed with the Insomnia Severity Index (ISI). It is a valid/reliable 
questionnaire that has been shown to adequately evaluate sleep quality and to detect cases of 
insomnia (Morin, Belleville, Bélanger, & Ivers, 2011). The ISI contains 7-items, each ranging 
from “None/Not Noticeable” (0) to “Very Severe/Very Dissatisfied” (4). Scores from all seven 
items are then added together to generate a total score. The summed score can be interpreted as 
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follows: 0-7 = No Clinically Significant Insomnia; 8-14 = Subthreshold Insomnia; 15-21 = 
Clinical Insomnia (Moderate Severity); 22-28 = Clinical Insomnia (Severe).  
 
Functional Outcomes  
6-Minute Walk Test (6-MWT) 
Participants walked around a 50-yard course as quickly as possible without running or 
jogging. Verbal encouragement was provided throughout the test by members of the research 
team. Participants were allowed to take a break if needed. A member of the research team tallied 
the number of laps the patient completed and final distances were converted to meters (m). 
 
Balance  
 Overall balance was objectively evaluated utilizing a sensory organization test (SOT) via 
a Neurocom Balance Master (Neurocom International Inc., OR, USA). Visual, somatosensory, 
and vestibular systems were assessed via dual force plates over the course of 18 trials in six 
difference conditions. Each trial lasted ~20 seconds, were randomized, and repeated three times. 
An overall balance composite score was automatically computed and recorded for data analysis. 
The various conditions were evaluated in random order and are listed below:  
1. Eyes Open; Stable Surface  
2. Eyes Closed; Stable Surface  
3. Eyes Open; Stable Surface; Visual Surround Disturbance  
4. Eyes Open; Unstable Surface  
5. Eyes Closed; Unstable Surface  
6. Eyes Open; Unstable Surface; Visual Surround Disturbance  
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Physiological Outcomes  
Cardiorespiratory Fitness (VO2peak)  
VO2peak was assessed using the gold standard for measuring cardiorespiratory fitness, a 
maximal cardiopulmonary exercise test (CPET). Maximal CPETs have been established as safe 
and feasible to complete in cancer populations (Jones et al., 2007). A cycle ergometer was used 
to complete the maximal CPET. Participants were familiarized with the maximal CPET 
procedure by allowing them to cycle up to ~75% of their heart rate reserve (HRR). Resting heart 
rate for this calculation were obtained from the resting electrocardiogram completed for 
screening purposes. Prior to the maximal CPET, Participants were asked to refrain from 
caffeine/supplement consumption on the morning of testing. 
 After cardiologist clearance and CPET familiarization, the maximal CPET was 
completed (at least 24 hours between testing days). To monitor whole body oxygen consumption 
(VO2) during exercise, a continuous incremental ramp protocol following standard ACSM 
exercise testing guidelines was implemented while simultaneously collecting breath by breath 
metabolic analysis via the Parvo Medics TrueMax 2400 Metabolic System (Parvo Medics, Salt 
Lake City, Utah, USA). Participants’ respiratory responses were obtained by the use of a Hans 
Rudolph 7450 Series V2 Respiratory Valve (Hans Rudolph Inc., Shawnee, Kans., USA). RPE 
was monitored by using a Borg 6– 20 RPE scale. Heart rate was also continuously monitored via 
a Pacer Polar heart rate monitor (Polar Electro Inc., Lake Success, N.Y., USA).  
Participants began the maximal CPET by sitting quietly on the cycle ergometer for 3-
minutes while resting metabolic data is collected. The first stage of the test started as a 2-minute 
unloaded warm up at 0 watts followed by a 3-minute loaded warm up phase of 20 watts. 
Following the warm-up stages, the wattage/workload increased continuously by 15 watts/min 
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until test termination. Test termination was determined if the patient reached volitional 
exhaustion or if the participant’s VO2 remained stable and/or decreased with an increase in 
workload while cycling.  
 
Muscular Strength  
Muscular strength was assessed via isokinetic and isometric leg extensions on the right 
leg and isometric row exercises on a HUMAC Norm Dynamometer (Computer Sports Medicine, 
Inc., Stoughton, MA, USA).  
The isokinetic leg extension was completed at 60/second. Subjects were placed in the 
dynamometer chair with harnesses placed over the shoulders, waist, and right leg. The right knee 
was aligned with the dynamometer’s center of axis of rotation at 90. After a brief warm-up, 
participants then proceeded to complete a total of three isokinetic leg extensions at a velocity of 
60/second with two minutes of rest between each extension. Members of the research team 
provided strong verbal encouragement during each extension. The highest peak torque (PT) in 
newton meters (Nm) of the three extensions was used for data analysis. 
For the isometric leg extension, the arm of the dynamometer was adjusted and locked at a 
position where the participant’s anterior tibialis was positioned perpendicular to the floor. 
Following a start command, participants extended the leg as hard as possible against the 
immovable arm for 3-4 seconds. A total of three repetitions were completed with two minutes 
rest in between each extension. The greatest maximal voluntary contraction (MVC) and rate of 
torque development (RTD) were used for data analysis. MVC was determined as the greatest 
amount of force produced during the sustained isometric contraction and reported in Nm. RTD 
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was determined by analyzing the slope of the developed torque from 20% to 80% of the MVC 
and reported as Newton meters per second (Nm/sec).  
The isometric row was completed with participants sitting upright and secured to the 
chair of the HUMAC Norm Dynamometer system. Elbows were bent (90-degree angle) at their 
sides, with hands palm down gripping a horizontal lever arm. Participants were allowed 2-3 
warm up pulls prior to testing. When instructed, participants pulled straight back as hard as 
possible on the lever arm for 3-4 seconds. participants completed three repetitions and the 
maximal PT (Nm) and RTD (Nm/sec) generated were used for analysis. 
 
Exercise Participation 
Adherence and Compliance  
 Adherence and compliance rates were evaluated to further determine the impact of the 
exercise program on CRF. Adherence rates were calculated by dividing total number of sessions 
completed over total number of possible sessions for the entire intervention (Equation 1). 
Compliance rates were determined separately for aerobic and resistance exercise. Compliance 
was reported as a percentage and determined by evaluation of if participants met the prescribed 
exercise intensity (determined by rate of perceived exercise [RPE]) of the completed training 
sessions.  
Equation 1.  
Adherence Rate = (# sessions completed / Total # of possible exercise sessions) * 100 
Exercise Intervention  
The 16-week exercise intervention took place at an established community-based 
exercise program for cancer survivors in the Research Triangle area (Chapel Hill, Durham, 
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Raleigh). Participants were asked to attend three exercise sessions per week with each session 
lasting ~one-hour in a group exercise format (Figure 2 – Exercise Program Outline). The 
exercise sessions involved progressive aerobic and resistance exercise. The exercise training 
program was adapted by experienced exercise trainers to meet specific participant needs, if 
necessary. The program reflects current physical activity guidelines for cancer survivors 
established by the American College of Sports Medicine (ACSM) (Campbell et al., 2019). 
ACSM recommends that moderate intensity combined exercise (Aerobic + Resistance) programs 
lasting at least 12 weeks performed two to three times per week can adequately reduce CRF.  
 
Figure 3.2 Exercise Program Outline (Get REAL & HEEL)  
 
 
Aerobic Exercise  
 Aerobic exercise involved a variety of training modalities to encourage cross-training and 
keep participants engaged with the program. Different modalities included cycling, walking, 
jogging, elliptical, rowing, or seated stepper. Volume and intensity of the aerobic exercise was 
progressively increased over the course of the intervention. Participants began their aerobic 
exercise training for 10-15 minutes per session at a low intensity as determined by RPE between 
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8-11 (light). Throughout the 16-weeks, aerobic exercise progressed to include 30 minutes 
training at an RPE of 12-14 (moderate). Any other progressions to higher intensities / volume 
during the 16-weeks of training were decided at the discretion of the exercise trainer with 
consideration for patient preference. 
 
Resistance Exercise    
Resistance exercise occurred during every exercise session (after aerobic exercise was 
completed). Resistance exercise was designed to target full body workouts with exercises that 
focused on large muscle groups in order to improve strength, balance, and functionality. 
Exercises included, for example, lateral raises, wall push-ups, rows, squats, bridges, planks, 
lateral pulldowns, etc. Each resistance exercise session was performed in a group-format / circuit 
style fashion, lasting about ~20-30 minutes. Volume and intensity of the resistance exercise 
sessions were progressive, beginning with two sets of 10-15 repetitions of light to moderate 
intensity (RPE 7-13) using no or very light resistance. Resistance exercise progressed to more 
moderate / high intensity (RPE 14-15) throughout the 16-weeks, completing two sets of 10 
repetitions per exercise with the use of dumbbells, machines, or resistance bands.  
 
Sample Size and Statistical Analysis 
Sample Size Justification  
 Sample size calculations for the proposed study were completed using G*Power 3.1 
software and based on “meaningful change” cutoffs for CRF when assessed via the PROMIS-F 
questionnaire. Provided that a “meaningful change” in CRF when obtained from the PROMIS-F 
questionnaire is two to three points (Yost, Eton, Garcia, & Cella, 2011), a mean change of three 
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was considered “meaningful” in response to community-based exercise. In order to achieve 
sufficient power of 0.80, a total of 24 EBC survivors needed to be recruited in order to 
effectively detect a statistically significant mean change of three points.  
 
Statistical Analysis  
 All data collected for the study were entered into a secure electronic database (REDCap; 
Vanderbilt University; Nashville, Tennessee, USA) and analyzed using RStudio 1.3 (Boston, 
MA, USA). The alpha level was set a priori for all statistical analyses at 0.05. Descriptive 
statistics were used to summarize study population characteristics and were expressed as mean + 
standard deviation (SD) or number (percent). Shapiro-wilk tests were used to assess normality of 
baseline descriptive characteristics. Assuming normal distributions, Independent t-tests were 
used to evaluate baseline descriptive characteristics to account for the variability between 
groups. If the normality assumption was violated, a Mann-Whitney U test was used. To further 
evaluate changes in CRF after community-based exercise, Cohen’s D effect sizes were 
calculated and interpreted as follows: trivial <0.20; small <0.50; medium <0.80; large >0.8 
(Cohen, 1988).     
 
Research Aim #1: To develop a baseline multi-factorial fatigue severity profile of early breast 
cancer (EBC) survivors enrolled in a community-based exercise program (Summary Table 3.2).  
 CRF was assessed for normality via a Shapiro-wilk test. Assuming normal distribution, 
independent t-tests were used to compare levels of CRF between EBC survivors and healthy 
controls. If the normality assumption was violated, comparisons between groups were assessed 
with a Mann-Whitney U test. Univariate linear regressions were used to evaluate the associations 
 87 
 
between baseline CRF and baseline demographic/clinical characteristics, physical 
activity/functional outcomes, psychosocial outcomes, and physiological outcomes. Regression 
assumptions were checked by generating and examining residual plots: Residual vs Fitted plots 
(Linearity Assumption); QQ-Plots (Residual Normality Assumption); Scale-Location Plots 
(Homogeneity of Residual Variance Assumption); Cook’s distance test to assess the assumption 
of residual error term independence. 
Table 3.2: Statistical Analysis Summary for Research Aim 1 


























Outcome Expectations for Exercise 
Composite Balance Score 
6MWT 






















Research Aim #2: To determine the impact of community-based exercise participation 
(adherence and compliance) on CRF in EBC survivors compared to healthy controls  
(Summary Table 3.3).  
 A mixed model ANOVA was used to evaluate the pre-post changes in CRF after 
participation in community-based exercise comparing EBC survivors to healthy controls. Prior to 
conducting the mixed model ANOVA, the data was examined for outliers, and checked for 
normality (Shapiro-Wilk), homogeneity of variance (Levene’s test), and sphericity (Mauchly’s 
test). To further evaluate the impact of the community-based exercise program on CRF in EBCS, 
a one-way within subjects’ ANOVA was used to compare CRF severity at baseline, immediately 
post exercise, and six-months post exercise in the EBCS group.  
Univariate linear regression analyses were used explore the relationship between changes 
in CRF from baseline to post intervention, post intervention to six-months post intervention, and 
baseline to six-months post intervention with adherence and compliance rates to community-
based exercise. Regression assumptions were assessed and checked as described in Research 
Aim 1. 
Paired and independent samples t-tests evaluated the pre-post intervention changes in 
demographic characteristics, physical activity / functional outcomes, psychosocial outcomes, and 
physiological outcomes within and between both groups (EBCS and CON), respectively. All 
outcomes were assessed for normality via a Shapiro-Wilk test prior to analysis. In the event that 
the normality assumption was violated, changes within each group were assessed via a 
Wilcoxon-Signed Rank test, and changes between each group were assessed via a Mann-




Table 3.3: Statistical Analysis Summary for Research Aim 2 
Aim 2: Effectiveness of Community-Based Exercise on Cancer-Related Fatigue  




Group (EBC vs CON) x Time 
























 Weight / BMI 
Group: EBC vs CON  
 




 PA*, OEE, ADLs, 
balance, & 6MWT 
 QOL, depression, 
pain, anxiety, sleep, and 
self-efficacy 
 VO2peak & Total Body 
Muscular Strength 
 
 = change score from pre to post  
*6m = 6-months post; PA = self-reported physical activity 
 
Research Aim #3: To examine the association of pre-post intervention changes in CRF with 
changes in demographic, physical activity/functional, psychosocial, and physiological outcomes 
in EBC survivors compared healthy controls (Summary Table 3.4). 
 Univariate linear regressions were used to evaluate the associations among post 
intervention CRF with post intervention demographic/clinical characteristics, physical 
activity/functional outcomes, psychosocial outcomes, and physiological outcomes. Additionally, 
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univariate linear regressions were used to evaluate the associations of pre-post intervention 
changes in CRF with pre-post changes in demographic characteristics, physical 
activity/functional outcomes, psychosocial outcomes, and physiological outcomes. Regression 
assumptions were assessed and checked as described in Research Aims 1 and 2. Based on 
significant unadjusted results, exploratory analyses were conducted to develop a multivariable 
model of CRF comprised of the different determinants listed above contributing to CRF after 
exercise participation. 
Table 3.4: Statistical Analysis Summary for Research Aim 3 
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*All statistical analyses will be conducted by examining associations between the change 









CHAPTER IV: MANUSCRIPT #1 
FATIGUE IN EARLY BREAST CANCER SURVIVORS AND SEDENTARY 
CONTROLS PRIOR TO PARTICIPATION IN COMMUNITY-BASED EXERCISE 
(Research Aim 1)  
 
Introduction 
Cancer-related fatigue (CRF) is defined as a distressing/persistent subjective feeling of 
tiredness and exhaustion that is related to the cancer and/or its treatment, which negatively 
impacts activities of daily living and quality of life (Berger et al., 2015; Curt et al., 2000). It is 
the most common patient reported side effect, persisting in ~20-50% of early breast cancer 
survivors (EBCS) after treatment completion (Bower et al., 2006; Matias et al., 2019). Despite its 
prevalence, the etiology of CRF is poorly understood. The complexity of CRF is evident in the 
on-going debate about its multi-factorial nature, encompassing physiological, psychosocial, 
functional, clinical, and demographic factors. The lack of clarity complicates effective fatigue 
management in cancer survivors.    
CRF has been associated with treatment type and disease stage as well as age, greater 
body mass index, lack of physical activity/diminished functional status, and worsened 
psychosocial outcomes such as overall quality of life, depression, and anxiety (Abrahams et al., 
2016; Inglis et al., 2020; Jones et al., 2016; Kessels, Husson, & van der Feltz-Cornelis, 2018; 
Kneis et al., 2016; Susanne, Michael, Peter, Andreas, & Thomas, 2019). There is evidence that 
impaired cardiorespiratory fitness (VO2peak) and lower muscular strength contribute to greater 
CRF severity (Adams et al., 2018; Kalter et al., 2016; O’Higgins et al., 2018; Winters-Stone et 
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al., 2008). This makes sense particularly in EBCS who are known to experience reduction in 
VO2peak across the cancer care continuum (Jones et al., 2012). However, CRF is highly complex, 
with much still to be learned about how psychological, demographic, functional, and 
physiological factors contribute to its severity and persistence. The more we know about the 
mechanisms underlying CRF, the more success we will have in developing interventions for 
optimizing fatigue management.   
Although the mechanisms around CRF remain unclear, one finding that has remained 
consistent is that aerobic and resistance exercise can be an effective intervention for alleviating 
CRF (Campbell et al., 2019; Kessels et al., 2018; Mustian et al., 2017; Serdà I Ferrer et al., 
2018). The evidence supporting exercise for the management of CRF has come primarily from 
randomized-controlled trials in laboratory/clinic-based settings. Impactful exercise opportunities 
for symptom management are becoming more readily available in the form of community-based 
exercise programs, which provide rehabilitation exercise to cancer survivors at little to no cost.  
Examples of these programs are the Get Real and HEEL Breast Cancer Program, Rocky 
Mountain Cancer Rehab Institute, and the Livestrong program associated with the YMCA. 
Although they have been shown to improve health-related quality of life (Covington et al., 
2019), evidence pertaining to the fatigue severity of participants in community-based exercise 
programs is limited. This is important to investigate since CRF itself is known to be a barrier to 
exercise participation (Cheifetz et al., 2015). Before assessing the effectiveness of community-
based exercise programs on the management of CRF, it is important to evaluate the level of 
fatigue of cancer survivors prior to participation in these types of programs, and to identify 
factors contributing to the development of CRF. 
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In the current study, we sought to better understand CRF in EBCS prior to participating 
in a community-based exercise program compared to non-cancer controls. The purpose of our 
investigation was to 1) determine baseline fatigue severity in EBCS prior to participating in a 
community-based exercise program compared to sedentary non-cancer controls, and 2) identify 
factors that may be associated with fatigue severity in both groups in an effort to better 
comprehend the multi-factorial nature of fatigue. Findings from this study will inform future 
community-based exercise programs regarding the fatigue profile of EBCS interested in 
participating in these programs which may, in turn, allow for development and testing of tailored 




Experimental Design  
 This was a non-randomized, cross-sectional study of women with EBCS and sedentary 
women of similar age without breast cancer (CON) that was designed to explore the severity and 
correlates of CRF in women prior to participation in a community-based exercise program. 
Participants in both groups underwent two days of testing that were held at least 24 hours apart. 
Day 1 testing consisted of an initial screening, followed by patient-reported outcome (PROs) 
questionnaires, functional testing, and familiarization with the maximal cardiopulmonary 
exercise test (CPET) procedure and upper/lower body muscular strength testing. After 24-48 
hours, participants returned on Day 2 to complete the maximal CPET and upper/lower body 
muscular strength test.  
 
Participants  
The study’s sample was drawn from participants in a recently completed intervention 
study (NCT03760536) testing the effectiveness of a community-based exercise program in 
EBCS compared to healthy controls. Thirty-three EBCS with histologically confirmed early 
stage breast cancer (Stage 0-III) who had completed their primary treatment within one year 
participated in the intervention study. EBCS primary treatment included surgery, chemotherapy, 
radiation, or any combination thereof, and patients could be on endocrine treatment. EBCS 
participants had both oncologist and cardiologist clearance to participate in maximal exercise 
testing in addition to a resting electrocardiogram (ECG) that was reviewed for clearance by a 
team cardiologist. Age-matched, sedentary females (n=21) were also recruited as the CON group 
and completed the same Day 1 and 2 assessments as the EBCS. A requirement for the CON 
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women was that they must not have been consistently participating in physical activity more than 
two times/week for the previous six months. All participants were required to be able to read and 
speak English.  
Recruitment of participants took place in the Research Triangle area including Chapel 
Hill (primary), Durham, Hillsborough, and Raleigh. Recruitment and reasons for study 
refusal/discontinuation can be seen in the Figure 4.1 (Recruitment Flow Chart). The study was 
approved by the Protocol Review Committee of the UNC Lineberger Comprehensive Cancer 
Center and the UNC Biomedical Institutional Review Board. All participants signed a written 
informed consent prior to participating in any study activities.  
 








Outcome Measurements  
Demographics and Breast Cancer Diagnosis and Treatment 
Height and weight were assessed using a calibrated Detecto Weight Beam Physician 
Scale (Detecto, Webb City, MO, USA) and body mass index (BMI) was calculated. Participants 
provided their demographic information via questionnaire pertaining to age, race, education, 
marital status, and status of employment. Medical history and electronic medical records were 
reviewed for information on breast cancer diagnosis, cancer treatment (type of chemotherapy, 
radiation, or both), current endocrine treatment (if any), and time since cancer treatment 
completion.  
 
Patient-Reported Outcomes  
Cancer-Related Fatigue  
 CRF was self-reported using the Patient-Reported Outcomes Measurement Information 
System – Fatigue (PROMIS-F) (Cessna et al., 2016). The PROMIS-F assesses fatigue within the 
past seven days, using a 5-point Likert type scale (1 = never, 5= always) and summed (the last 
item is reverse scored). Higher scores indicate greater severity of fatigue. PROMIS Measurement 
Score Cut Points were used to classify fatigue severity: “Within Normal Limits” (7-16.5), “Mild” 
(16.5-24), “Moderate” (25-29.5), and “Severe” (30-35).  
 
Quality of Life (QOL) 
 Health-related quality of life of was assessed with the Functional Assessment of Cancer 
Therapy – General (FACT-G) (Cella et al., 1993) questionnaire in the EBCS group. The FACT-
G assesses QOL within four sub-domains: Physical, Social/Family, Emotional, and Functional 
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Well-Being. The FACT-G is a 27-item questionnaire with each item on a 5-point Likert-type 
scale (0 = not at all, 4 = very much). Overall QOL is determined by summing each sub-domain 
category together and higher scores reflect greater QOL.  
For comparison with the CON group, the PROMIS Global Health (GH) (Barile et al., 
2013) questionnaire was administered to quantify physical and mental health/quality of life. The 
PROMIS-GH is a 10-item questionnaire designed to provide a generic depiction of an 
individual’s physical and mental health. Physical and mental health are reported as separate 
scores and are computed by summing specific questions on a Likert-type scale. Both scores 
range from four to 20 and greater scores indicate better overall physical and mental health.   
 
Self-Reported Physical Activity 
Participants self-reported their current physical activity levels using the International 
Physical Activity Questionnaire (IPAQ) (Hagströmer, Oja, & Sjöström, 2006). IPAQ assesses 
the (1) average number of days of the week the participant engages in continuous walking and 
moderate to vigorous intensity exercise and (2) average number of minutes per day of each 
respective intensity of exercise. These answers were then by multiplied to compute an average 
minutes / week the patient engages in moderate and vigorous intensity exercise and continuous 
walking. 
 
Outcome Expectations for Exercise (OEE) 
OEE is an 8-item scale designed to assess the outcome expectations/benefits that are 
associated with exercise participation (Resnick et al., 2000). Participants answer each question to 
the degree in which they agree or disagree with the statement describing a benefit of exercise. 
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Responses range from “Strongly Agree” (1) to “Strongly Disagree” (5). Scores from each 
question are summed, and lower scores indicate greater outcome expectations for exercise. 
 
Perceived Self-Efficacy for Fatigue Self-Management (PSEFSM) 
The PSEFSM questionnaire is a valid and reliable six-item scale designed to assess how 
confident an individual is in completing certain activities within the context of their own fatigue 
level (Hoffman et al., 2011). Responses for each question range from “Not at all confident” (1) 
to “Totally confident” (10). Scores from each question are summed, and greater scores 
correspond to better overall self-efficacy in the management of fatigue levels (i.e., individuals 




 The PROMIS-Pain Interference Short Form (8a) (Revicki et al., 2009) questionnaire was 
used to assess the frequency and severity of pain in the last seven days. Each item is on a 5-point 
Likert Type scale: 1 = Not at all; 5 = Very Much. Items are summed together, and higher scores 
indicate greater severity of pain interference.   
 
Depression / Anxiety  
The Mental Health Inventory – 17 (MHI-17) is a 17-item questionnaire that enquires 
about an individual’s mood over the past two weeks (Pergolotti et al., 2019). Each item is 
answered with responses ranging from “All of the time” to “None of the time”. To obtain an 
overall depression score, items one through nine are summed and totaled, ranging from 0-43 
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(higher scores = more depressed). An overall anxiety score is obtained by summing items 10 
through 14, ranging from 0-20 (higher scores = more anxious).  
 
Sleep Quality 
Sleep quality was assessed with the Insomnia Severity Index (ISI) (Yusufov, Zhou, & 
Recklitis, 2019). It is a valid and reliable questionnaire that has been shown to adequately 
evaluate sleep quality and to detect cases of insomnia (Morin et al., 2011). The ISI contains 
seven items, each ranging from “None/Not Noticeable” (0) to “Very Severe/Very Dissatisfied” 
(4). Scores from all seven items are then added together to generate a total score. The summed 
score can be interpreted as follows: 0-7 = No Clinically Significant Insomnia; 8-14 = 
Subthreshold Insomnia; 15-21 = Clinical Insomnia (Moderate Severity); 22-28 = Clinical 
Insomnia (Severe).  
 
Instrumental Activities of Daily Living (IADL) 
 IADL is a 7-item questionnaire designed to assess the ability of individuals to complete 
basic tasks often required in everyday life (Fillenbaum, 1981). Responses to each question 
include “Without Help” (2), “With Some Help” (1), and “Are Completely Unable” (0). Scores 
from each from each question are added to obtain a total (Range 0-14). Greater scores indicate an 








6-Minute Walk Test 
Participants walked around a 50-yard course as quickly but safely as possible without 
running or jogging. Verbal encouragement was provided throughout the test by members of the 
research team. A member of the research team tallied the number of laps the patient completed 
and final distances were converted to meters (m). 
 
Balance 
 Overall balance was objectively evaluated utilizing a sensory organization test (SOT) via 
a Neurocom Balance Master (Neurocom International Inc., OR, USA). Visual, somatosensory, 
and vestibular systems were assessed via dual force plates over the course of 18 trials in six 
difference conditions. Each trial lasted ~20 seconds, were randomized, and repeated three times. 
An overall balance composite score was automatically computed and recorded for data analysis. 
The various conditions were evaluated in random order and are listed below:  
 
1. Eyes Open; Stable Surface 
2. Eyes Closed; Stable Surface 
3. Eyes Open; Stable Surface; Visual Surround Disturbance 
4. Eyes Open; Unstable Surface 
5. Eyes Closed; Unstable Surface 





Physiological Outcomes  
Cardiorespiratory Fitness (VO2peak) 
VO2peak was assessed using the gold standard for measuring cardiorespiratory fitness, a 
maximal cardiopulmonary exercise test (CPET). Maximal CPETs have been established as safe 
and feasible to complete in cancer populations (Jones et al., 2007). A cycle ergometer was used 
to complete the maximal CPET. Participants were familiarized with the maximal CPET 
procedure by allowing them to cycle up to ~75% of their heart rate reserve (HRR). Resting heart 
rate for this calculation were obtained from the resting electrocardiogram completed for 
screening purposes. Prior to the maximal CPET, participants were asked to refrain from 
caffeine/supplement consumption on the morning of testing. 
 After cardiologist clearance and CPET familiarization, the maximal CPET was 
completed (at least 24 hours between testing days). To monitor whole body oxygen consumption 
(VO2) during exercise, a continuous incremental ramp cycling protocol following standard 
ACSM exercise testing guidelines was implemented while simultaneously collecting breath by 
breath metabolic analysis via the Parvo Medics TrueMax 2400 Metabolic System (Parvo Medics, 
Salt Lake City, Utah, USA). Participants’ respiratory responses were obtained by the use of a 
Hans Rudolph 7450 Series V2 Respiratory Valve (Hans Rudolph Inc., Shawnee, Kans., USA). 
RPE was monitored by using a Borg 6–20 RPE scale (Borg, 1970). Heart rate was also 
continuously monitored via a Pacer Polar heart rate monitor (Polar Electro Inc., Lake Success, 
N.Y., USA).  
Participants began the maximal CPET by sitting quietly on the cycle ergometer for 3-
minutes while resting metabolic data is collected. The first stage of the test started as a 2-minute 
unloaded warm up at 0 watts followed by a 3-minute loaded warm up phase of 20 watts. 
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Following the warm-up stages, the wattage/workload increased continuously by 15 watts/min 
until test termination. Test termination was determined when the patient reached volitional 
exhaustion or if the participant’s VO2 plateaus and does not increase more than 150 ml min-1 
with a further increase in workload. 
 
Muscular Strength 
Muscular strength was assessed via isokinetic and isometric leg extensions on the right 
leg and isometric row exercises on a HUMAC Norm Dynamometer (Computer Sports Medicine, 
Inc., Stoughton, MA, USA). The isokinetic leg extension was completed at 60/second. 
Participants were placed in the dynamometer chair with harnesses placed over the shoulders, 
waist, and right leg. The right knee was aligned with the dynamometer’s center of axis of 
rotation at 90. After a brief warm-up, participants then proceeded to complete a total of three 
isokinetic leg extensions at a velocity of 60/second with two minutes of rest between each 
extension. Members of the research team provided strong verbal encouragement during each 
extension. The highest peak torque (PT) of the three extensions was used for data analysis. 
For the isometric leg extension, the arm of the dynamometer was adjusted and locked at a 
position where the participant’s anterior tibialis was positioned perpendicular to the floor. 
Following a start command, participants extended the leg as hard as possible against the 
immovable arm for 3-4 seconds. A total of three repetitions were completed with two minutes 
rest in between each extension. The greatest maximal voluntary contraction (MVC) and rate of 
torque development (RTD) were used for data analysis. MVC was determined as the greatest 
amount of force produced during the sustained isometric contraction. RTD was determined by 
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analyzing the slope of the developed torque from 20% to 80% of the MVC and reported as 
Newton meters per second (Nm/sec).  
The isometric row was completed with participants sitting upright and secured to the 
chair of the HUMAC Norm Dynamometer system. Elbows were bent (90-degree angle) at their 
sides, with hands palm down gripping a horizontal lever arm. Participants were allowed 2-3 
warm up attempts prior to testing. When instructed, participants pulled straight back as hard as 
possible on the lever arm for 3-4 seconds. participants completed three repetitions and the 
maximal PT and RTD generated were used for analysis. 
 
Statistical Analysis  
 All data were entered into a secure electronic database (REDCap; Vanderbilt University; 
Nashville, Tennessee, USA) and analyzed using RStudio 1.3 (Boston, MA, USA). The alpha 
level was set a priori for all statistical analyses at 0.05. Descriptive statistics were used 
summarize study population characteristics and were expressed as mean + standard deviation 
(SD) or number (percent). Independent t-tests for continuous variables and chi-square tests for 
categorical variables were used to evaluate baseline descriptive characteristics to account for the 
variability between EBCS and CON groups.  
 CRF data were assessed for normality via a Shapiro-Wilk test. Due to a non-normal 
distribution, a Mann-Whitney U test was used to compare fatigue levels between EBCS and 
CON. Univariate linear regressions were conducted to evaluate associations of fatigue with 
demographic characteristics, physical activity/functional outcomes, psychosocial outcomes, and 
physiological outcomes. Regression assumptions were checked and confirmed by conducting a 
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Cook’s distance test for residual error term independence and generating residual plots for 





Baseline Demographics and Fatigue Severity 
 Baseline characteristics (mean ± SD) for the sample are shown in Tables 4.1 and 4.2. Age 
(54  11 vs 54  8, p>0.05) and weight (76.3  12.1 vs 76.9  13.9, p>0.05) were not statistically 
different between EBCS and CON. Height (167.0  7.3cm vs 161.8  6.4cm, p<0.05), depression 
(9.5  7.8 vs 4.8  3.3, P<0.05), pain (11.5  6.6 vs 8.9  1.7, p<0.05), sleep quality (8.4  5.4 vs 
5.5  3.7, p<0.05), and perceived self-efficacy for fatigue self-management (41.7  11.8 vs 50.3 
 10.9, p<0.05) were significantly different between EBCS and CON. Fatigue severity was not 
significantly different between EBCS and CON (16.9  5.8 vs 14.2  3.4, p=0.121) as shown in 
Figure 4.2. However, descriptively, fatigue severity for EBCS was considered “mild”, while for 
CON participants were deemed “within normal limits” as determined by the PROMIS 
Measurement Score Cut Points. 
 




Table 4.1: Study Participant Characteristics – mean (SD) or number (%) 
Variable EBCS (N=33) CON (N=21) 
Age (years) 54 (11) 54 (8) 
Height (cm) 167.0 (7.3) 161.8 (6.4)  
Weight (kg) 76.3 (12.1) 76.9 (13.9) 
Race    
White 28 (84.8) 18 (85.7) 
African American or Other 5 (15.2) 3 (14.3) 
Body Mass Index (BMI)    
Normal (18-25) 10 (30.3) 3 (14.3) 
Overweight (25-30) 16 (48.5) 10 (47.6) 
Obese (> 30) 7 (21.2) 8 (38.1) 
Education    
High school or less 3 (9.1) 0 (0) 
More than high school 30 (90.9) 21 (100) 
Employed more than 32 h a week   
No  17 (51.5) 2 (9.5) 
Yes  16 (48.5) 19 (90.5) 
Married      
No 11 (33.3) 9 (42.9) 
Yes 22 (66.7) 12 (57.1) 
Breast Cancer Stage   
I 9 (29.0) -- 
II 15 (48.4) -- 
III 7 (22.6) -- 
Surgery   
Mastectomy  10 (30.3) -- 
Lumpectomy   23 (69.7) -- 
Treatment Type    
Chemotherapy Only 5 (16.1) -- 
Radiation Only  12 (38.7) -- 
Chemo + Radiation 10 (32.3) -- 
Surgery Only  4 (12.9) -- 
Endocrine Therapy   
No 8 (24.2) -- 
Yes 25 (75.8) -- 
Menopausal Status   
Pre 12 (36.4) -- 
Post 21 (63.6) -- 
Average Days since Treatment Completion 94 (9) -- 





Table 4.2: Study Outcome Measurements [Baseline] – Mean (SD) 
Variable (scale range) EBCS CON 
Psychosocial Outcomes    
PROMIS Physical Global Health (4 – 20)  12.5 (2.5) 11.6 (4.0) 
PROMIS Mental Global Health (4 – 20) 10.8 (2.9) 13.5 (3.6) 
FACT- General (0 – 108) 83.5 (13.8) -- 
Physical (0 – 28)  22.3 (4.5) -- 
Social/Family (0 – 24) 20.2 (5.2) -- 
Emotional (0 – 28) 20.5 (3.3) -- 
Functional (0 – 28) 20.5 (4.3) -- 
Depression [MHI] (0 – 43) 9.5 (7.8) 4.8 (3.3) 
Anxiety [MHI] (0 – 20) 4.9 (4.0) 3.9 (2.7) 
PROMIS-Pain (8 – 40)  11.5 (6.6) 8.9 (1.7) 
Sleep Quality [ISI] (0 – 28) 8.4 (5.4) 5.5 (3.7) 
Self-Efficacy for Fatigue Self-Management 
(6 – 60)  
41.7 (11.8) 50.3 (10.9) 
Physical Activity / Functionality Outcomes  
Self-Reported Physical Activity (min/week)     
Moderate Physical Activity  116.5 (184.4) 42.4 (100.6) 
Vigorous Physical Activity  43.6 (62.1) 16.4 (43.6) 
Continuous Walking 323 (388) 198 (187) 
Outcome Expectations for Exercise (8 – 40) 14.9 (5.5) 16.4 (8.2) 
Instrumental Activities of Daily Living  
(0 – 14) 
13.9 (0.3) 14.0 (0.0) 
Balance  72.1 (11.1) 76.4 (9.2) 
6-Minute Walk  533.0 (74.3) 538.1 (57.8) 
Physiological Outcomes  
VO2peak (ml-1•kg-1•min-1) 20.8 (5.1) 21.2 (3.9) 
Lower Body Strength      
Isokinetic LE PT (Nm/sec) 79.8 (20.2) 72.7 (22.1) 
Isometric LE MVC (Nm)  101.9 (26.0) 108.5 (28.5) 
Isometric LE RTD (Nm/sec) 306.2 (106.2) 269.9 (143.9) 
Upper Body Strength     
Isometric Row MVC (Nm) 61.6 (22.3) 68.7 (18.8) 
   Isometric Row RTD (Nm/sec) 148.8 (81.8) 138.6 (62.8) 






Observed Associations with Fatigue   
 Lower fatigue severity in EBCS was significantly associated with better overall self-
reported physical health (adj R2 = 0.414; p<0.001), mental health (adj R2 = 0.414; p<0.001), 
health-related quality of life (adj R2 = 0.447; p<0.001), depression (adj R2 = 0.360; p<0.001), 
self-efficacy for fatigue self-management (adj R2 = 0.385; p<0.01), outcome expectations for 
exercise (adj R2 = 0.208; p<0.001), and balance (adj R2 = 0.237; p<0.001). Lower fatigue in 
CON participants was associated with better self-efficacy (adj R2 = 0.364; p<0.01) and sleep 
quality (adj R2 = 0.196; p <0.05). No physiological, self-reported physical activity, or treatment-
type were associated with fatigue severity in either group. All univariate linear regression results 
















Table 4.3: Univariate analysis of associations with Cancer-Related Fatigue (Baseline) 
  EBCS  CON 
Variable  Estimate (SE) Adj. R2  Estimate (SE) Adj. R2 
Demographic Characteristics        
Age  0.168 (0.091) 0.084 -0.117 (0.113) 0.006 
Body Mass Index (BMI) -0.278 (0.213) 0.025 0.034 (0.187) -0.088 
Body Weight  -0.001 (0.090) -0.037 0.008 (0.064) -0.089 
Psychosocial Outcomes    
PROMIS Global Health (Physical)  -1.603 (0.351) 0.451 -0.410 (0.506) -0.030 
PROMIS Global Health (Mental) -1.432 (0.314) 0.425 -0.274 (0.391) -0.044 
FACT- General -0.283 (0.055) 0.447 -- -- 
Physical  -0.860 (0.168) 0.441 -- -- 
Social/Family -0.525 (0.176) 0.199 -- -- 
Emotional  -0.473 (0.298) 0.045 -- -- 
Functional -0.927 (0.172) 0.468 -- -- 
Depression (MHI) 0.513 (1.125)  0.360 -0.073 (0.268) -0.084 
Anxiety (MHI) 0.471 (0.266) 0.071 -0.080 (0.341) -0.086 
PROMIS-Pain  0.287 (0.156) 0.079 -0.658 (0.596)  0.018 
Sleep Quality (ISI) 0.230 (0.212) 0.006 0.403 (0.203) 0.196 
Self-Efficacy for Fatigue Self-
Management 
-0.318 (0.074) 0.385 -0.172 (0.061 0.364 
Physical Activity / Functionality Outcomes  
Self-Reported Physical Activity 
(min/week) 
    
Moderate Physical Activity  -0.001 (0.006) -0.037 -0.016 (0.010) 0.113 
Vigorous Physical Activity  -0.020 (0.017) 0.013 -0.061 (0.060) 0.005 
Continuous Walking 0.002 (0.003) 0.026 0.001 (0.005 -0.086 
Outcome Expectations for Exercise  0.525 (0.185) 0.208 0.038 (0.095) -0.075 
Instrumental Activities of Daily Living  -5.350 (3.069) 0.068 -- 
Balance  -0.257 (0.082) 0.237 0.027 (0.152) -0.088 
6-Minute Walk  -0.023 (0.015) 0.049 0.004 (0.018) -0.085 
Physiological Outcomes   
VO2peak  -0.233 (0.204) 0.011 0.178 (0.313) -0.060 
Lower Body Strength      
Isokinetic Leg Extension (PT) 0.018 (0.057) -0.033 0.026 (0.052) -0.066 
Isometric Leg Extension (MVC)  -0.008 (0.042) -0.036 0.012 (0.030) -0.074 
Isometric Leg Extension (RTD) 0.010 (0.010) -0.001 0.007 (0.005) 0.067 
Upper Body Strength     
Isometric Row (MVC) -0.007 (0.048) -0.036 -0.020 (0.048) -0.074 
Isometric Row (RTD) -0.004 (0.014) -0.034 0.007 (0.014) -0.070 




The purpose of this study was to report CRF severity and associated factors in a sample 
of EBCS and healthy controls prior to participation in a community-based exercise program. 
Fatigue severity in the EBCS group was not significantly different from the CON group but was 
a priori classified “mild” as compared to “normal” in CON. The “mild” fatigue severity reported 
in our EBCS sample is contrary to previous reports showing that ~20-50% of breast cancer 
survivors continue to experience substantial fatigue for up to two years after primary treatment 
(Bower et al., 2006; Matias et al., 2019). Comparatively, only ~3% of EBCS in our study 
reported moderate to severe CRF. In our sample, CRF in EBCS was also significantly associated 
with psychosocial outcomes as well as exercise outcome expectations and functionality, while 
few associations were observed in the CON group. Demographics, self-reported physical 
activity, and physiological outcomes showed no association with fatigue in either group. These 
findings provide valuable information about the characteristics of EBCS currently accessing 
community-based exercise programs. This information, in turn, will allow for advancement and 
assessment of targeted interventions aimed at improving the benefits of community-based 
exercise programs on CRF. 
 CRF has been reported as a barrier to participation in both lab/clinic based exercise 
programs and community-based exercise programs across multiple cancer survivor populations 
(Aycinena et al., 2017; Cheifetz et al., 2015; Gho, Munro, Jones, & Steele, 2014; Sue Kim, Han, 
Lee, & Jang, 2020; Olson et al., 2014; Yildiz Kabak, Gursen, Aytar, Akbayrak, & Duger, 2020). 
Patients who consistently feel a sense of tiredness and exhaustion with no improvement may feel 
they do not have the “energy” to exercise, as this requires additional exertion beyond 
requirements of daily life.  This appears not to be the case for EBCS in the present study, as they 
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mostly reported mild fatigue and do not report issues in carrying out activities of daily living. 
Moreover, there were no significant differences from CON in terms of balance and 6MWT 
performance. Lower fatigue severity was also associated with better self-efficacy for fatigue 
management and outcome expectations for exercise. This is of importance as poor self-efficacy 
and negative perceptions of physical activity have been identified as possible barriers to exercise 
participation in breast cancer survivors as well (Aycinena et al., 2017; Haas, 2011; Olson et al., 
2014). These findings suggest that EBCS agreeing to participate in the community-based 
exercise program not only have the physical capability of doing so, but also feel they can 
sufficiently manage their own fatigue and have a positive perception of exercise participation 
despite cancer-related side effects.  
These findings also suggest that EBCS experiencing more severe fatigue may not be 
accessing community-based exercise programs, which underscores the challenge of attracting 
more severely fatigued patients into interventions that may help mitigate this side effect. In 
community-based settings that have explored the effects of exercise on CRF, mild fatigue 
severity at baseline is commonly reported (Irwin et al., 2017; Leach et al., 2015, 2016; Loughney 
et al., 2019; Musanti et al., 2019; Nock et al., 2015; Schumacher & McNiel, 2018). Although not 
directly addressed in the present study, it is plausible that information about the benefits of 
exercise participation on CRF are not routinely provided to patients. The frequency of physical 
activity communication between oncology clinicians and cancer survivors has been shown to be 
highly variable yet feasible (Nyrop et al., 2016). This inconsistency may contribute to low levels 
of physical activity or understanding of fatigue-specific benefits from exercise participation in 
breast cancer patients (Blaney, Lowe-Strong, Rankin-Watt, Campbell, & Gracey, 2013; Browall, 
Mijwel, Rundqvist, & Wengström, 2018; Jones, Reinhoudt, Hilverda, Rutjes, & Hayes, 2020).  
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As a result, it is possible that EBCS experiencing more severe fatigue did not take advantage of 
the community-based exercise program in this study because they were not aware of the benefits 
nor of the program itself. These explanations can only be speculated at this time, yet they are 
important to consider as exercise continues expand into community-based settings and CRF is 
commonly cited as a barrier to exercise participation (Cheifetz et al., 2015).  
While fatigue was not statistically different between EBCS and CON groups, it was 
associated with multiple psychosocial / functional outcomes in EBCS whereas fatigue in the 
CON group was only associated with self-efficacy and sleep quality. These findings may suggest 
the multi-factorial nature and uniqueness of CRF in EBCS as compared to non-CRF fatigue in 
cancer-free women. As CRF is specific to the cancer process (Berger et al., 2010), it is not 
surprising that the CON group exhibited no fatigue and few associations with commonly-
reported treatment related side effects. Additionally, lower fatigue in EBCS was related to 
outcomes such as better quality of life, depression, anxiety, balance, and ability to perform 
activities of daily living, which have been routinely associated with CRF (Berger et al., 2015; 
Jones et al., 2016; Kneis et al., 2016; Minton, Alexander, & Stone, 2012). 
To our knowledge, our study is the first to show that the relationship between fatigue and 
various psychosocial and functional outcomes persist in a community-based exercise setting. 
This finding is important as community-based exercise programs are often designed to provide 
cancer survivors with both physical and psychological benefits, often resulting in improved 
functionality, physical/mental health, and quality of life  (Covington et al., 2019; Irwin et al., 
2017; Schumacher & McNiel, 2018; Spector et al., 2012). Therefore, it is reasonable to consider 
that community-based exercise programs may be inherently configured to target psychological 
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and functional factors that are associated with fatigue, creating a viable option to improve CRF 
and overall quality of life, although more research is needed to confirm this. 
No significant associations were observed between CRF and any physiological outcomes 
(VO2peak, muscular strength) in EBCS and CON. Identifying the physiological mechanisms of 
CRF has proven difficult, with many theories proposed but none confirmed (O’Higgins et al., 
2018; Ryan et al., 2007; Saligan et al., 2015). This may be partly due to the objective 
measurement of physiological outcomes vs. the subjective nature in which CRF is assessed. As 
our findings in EBCSs suggest, reduced VO2peak and less muscular force does not necessarily 
manifest as subjectively feeling chronically tired or exhausted, although the small sample size 
make this far from conclusive. Out findings do provide some insights for community-based 
exercise programs as a tool for CRF management. For example, the low VO2peak values 
expressed in EBCS in our study provide justification for exercise participation as this can help 
improve cardiorespiratory fitness. To the extent that exercise participation also improves CRF, it 
is conceivable that these changes may be associated with each other after exercise training as this 
is where the relationship has most commonly been reported (Adams et al., 2018; Courneya et al., 
2003; Kalter et al., 2016).  
 Certain limitations of the study should be addressed. The small study sample was 
comprised of mostly white women with EBCS who agreed to participate in a community-based 
exercise program. EBCS in our study also reported substantially lower fatigue severity at 
baseline as compared to previous studies in EBCS and, therefore, may not be representative of 
the general population of early breast cancer survivor. Additionally, many of the proposed 
central physiological mechanisms hypothesized to be associated with CRF were not assessed 
(i.e., cytokine dysregulation) (O’Higgins et al., 2018). Future research should address these 
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limitations in order to expand outreach of community-based programs, particularly among racial 
minorities and women who are experiencing more severe fatigue. Studies are also needed to 
analyze physical activity conversations and referrals within cancer care clinics including the 
identification of specific facilitators and barriers specific to community-based exercise programs 
and strategies to address these barriers. Future studies should also continue testing the 
effectiveness of community-based exercise programs in their ability to alleviate fatigue. Provided 
these exercise programs are both viable and low-cost, they may be a feasible and accessible 
resource for the management of CRF.   
 
Conclusion 
The present study showed that EBCS agreeing to participate in community-based 
exercise reported mild fatigue severity at baseline at levels that were not significantly different 
from the CON group. Fatigue severity was associated with several psychosocial and functional 
outcomes in EBCS that was observed to a lesser extent in the CON group. These findings 
highlight the uniqueness of fatigue experienced in EBCS as well as providing data for future 
effectiveness research and outreach in community-based exercise programs focused on fatigue 
management. Future research should address whether 1) moderate to severe fatigue plays a 
significant role in the interest/willingness of EBCS to participate in community-based exercise 
programs, 2) the extent to which community-based exercise can alleviate CRF and the reasons 
why factors explored in the present study are associated with this improvement,  and 3) how 
clinic-based exercise education and referrals to community-based exercise programs can be 










CHAPTER V: MANUSCRIPT #2 
IMPACT OF A COMMUNITY-BASED EXERCISE PROGRAM ON FATIGUE IN 
EARLY BREAST CANCER SURVIVORS (Research Aims 2 & 3)  
 
Introduction 
 Advancements in breast cancer treatments have resulted in 90% and 83% survival rates at 
5 and 10 years, respectively, in women with early breast cancer (“Cancer Facts & Figures,” 
2019). However, cancer treatments often produce side effects including pain, nausea, sleep 
disruption, depression, anxiety, diminished aerobic capacity / functionality, fatigue, and 
diminished quality of life (Jones et al., 2012; Nyrop et al., 2019). Of these side effects, cancer-
related fatigue (CRF) is the most commonly reported and can persist long after primary treatment 
has been completed (Berger et al., 2010; Bower et al., 2006; Matias et al., 2019; Reinertsen et al., 
2010).  
CRF is a multi-factorial symptom in that a combination of factors contributes to its 
development and persistence. These can include psychosocial factors such as depression and 
anxiety (Charalambous & Kouta, 2016; Iwase et al., 2015; Minton et al., 2012; Reinertsen et al., 
2010), low physical activity / functionality (Kessels et al., 2018; Romero et al., 2018), clinical 
characteristics such as treatment type/regimen (Nyrop et al., 2019; Thong et al., 2018), and 
physiological alterations such as reduced cardiorespiratory fitness (VO2peak) and muscular 
strength (Adams et al., 2018; Morishita, Wakasugi, et al., 2018; O’Higgins et al., 2018; Winters-
Stone et al., 2008). Similarly, treatment-related side effects such as sleep disturbances, pain, and 
depression/anxiety can also exacerbate CRF severity (Carpenter et al., 2004; Haas, 2011; 
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Stepanski et al., 2009). CRF is a burdensome symptom that often results in diminished physical 
activity participation, which negatively impacts functionality and ability to perform simple daily 
tasks. A persistent pattern of fatigue leading to decreased physical activity participation and 
diminished overall functionality is referred to as the “Debilitating Fatigue Cycle” (DFC) 
(Battaglini, Dennehy, Groff, Kirk, & Anton, 2006).  
 Evidence suggests that regular exercise may reduce cancer treatment-related side effects 
such as depression, anxiety, physical function, VO2peak, and sleep quality (Campbell et al., 2019), 
all of which may in turn influence fatigue and overall quality of life. Furthermore, engagement in 
physical activity has been associated with lower fatigue severity in cancer survivors (Matias et 
al., 2019). Regular participation in structured aerobic and resistance exercise in laboratory/clinic-
based randomized controlled trials (RCTs) has been shown to be highly effective in alleviating 
CRF, even more so than pharmaceutical and psychological interventions (Kessels et al., 2018; 
Mustian et al., 2017; Serdà I Ferrer et al., 2018).  It is clear that exercise can break the DFC in 
addition to improving many factors believed to influence the development of fatigue in 
individuals with cancer while promoting better overall quality of life. The evidence supporting 
exercise training for CRF management after primary cancer treatment is now so strong that 
physical activity guidelines for fatigue management have been published (Campbell et al., 2019). 
The question now is whether the robust evidence from RCTs in laboratory settings translate to 
less “controlled” community-based exercise programs.  
Community-based exercise programs are designed to be accessible/lower cost, 
rehabilitative services for cancer survivors to help improve physical fitness/functionality and 
provide social support, all of which can help to enhance quality of life of survivors (Covington et 
al., 2019; Musanti & Murley, 2016). Examples of community-based exercise programs include 
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the Livestrong program associated with the YMCA, the Rocky Mountain Cancer Rehab Institute, 
and the Get Real & HEEL Breast Cancer Program. The current literature regarding CRF 
management through community-based exercise programs is mixed, with some reporting 
improved fatigue (Battaglini et al., 2006; De Jesus et al., 2017; Leach, Danyluk, Nishimura, & 
Culos-Reed, 2016; Musanti, Chao, & Collins, 2019; Santa Mina et al., 2017) and others no 
improvement (Irwin et al., 2017; Loughney et al., 2019; Schumacher & McNiel, 2018). Many 
factors contribute to this inconsistency, including a lack of pre-intervention assessments of 
fatigue levels, varying exercise regimen/prescription parameters, and lack of reporting on 
exercise adherence and compliance. These unknowns limit our ability to fully understand how 
and how much CRF is responsive to community-based exercise programs.  
Furthermore, it is important to discern how various psychosocial, physiological, 
functional, and demographic factors may be driving the changes in fatigue in response to 
exercise training. For example, younger age, greater body mass index (BMI), worse 
depression/anxiety and self-reported pain, lower physical activity participation, impaired balance 
/ functionality, and diminished sleep quality have all been associated with greater CRF severity 
(Inglis et al., 2020; Kneis et al., 2016; Matias et al., 2019; Minton et al., 2012; Spratt et al., 2012; 
Tibubos et al., 2019). It is also not uncommon for breast cancer survivors participating in 
structured aerobic/resistance exercise to observe improvements not only in CRF, but also in 
physical function (i.e., six-minute walk test), VO2peak, muscular strength, body composition, and 
overall quality of life (De Luca et al., 2016; Dimeo et al., 2008; Kampshoff et al., 2015; Spector 
et al., 2012). Multiple factors have been associated, or speculated to be associated, with greater 
CRF both in and outside exercise-based settings. However, the association of pre-post exercise 
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intervention changes in fatigue and factors associated with fatigue have not been thoroughly 
investigated in community-based exercise programs.  
Community-based programs have the potential for providing larger number of survivors 
with the opportunity to engage in regular exercise in a low-cost and socially stimulating 
environment. Therefore, studying the impact of these programs on the common symptom of CRF 
is a key first step in evaluating the value of such programs aimed at improving the overall health 
and quality of life of cancer survivors. Likewise, due to the multifactorial nature of CRF and the 
multidimensional benefits of exercise, it is possible that exercise-driven improvements in fatigue 
may be associated with physical fitness/functional and psychosocial changes that are also 
responsive to exercise. A better understanding of these associations may provide valuable insight 
into the factors behind the exercise-fatigue relationship and, in turn, open up opportunities for 
designing and improving upon targeted strategies to intervene in the DFC within community-
based settings.  
The primary purpose of this study was to evaluate the impact of participation in a well-
established community-based exercise program on CRF in early breast cancer survivors (EBCS) 
as compared to sedentary controls (CON). Impact was assessed with consideration for both 
adherence and compliance to the training protocol. The study also sought to identify potential 
psychosocial, physical activity/functional, clinical/demographic, and physiological factors that 




Community-Based Exercise Intervention 
The 16-week exercise intervention took place at an established community-based 
exercise program at the University of North Carolina at Chapel Hill (Get Real & HEEL Breast 
Cancer Exercise Program) in the Research Triangle area (Chapel Hill, Durham, Raleigh). 
Participants were asked to attend three exercise sessions per week with each session lasting 
~one-hour in a group exercise format. The exercise sessions involved progressive aerobic and 
resistance exercise. The exercise training program was adapted by experienced exercise trainers 
to meet specific participant needs, when necessary. The program reflects current physical activity 
guidelines for cancer survivors established by the American College of Sports Medicine (ACSM) 
(Campbell et al., 2019).  
 
Aerobic Exercise 
Aerobic exercise involved a variety of training modalities to encourage cross-training and 
keep participants engaged with the program. Different modalities included cycling, walking, 
jogging, elliptical, rowing, or seated stepper. Volume and intensity of the aerobic exercise was 
progressively increased over the course of the intervention. Participants began their aerobic 
exercise training for 10-15 minutes per session at a low intensity as determined by RPE between 
8-11 (light). Throughout the 16-weeks, aerobic exercise progressed to include 30 minutes 
training at an RPE of 12-14 (moderate). Any other progressions to higher intensities / volume 
during the 16-weeks of training were decided at the discretion of the exercise trainer with 






Resistance exercise occurred during every exercise session (after aerobic exercise was 
completed). Resistance exercise was designed to target full body workouts with exercises that 
focused on large muscle groups in order to improve strength, balance, and functionality. 
Exercises included, for example, lateral raises, wall push-ups, rows, squats, bridges, planks, 
lateral pulldowns, etc. Each resistance exercise session was performed in a group-format / circuit 
style fashion, lasting about ~20-30 minutes. Volume and intensity of the resistance exercise 
sessions were progressive, beginning with two sets of 10-15 repetitions of light to moderate 
intensity (RPE 7-13) using no or very light resistance. Resistance exercise progressed to 
moderate / high intensity (RPE 14-15) throughout the 16-weeks, completing two sets of 10 









This was a two-arm, non-randomized, pre-post intervention study testing the impact of an 
established community-based exercise program on fatigue and identifying potential associations 
of training induced changes in CRF with changes in factors that may contribute to fatigue. The 
two arms were EBCS and non-cancer sedentary controls (CON). Study participants for both 
groups underwent two days of testing that were held at least 24 hours apart both before and after 
the community-based exercise intervention in a controlled laboratory setting. After the 16 weeks 
of training, participants reported back for two days of post-testing, which occurred in the same 
order as baseline testing. The EBCS group also participated in a 6-month follow up (6MFU) 
testing session where patient-reported outcomes (PROs) were collected.   
 
Participants 
 EBCS were enrolled in an intervention study (NCT03760536) examining the impact of 
an established community-based exercise program on a variety of physiological and 
psychosocial outcomes. In all, 29 EBCS with histologically confirmed early stage breast cancer 
(Stage 0-III) who had completed their primary treatment within 1 year participated in the study. 
Primary treatment included surgery, chemotherapy, radiation, or any combination thereof, and 
participants could continue to be on endocrine treatment during the intervention study. Both 
oncologist and cardiologist clearance were required after review of a resting electrocardiogram 
for participation in maximal exercise testing. Age-matched, sedentary females (n=13) were also 
recruited as a comparison group (CON) and completed the same 2-day assessments pre-post 
exercise intervention as the EBCS. Women enrolled in the CON group had not been consistently 
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participating in physical activity more than two times/week for the previous six months. All 
participants had to be able to read and speak English. 
Participants were screened and were provided time commitment information for 
participation in the exercise study. Recruitment and reasons for study refusal / discontinuation 
can be seen in the Figure 5.1 (Recruitment Flow Chart). The study was approved by the Protocol 
Review Committee at UNC Lineberger Comprehensive Cancer Center and the UNC Institutional 
Review Board. All participants reviewed and signed informed consent forms prior to initiating 
study activities. 
 






Demographics and Treatment History 
Height and weight were assessed via a calibrated Detecto Weight Beam Physician Scale 
(Detecto, Webb City, MO, USA) in addition to calculating their body mass index (BMI). 
Participants provided their own demographic information via questionnaire. Medical history and 
electronic medical records were reviewed for information regarding current medications previous 
diagnoses or health complications and breast cancer related information (treatment type, time 
since treatment completion, tumor stage).  
 
Patient-Reported Outcomes  
 Participants completed questionnaires relating to CRF: PROMIS-Fatigue (Cessna et al., 
2016), quality of life: functional assessment of cancer therapy – general (FACT-G) (Cella et al., 
1993), PROMIS Global Health (PROMIS-GH) (Barile et al., 2013), and mental health inventory 
– 17 (MHI-17) (Pergolotti et al., 2019). Participants also completed questionnaires related to 
self-reported physical activity: international physical activity questionnaire (IPAQ) (Hagströmer 
et al., 2006), outcome expectations for exercise (OEE) (Resnick et al., 2000), perceived self-
efficacy for fatigue self-management (PSEFSM) (Hoffman et al., 2011), pain: PROMIS-Pain 
(Revicki et al., 2009), sleep quality: insomnia severity index (ISI) (Morin et al., 2011), and 
instrumental activities of daily living (IADL) (Fillenbaum, 1981).  
 
Functional Outcome Measures 
6-Minute Walk Test 
Participants walked around a 50-yard course as quickly as possible without running or 
jogging. Verbal encouragement was provided throughout the test by members of the research 
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team. Participants were allowed to take a break if needed. A member of the research team tallied 
the number of laps the patient completed and final distances were converted to meters (m). The 
6-minutes-walk test was conducted following standardize procedures proposed by (Ross, 
Murthy, Wollak, & Jackson, 2010). 
 
Balance 
 Overall balance was objectively evaluated utilizing a sensory organization test (SOT) via 
a Neurocom Balance Master (Neurocom International Inc., OR, USA). Visual, somatosensory, 
and vestibular systems were assessed via dual force plates over the course of 18 trials in six 
difference conditions. Each trial lasted ~20 seconds, were randomized, and repeated three times. 
An overall balance composite score was automatically computed and recorded for data analysis. 
The various conditions were evaluated in random order and are listed below:  
1. Eyes Open; Stable Surface  
2. Eyes Closed; Stable Surface  
3. Eyes Open; Stable Surface; Visual Surround Disturbance  
4. Eyes Open; Unstable Surface  
5. Eyes Closed; Unstable Surface  
6. Eyes Open; Unstable Surface; Visual Surround Disturbance  
 
Physiological Outcome Measures  
Cardiorespiratory Fitness (VO2peak) 
VO2peak was assessed using the gold standard for measuring cardiorespiratory fitness, a 
maximal cardiopulmonary exercise test (CPET). Maximal CPETs have been established as safe 
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and feasible to complete in cancer populations (Jones et al., 2007). A cycle ergometer was used 
to complete the maximal CPET. Participants were familiarized with the maximal CPET 
procedure a day prior to testing by allowing them to cycle up to ~75% of their heart rate reserve 
(HRR). Resting heart rate for this calculation were obtained from the resting electrocardiogram 
completed for screening purposes. Prior to the maximal CPET, participants were asked to refrain 
from caffeine/supplement consumption on the morning of testing. 
 The maximal CPET consisted of a continuous incremental ramp protocol following 
standard ACSM exercise testing guidelines with simultaneous breath by breath metabolic 
analysis using the Parvo Medics TrueMax 2400 Metabolic System (Parvo Medics, Salt Lake 
City, Utah, USA). Participants’ respiratory responses were captured by a Hans Rudolph 7450 
Series V2 Respiratory Valve (Hans Rudolph Inc., Shawnee, Kans., USA). Rate of Perceived 
Exertion (RPE) was monitored by using a Borg 6– 20 RPE scale (Borg, 1970). Throughout the 
test, heart rate was continuously monitored using a Pacer Polar heart rate monitor (Polar Electro 
Inc., Lake Success, N.Y., USA).  
Participants began the maximal CPET by sitting quietly on the cycle ergometer for 3-
minutes while resting metabolic data was collected. The first stage of the test started as a 2-
minute unloaded warm up at 0 watts followed by a 3-minute loaded warm up phase of 20 watts. 
Following the warm-up stages, the wattage/workload increased continuously by 15 watts/min 
until test termination. Test termination was determined if the patient reached volitional 
exhaustion or if the participant’s VO2 plateaued and did not increase more than 150 ml min-1 






Muscular strength was assessed using an isokinetic and isometric leg extensions on the 
right leg and isometric row exercises on a HUMAC Norm Dynamometer (Computer Sports 
Medicine, Inc., Stoughton, MA, USA).  
The isokinetic leg extension was completed at 60/second. Participants were placed in the 
dynamometer chair with harnesses placed over the shoulders, waist, and right leg. The right knee 
was aligned with the dynamometer’s center of axis of rotation at 90. After a brief warm-up, 
participants then proceeded to complete a total of three isokinetic leg extensions at a velocity of 
60/second with two minutes of rest between each extension. Strong verbal encouragement was 
provided during each repetition. The highest peak torque (PT) in newton meters (Nm) of the 
three extensions was used for data analysis. 
For the isometric leg extension, the arm of the dynamometer was adjusted and locked at a 
position where the participant’s anterior tibialis was positioned perpendicular to the floor. 
Following a start command, participants extended the leg as hard as possible against the 
immovable arm for 3-4 seconds. A total of three repetitions were completed with two minutes 
rest in between each extension. The greatest maximal voluntary contraction (MVC) and rate of 
torque development (RTD) were used for data analysis. MVC was determined as the greatest 
amount of force produced during the sustained isometric contraction and reported in Nm. RTD 
was determined by analyzing the slope of the developed torque from 20% to 80% of the MVC 
and reported as Newton meters per second (Nm/sec).  
The isometric row was completed with participants sitting upright and secured to the 
chair of the HUMAC Norm Dynamometer system. Elbows were bent (90-degree angle) at their 
sides, with hands palm down gripping a horizontal lever arm. Participants were allowed 2-3 
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warm up pulls prior to testing. When instructed, participants pulled straight back as hard as 
possible on the lever arm for 3-4 seconds. participants completed three repetitions and the 
maximal PT (Nm) and RTD (Nm/sec) generated were used for analysis. 
 
Adherence and Compliance  
Adherence and compliance were evaluated to further determine the impact of the exercise 
program on CRF. Adherence was calculated by dividing total number of sessions attended by the 
total number of possible sessions for the entire intervention period (Equation 1) and was 
determined separately for aerobic and resistance exercise. Aerobic compliance was defined as 
participants achieving > 80% of the prescribed aerobic exercise duration within the target RPE 
range. Resistance compliance was defined as the participant achieving > 80% of the prescribed 
volume (repetitions X sets) within the target RPE range. 
Equation 1. 
Adherence Rate = (# sessions completed / Total # of possible exercise sessions) * 100 
  
Sample Size Justification & Statistical Analysis 
Sample size calculations for the proposed study were completed using G*Power 3.1 
software and were based on “meaningful change” in CRF when assessed via the PROMIS-
Fatigue questionnaire. “Meaningful change” in CRF obtained from the PROMIS-F questionnaire 
is two to three points (Yost et al., 2011); therefore, a mean change of three was considered 
“meaningful” in response to community-based exercise. To achieve sufficient power of 0.80 and 
alpha=.05, a total of 24 EBC survivors were required to effectively detect a statistically 
significant mean change of three points. 
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Data were collected and entered into REDCap (Vanderbilt University; Nashville, 
Tennessee, USA). Statistical analyses were performed with RStudio 1.3 (Boston, MA, USA). 
The alpha level was set a priori for all statistical analyses at 0.05. Descriptive statistics expressed 
as mean + standard deviation (SD) or number (percent) were used to demonstrate study sample 
characteristics for means of comparison between groups. Shapiro-wilk tests were implemented to 
address data normality. Provided the data were normally distributed, Independent t-tests were 
used to compare baseline characteristics between groups. In the event the normality assumption 
was violated, Mann-Whitney U tests were used.  
 A mixed model ANOVA was used to evaluate the changes in CRF after participation in 
community-based exercise comparing EBCS and CON. Normality (shapiro-wilk) and 
homogeneity of covariance and variance (Levene’s test) assumptions were all checked and 
confirmed prior to conducting the mixed model ANOVA.  To further evaluate changes in CRF 
after community-based exercise, Cohen’s D effect sizes were calculated and interpreted as 
follows: trivial <0.20; small <0.50; medium <0.80; large >0.8 (Cohen, 1988).  In a subsample 
(n=14) of EBCS, one-way within subjects’ ANOVA was used to compare changes in CRF at 
baseline, immediately post, and six months post intervention. Univariate linear regression 
analyses were used explore the relationship between changes in CRF from baseline to post 
intervention, post intervention to six-months post intervention, and baseline to six-months post 
intervention with adherence and compliance rates to community-based exercise. Regression 
assumptions were checked by generating and examining residual plots.  
Univariate linear regressions were also used to evaluate the associations among post 
intervention CRF with post intervention demographic/clinical characteristics, physical 
activity/functional outcomes, psychosocial outcomes, and physiological outcomes. Additionally, 
 129 
 
univariate linear regressions were used to evaluate the associations among changes (post minus 
pre) in CRF with changes (post minus pre) in demographic characteristics, physical 
activity/functional outcomes, psychosocial outcomes, and physiological outcomes.   
 Exploratory analyses were implemented to explore the changes in demographic 
characteristics, physical activity / functional outcomes, psychosocial outcomes, and 
physiological outcomes after community-based exercise participation. These changes were 
examined between (EBCS vs CON) and within (Pre vs Post) each group with independent and 
paired samples t-tests, respectively. All outcomes were assessed for normality via a Shapiro-
Wilk test prior to analysis. In the event that the normality assumption was violated, changes 
within each group were assessed via a Wilcoxon-Signed Rank test, and changes between each 





Baseline Demographics  
Baseline characteristics for the sample are presented in Tables 5.1 and 5.2. Age (54 years 
 12 vs 54 years  8, P=0.867) and weight (76.9 kg  12.6 vs 75.1 kg  14.6, P=0.472) were not 
statistically different between EBCS and CON, although height was (167.2 cm  7.4 vs 160.3 cm 
 5.4, P<0.05), respectively. Fatigue was not statistically different between EBCS and CON at 
baseline (17.1  5.9 vs 14.2  3.1, P>0.05). EBCS were significantly different from CON in 
reporting higher levels of depression (9.4  7.1 vs 4.5  3.5, P<0.05), pain (11.7  6.9 vs 8.8  
1.5, P=<0.05), perceived self-efficacy for fatigue self-management (40.9  11.8 vs 50.8  11.6, 
P<0.05), and greater levels of moderate (119.8 min/week  195.8 vs 26.9 min/week  83.2, 
P<0.05) and vigorous (43.4 min/week  63.6 vs 5.7 min/week  14.9, P<0.05) physical activity. 
 
Impact of Community-Based Exercise on Fatigue  
 Comparisons between and within groups can be seen in Figure 5.2. The mixed model 
ANOVA did not reveal a significant interaction (p = 0.054). However, EBCS did show an 
improvement in fatigue post training (-2.6, Cohen’s D = 0.51) whereas CON did not (0.0, 
Cohen’s D = 0.02).  A sensitivity analysis was conducted after removing an outlier from the 
EBCS group and showed that this change was not significant at the 0.05 level (p = 0.056). The 
repeated measures analysis in a subsample (n=14) of EBCS showed a significant improvement in 
CRF from baseline to post exercise (-4.7, p = 0.002, Cohen’s D = 0.92) as well as baseline to six 
months post community-based exercise participation (-3.4,  p = 0.034, Cohen’s D = 0.59). 
Another sensitivity analysis was conducted after removing an outlier from the EBCS group, 
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which showed that the improvement in fatigue from baseline to the 6MFU no longer remained 
significant (p > 0.05). These analyses are shown in Figure 5.3. 
 
Figure 5.2: Cancer-Related Fatigue Change after Community Based Exercise  
 
Figure 5.3: Baseline / Post / 6MFU Cancer-Related Fatigue Comparison (EBCS Only) 
 
* p < 0.05 
*** p < 0.001 
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Table 5.1: Study Participant Characteristics – mean (SD) or number (%) 
Variable EBCS (N=29)  CON (N=13) 
Age (years) 53.9 (11.9) 53.8 (8.4) 
Height (cm) 167.2 (7.4) 160.3 (5.4) 
Weight (kg) 76.9 (12.6)  75.1 (14.6) 
Race    
White 25 (86.2) 13 (100) 
African American or Other 4 (13.8) 0 (0) 
Body Mass Index (BMI)  
 
 
Normal (18-25) 9 (31.1) 2 (15.4) 
Overweight (25-30) 13 (44.8) 7 (53.8) 




High school or less 1 (3.4) 0 (0) 
More than high school 28 (96.6) 13 (100) 
Employed more than 32 h a week 
 
 
No  16 (55.2) 1 (7.7) 
Yes  13 (44.8) 12 (92.3) 
Married    
 
 
No 9 (32.1) 5 (38.5) 
Yes 19 (67.9) 8 (61.5) 
Breast Cancer Stage   
I 8 (28.6) -- 
II 14 (50.0) -- 
III 6 (21.4) -- 
Surgery   
Mastectomy  8 (27.6) -- 
Lumpectomy   21 (72.4) -- 
Treatment Type    
Chemotherapy Only 5 (17.2) -- 
Radiation Only  12 (41.4) -- 
Chemo + Radiation 9 (31.1) -- 
Surgery Only  3 (10.3) -- 
Endocrine Therapy   
No 8 (27.6) -- 
Yes 21 (72.4) -- 
Menopausal Status   
Pre 10 (34.5) -- 
Post 19 (65.5) -- 
Average Days since Treatment Completion 97.9 (89.9) -- 




Table 5.2: Outcome Measures [Baseline] – Mean (SD) 
Variable (scale range) EBCS   CON  
Psychosocial Outcomes    
PROMIS Physical Global Health (4 – 20) 12.4 (2.4) 14.2 (1.8) 
PROMIS Mental Global Health (4-20) 10.8 (2.7) 12.6 (2.3) 
FACT- General (0 – 108) 82.6 (13.5) -- 
Physical (0 – 28) 22.0 (4.7) -- 
Social/Family (0 – 24) 20.0 (4.8) -- 
Emotional (0 – 28) 20.4 (3.5) -- 
Functional (0 – 28) 20.2 (4.1) -- 
Depression [MHI] (0-43) 9.4 (7.1) 4.5 (3.5) 
Anxiety [MHI] (0-20) 5.0 (4.0) 4.7 (2.7) 
PROMIS-Pain (8 – 40) 11.7 (6.9) 8.8 (1.5) 
Sleep Quality [ISI] (0 – 28) 8.6 (5.3) 6.5 (3.9) 
Self-Efficacy for Fatigue Self-Management 
(6 – 60) 
40.9 (11.8) 50.8 (11.6) 
Physical Activity / Functionality Outcomes  
Self-Reported Physical Activity (min/week)     
Moderate Physical Activity  119.8 (195.8) 26.9 (83.2) 
Vigorous Physical Activity  43.4 (63.6) 5.7 (14.9) 
Continuous Walking 309.0 (396.0) 160.6 (181.8) 
Outcome Expectations for Exercise (8 – 40) 15.5 (5.5) 16.9 (9.7) 
Instrumental Activities of Daily Living  
(0 – 14) 
13.9 (0.4) 14.0 (0.0) 
Balance  71.9 (11.8) 78.9 (6.1) 
6-Minute Walk  537.9 (74.7) 564.1 (51.2) 
Physiological Outcomes  
VO2peak (ml-1*kg-1*min-1) 20.9 (5.4) 22.5 (2.9) 
Lower Body Strength      
Isokinetic LE PT (Nm/sec) 78.2 (20.1) 73.7 (17.7) 
Isometric LE MVC (Nm)  100.0 (27.1) 113.6 (31.1) 
Isometric LE RTD (Nm/sec) 293.3 (106.8) 269.4 (161.8) 
Upper Body Strength     
Isometric Row MVC (Nm) 61.4 (23.5) 72.1 (19.4) 
       Isometric Row RTD (Nm/sec) 149.9 (85.6) 156.0 (65.2) 
Exercise Adherence and Compliance (%)   
       Aerobic Adherence 72.5 (19.8) 67.8 (18.9) 
        Aerobic Compliance 53.6 (20.6) 65.9 (18.9) 
        Resistance Adherence  72.9 (20.2) 68.3 (19.5) 
        Resistance Compliance 28.7 (10.8) 36.7 (6.3) 




Associations of Cancer-Related Fatigue after Exercise Participation  
Changes in CRF from baseline to post exercise intervention were not significantly 
associated with aerobic exercise adherence/compliance or resistance exercise 
adherence/compliance in either group (Appendix 1: Supplemental Table 1). The improvement in 
fatigue from baseline to 6MFU (n=14) observed in EBCS was significantly associated (p<0.05) 
with aerobic exercise compliance (adj R2 = 0.227) but not with resistance exercise compliance 
(adj R2 = 0.159) or aerobic (adj R2 = -0.082) and resistance exercise adherence (adj R2 = -0.083). 
Although no statistically significant change in CRF was observed from post-intervention to 
6MFU, increasing fatigue was significantly associated (p<0.05) with greater aerobic (adj R2 = 
0.268) and resistance (adj R2 = 0.290) exercise adherence whereas aerobic (adj R2 = -0.044) and 
resistance (adj R2 = 0.022) exercise compliance were not associated with fatigue in any way.  
 Univariate linear regression analyses revealed that lower CRF post-intervention in EBCS 
was mostly associated with positive psychosocial outcomes. Specifically, lower CRF was 
significantly associated (p <0.05) with better overall self-reported physical health (adj R2 = 
0.617), mental health (adj R2 = 0.331), quality of life (adj R2 = 0.364), depression (adj R2 = 
0.223), pain (adj R2 = 0.220), self-efficacy for fatigue self-management (adj R2 = 0.433), 
outcome expectations for exercise (adj R2 = 0.227), objectively assessed balance (adj R2 = 
0.136), and better 6MWT performance (adj R2 = 0.163). Lower fatigue levels also appeared to be 
related to greater VO2peak as well (adj R2 = 0.121). By contrast, CON fatigue was only associated 
with higher self-efficacy for fatigue self-management (adj R2 = 0.192) and lower self-reported 
pain (adj R2 = 0.167). The improvements (change scores) in CRF for EBCS were associated with 
improved self-reported physical health (adj R2 = 0.404), depression (adj R2 = 0.205), pain (adj R2 
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= 0.125), outcome expectations for exercise (adj R2 = 0.398), and 6MWT (adj R2 = 0.141).  All 
univariate linear regression results are provided in Supplemental Tables 2 and 3 (Appendix 1). 
 
Exploratory Analyses  
 Baseline to post-intervention change score comparisons for the demographic, 
psychosocial, physical activity / functionality, and physiological outcomes are provided in 
Supplemental Table 4 (Appendix 1). In summary, EBCS showed significant improvements in 
multiple psychosocial outcomes (quality of life, depression, anxiety, sleep quality, self-efficacy), 
self-reported vigorous activity, outcome expectations for exercise, balance, and 6MWT after 16 
weeks of participation in community-based exercise. Compared to the CON group, EBCS 
showed significantly greater improvements especially in self-reported depression, self-efficacy, 





Evidence for improvement in CRF after community-based exercise participation for 
cancer survivors are inconsistent (Battaglini et al., 2006; De Jesus et al., 2017; Irwin et al., 2017; 
Leach et al., 2016; Loughney et al., 2019; Musanti et al., 2019; Santa Mina et al., 2017; 
Schumacher & McNiel, 2018). Since CRF is multi-factorial and associated with a variety 
treatment-related side effects (Adams et al., 2018; Andreas Charalambous & Kouta, 2016; 
Kessels et al., 2018; Nyrop et al., 2019; O’Higgins et al., 2018; Patel & Demontis, 2014; Romero 
et al., 2018; Thong et al., 2018; Winters-Stone et al., 2008), it is important to gain a deeper 
understanding of fatigue’s association with psychosocial, functional, demographic, and 
physiological outcomes that may also be responsive to exercise intervention. This understanding 
can then lead to better tailored exercise interventions for fatigue management.  
 At baseline, EBCS were classified as experiencing “mild fatigue severity” according to 
the PROMIS Measurement Score Cut Points while CON fatigue was “within normal limits”. 
Though not statistically significant, participation in the Get Real & HEEL Breast Cancer 
Exercise program did improve CRF in EBCS resulting in a fatigue classification change from 
“mild” to “within normal limits”. Although change in fatigue did not remain significant for 
EBCS in the sensitivity analysis, the change in classification from “mild” to “within normal 
limits” may be clinically important. On the other hand, no changes in fatigue were observed in 
the control group after participating in the same exercise intervention, nor was their fatigue 
associated with many of the psychosocial, functional/physical activity, physiological, or 
demographic outcomes with the exception of sleep quality. Assuming that CRF develops as a 
result of cancer itself and subsequent treatments (Berger et al., 2010), in hindsight, these findings 
are not surprising. The absence of fatigue in the CON group was likely due to them not having 
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been subjected cancer treatments left little room for improvement in response to exercise 
training. These findings supplement some of the initial investigations CRF in community-based 
exercise programs (Battaglini et al., 2006; De Jesus et al., 2017; Leach et al., 2016; Musanti et 
al., 2019; Santa Mina et al., 2017; Wagoner, Lee, & Battaglini, 2021) supporting this program as 
a viable treatment option for fatigue management in EBCS.  
 The improvement in CRF after exercise participation was not significantly associated 
with either exercise adherence or compliance, whether aerobic or resistance. Although we had 
assumed a dose-response for the impact of exercise on CRF, previous literature has shown 
otherwise. In fact, any level of physical activity, regardless of mode, setting, or type of cancer, 
appears to improve CRF in a non-linear fashion (Kummer, Catuogno, Perseus, Bloch, & 
Baumann, 2013; Oberoi et al., 2018; Stevinson et al., 2009). Therefore, it is not surprising that 
the improvement in CRF immediately after exercise training was not associated with the 
adherence and compliance measures designed to assess participation in a progressive exercise 
intervention. Although it must be noted that it is important for exercise intervention studies to 
report adherence and compliance.  
Although no significant change in fatigue severity was observed from post to 6MFU, a 
sub-analysis (n=14 EBCS) showed that improvements in CRF from baseline to the 6MFU 
timepoint were associated with greater aerobic exercise compliance during the intervention. 
EBCS were encouraged (though were not required) to remain physically active from the end of 
the 16-week intervention to the 6MFU. As such, we speculate that the community-based 
program provided the EBCS with the knowledge and confidence to remain physically active, 
which in turn contributed to continued fatigue management, as has been previously suggested 
(Matias et al., 2019). However, our results are somewhat conflicted as increased fatigue from 
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post intervention to 6MFU appeared to be associated with greater aerobic/resistance exercise 
adherence during the intervention, but not compliance. Although purely speculative, it is possible 
that attending the community-based exercise sessions and interacting with exercise trainers and 
peers may be an important aspect of the rehabilitation process regardless of the level of 
compliance of the exercise intervention. Understanding why these potentially contradictory 
relationships at different timepoints may be occurring is important, however, but not possible to 
investigate in the small sample of the sub-analysis. Additional longitudinal research in a larger 
sample is needed to better understand the longer term or sustained influences of community-
based exercise on behavioral change and CRF.   
Interestingly, improvements in CRF were associated with only one physiological 
outcome in EBCS. While VO2peak was an associated physiological outcome with fatigue, the 
relationship only existed at a single time point (post-test). Changes in fatigue were not associated 
with changes in VO2peak nor was fatigue associated with muscular strength. Testing modality 
could have played a role in these findings, particularly with regard to muscular strength. 
Although an association between lower body strength and CRF has been suggested in previous 
studies, strength outcomes have primarily been assessed through functional tests such as 30-
second chair stands (Winters-Stone et al., 2008) as compared to the objective strength test in the 
present study (isokinetic/isometric dynamometry). Additionally, preliminary reports of an 
association between CRF and VO2peak in response to exercise have also reported significant 
improvements in both outcomes (Adams et al., 2018; Courneya et al., 2003; Kalter et al., 2016). 
In our study, EBCS only significantly improved their CRF, but not VO2peak. While this was a 
physical exercise training intervention, these well-established markers of physical fitness did not 
significantly improve from pre to post, which is contrary to previous studies (Battaglini et al., 
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2014; Hanson, Wagoner, Anderson, & Battaglini, 2016). Despite attempting to generate a dose-
response with the exercise protocol for the present study, the reduced exercise compliance with 
both aerobic and resistance exercises could have contributed to the lack of significant 
improvement in VO2peak and muscular strength, resulting in the lack of associations with the 
improvements in CRF.  
While no improvement was observed in physical fitness parameters, significant 
improvements in a variety of psychosocial (quality of life, depression, anxiety, self-efficacy, and 
physical/mental health) and functional (balance, 6MWT, etc) outcomes in the EBCS group were 
observed. These findings are consistent with previous literature within community-based 
exercise settings for cancer survivors (Irwin et al., 2017; Leach et al., 2016; Schumacher & 
McNiel, 2018). More importantly, the improvements in multiple psychosocial and physical 
function outcomes were also associated with observed improvements in fatigue. This finding is 
novel, as we believe it is the first to show that the psychosocial and functional benefits from 
community-based exercise may be important components that can positively impact CRF in 
EBCS. This could be attributed to the small group-based exercise design that community-based 
programs provide. Group-based exercise has been shown to facilitate program participation in a 
variety of cancer survivor populations by inherently offering peer support and understanding of 
various cancer experiences that may be lacking in other types of locations / training venues 
(Blaney et al., 2010; Leach, Potter, & Hidde, 2019). Community-based settings may be naturally 
constructed to target both physical function and psychosocial outcomes commonly related to 
CRF, leading to a development of both social support and improved physical health. This in turn 
could have contributed to CRF’s observed improvement in the present study. 
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Overall, these findings are encouraging with regard to community-based exercise 
programs alleviating CRF in EBCS. Despite no significant association with exercise adherence 
or compliance, the community-based program provided a potential benefit in alleviating CRF by 
positively altering many of the believed factors involved in the development of CRF. These 
findings also highlight the extended benefits of the program. Not only was the physical exercise 
intervention beneficial, as indicated by improvements in physical function, but the communal 
aspect of this setting in which peer support and social connections are created may have 
encouraging psychosocial implications, making it a practical option for managing CRF and its 
related components. More research is needed to discern exactly how/why CRF in EBCS 
improves after community-based exercise training so better targeted interventions can be 
administered in community-based centers for the management of CRF.  
The extent to which the results from our study extend beyond this small sample should be 
applied with caution as certain limitations should be considered. First, the study’s sample size 
was small which could have contributed to the lack of observed interaction effect. The sample 
size was a result of difficulty in the recruitment of participants, likely due to the lack of an 
established “clinic to exercise” pathway that would allow for adequate referrals to community-
based programs. Future studies should be aware of this issue and attempt to implement strategic 
referral pathways (Mina et al., 2018). Second, the “exercise compliance” measure used to 
capture exercise intensity was based on attaining a particular RPE during exercise, as this 
common practice. Due to the subjective nature of RPE, it is possible that this masked the true 
exercise compliance and its relationship with CRF. Lastly, the sample of EBCS overwhelmingly 
reported mild fatigue severity pre-intervention, which may not be a true representation of the 
EBCS population as whole. However, the sample may be a valid representation of women able 
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to access and physically participate in community-based exercise programs. Therefore, future 
studies should aim to improve community-based program outreach to achieve equal-opportunity 
access for all types of cancer survivors and especially improve on the ability to capture those 
suffering from severe fatigue as well as racial balance. This will provide a more comprehensive 
understanding of the fatigue trajectory while participating in community-based exercise. 
 
Conclusion 
Community-based exercise participation appears to be beneficial for alleviating CRF in 
EBCS. Improvement in CRF for EBCS was also associated with improvements in physical 
function and psychosocial outcomes. These results provide evidence that both the physical 
exercise intervention and communal aspect of the community-based program may have a 
prominent combined impact in effectively alleviating CRF in EBCS. This may further suggest 
that community-based exercise programs are uniquely positioned to provide an accessible 
treatment strategy for managing CRF and its multi-factorial nature. These findings are 
encouraging as exercise for individuals with cancer begins to shift away from tightly controlled 
research settings and towards implementation on the community level. More research is needed 
to further elucidate the impact of exercise interventions conducted in a community-based setting 












CHAPTER VI: RESEARCH SYNTHESIS 
 
Major Findings  
 The present study revealed several important findings regarding cancer-related fatigue 
and its potential correlates within in a community-based exercise setting for early breast cancer 
survivors. Major findings are summarized below.  
Research Aim 1 
 At baseline, cancer-related fatigue was not significantly different between early breast 
cancer survivors and healthy-sedentary controls (16.9  5.75 vs 14.2  3.4, p=0.121). Fatigue 
severity level was considered “mild” for early breast cancer survivors and “within normal limits’ 
for healthy-sedentary controls as determined by the PROMIS Measurement Score Cut Points. 
Univariate analyses revealed fatigue in early breast cancer survivors to be associated with 
numerous psychosocial and functional outcomes but not in healthy sedentary controls. Lower 
fatigue severity in early breast cancer survivors was shown be significantly associated with better 
overall self-reported physical health (adj R2 = 0.414), mental health (adj R2 = 0.414), health-
related quality of life (adj R2 = 0.447), depression (adj R2 = 0.360), anxiety (adj R2 = 0.071), pain 
(adj R2 = 0.079), self-efficacy for fatigue self-management (adj R2 = 0.385), outcome 
expectations for exercise (adj R2 = 0.208), instrumental activities of daily living (adj R2 = 0.068), 
and balance (adj R2 = 0.237). No physiological, self-reported physical activity, or treatment-
related outcomes were associated with fatigue severity in either early breast cancer survivors or 
healthy-sedentary controls.  
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Research Aims 2 & 3  
 In response to community-based exercise, this study showed that early breast cancer 
survivors improved their fatigue levels whereas healthy sedentary controls showed no change (-
2.6 vs 0.0). However, these changes in fatigue levels were not significantly associated with 
aerobic exercise adherence/compliance or resistance exercise adherence/compliance. A repeated 
measures analysis examining changes in cancer-related fatigue revealed that a partial sample 
(n=14) of early breast cancer survivors showed a significant improvement in cancer-related 
fatigue from baseline to six months post intervention (-3.4, p-value = 0.007). This change in 
cancer-related fatigue was shown to be associated with both aerobic exercise compliance (adj R2 
= 0.227) and resistance exercise compliance (adj R2 = 0.159), but not adherence.  
 Additionally, cancer-related fatigue was associated with various psychosocial and 
functional outcomes after participation in community-based exercise for early breast cancer 
survivors compared to sedentary healthy controls whose fatigue was only associated with self-
efficacy for fatigue self-management (adj R2 = 0.192) and self-reported pain (adj R2 = 0.167). 
Lower fatigue in early breast cancer survivors was associated with older age (adj R2 = 0.097), 
better overall self-reported physical health (adj R2 = 0.617), mental health (adj R2 = 0.331), 
health-related quality of life (adj R2 = 0.364), depression (adj R2 = 0.223), pain (adj R2 = 0.220), 
self-efficacy for fatigue self-management (adj R2 = 0.433), outcome expectations for exercise 
(adj R2 = 0.227), balance (adj R2 = 0.136), 6MWT (adj R2 = 0.163), and VO2peak (adj R2 = 
0.121). With regard to changes in cancer-related fatigue from pre to post intervention, improved 
fatigue in early breast cancer survivors was associated with improved self-reported physical 
health (adj R2 = 0.404), emotional well-being (adj R2 = 0.297), depression (adj R2 = 0.205), pain 
(adj R2 = 0.125), outcome expectations for exercise (adj R2 = 0.398), and 6MWT (adj R2 = 
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0.141). No physiological, self-reported physical activity, or treatment related outcomes were 
associated with fatigue severity in either early breast cancer survivors or healthy-sedentary 
controls. 
 
Significance of the Study and Implication of Results  
 Cancer-related fatigue is the most common treatment-related patient reported side effect 
and can persist years after treatment has been completed (Barsevick et al., 2013; Bower et al., 
2006; Minton & Stone, 2008). Exercise training has been shown to be effective in alleviating this 
symptom both during and after anti-cancer therapy (Kessels et al., 2018; Mustian et al., 2017; 
Serdà I Ferrer et al., 2018). Recently updated exercise guidelines from the American College of 
Sports Medicine include evidence-based exercise intervention recommendations to manage 
cancer-related fatigue (Campbell et al., 2019). Despite exercise being a well-established 
treatment for cancer-related fatigue, it is unclear whether this effect translates from lab-based 
settings to more “real world” settings such as community-based exercise programs.  
Preliminary evidence would indicate that community-based settings are somewhat 
effective at alleviating cancer-related fatigue, but the heterogeneity among the different cancer 
types and exercise intervention parameters leave much to be determined in this setting 
(Battaglini et al., 2006; Leach et al., 2016; Santa Mina et al., 2017; Wagoner et al., 2021). Of 
note, it is unclear whether patients who currently experience severe fatigue are accessing these 
types of programs. Furthermore, although both prevalent and persistent, there are many questions 
as to what factors (psychological, physiological, functional, etc) may influence cancer-related 
fatigue both in its manifestation and subsequent improvement in response to exercise training, 
which is likely a product of its complexity / multi-factorial nature. The present study sought to 
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begin addressing these gaps by (1) assessing the fatigue severity of early breast cancer survivors 
motivated to participate community-based exercise, (2) evaluating the impact of participation in 
a well-established community-based exercise program on cancer-related fatigue, and (3) 
exploring various factors that may influence cancer-related fatigue both before and after 
community-based exercise participation.  
The study’s baseline fatigue analysis indicated that early breast cancer survivors 
motivated to participate in community-based exercise tend to report more mild fatigue severity 
than what has been previously reported in the breast cancer population after primary treatment 
(Abrahams et al., 2016; Bower et al., 2006). Only one participant in the entire sample was 
classified as experiencing severe fatigue. These results may suggest that early breast cancer 
survivors motivated to participate in a community-based exercise program may be more apt to do 
so because they feel they have the energy reserves to exert themselves (i.e., mild fatigue but not 
debilitating). It is also important to understand why early breast cancer survivors experiencing 
more severe fatigue are not accessing these types of programs. Fatigue is a commonly reported 
barrier to exercise participation, despite the overwhelming positive effects of exercise training on 
its alleviation (Cheifetz et al., 2015). It is possible that a lack of “exercise education” may be at 
play. In the present study, participants experiencing more severe fatigue appeared to have lower 
outcome expectations for exercise. Although this could not be assessed in the current sample, 
this observation could indicate a lack of accessible information regarding the positive effects of 
exercise on cancer-related fatigue in earlier phases of the cancer-care continuum. This has been 
supported by previous studies showing that although it is feasible for physicians to have physical 
activity conversations with early stage cancer patients, these conversations are not consistent 
(Nyrop et al., 2016). As it is not intuitive to think chronic fatigue can be improved by exerting 
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oneself, those experiencing more severe fatigue may require educational opportunities about the 
benefits of exercise participation for fatigue management during treatment.   
Despite similar severity level, fatigue appeared to be driven by psychosocial / functional 
outcomes in early breast cancer survivors, whereas no associations were observed with fatigue in 
healthy-sedentary controls at baseline. These results not only provide valuable information on 
the “type” of fatigue breast cancer survivors experience prior to community-based exercise, but 
also highlight the current understanding of cancer-related fatigue as complex and multi-factorial. 
The observed association of cancer-related fatigue with various psychosocial outcomes provides 
additional support for previous studies showing associations with quality of life (Jones et al., 
2016; Minton et al., 2012). This may manifest from other observed associations with depression, 
anxiety, and functional factors such as balance and completing activities of daily living, 
reiterating the notion that cancer-related fatigue comprises of both psychological and physical 
components (Berger et al., 2010; Kneis et al., 2016; Minton et al., 2012). These results are 
promising for community-based exercise programs. In addition to improving physical fitness and 
physical activity participation, these programs often provide cancer survivors a safe space to 
interact with other survivors who have undergone similar experiences, resulting in alleviation of 
psychological distress that is commonly experienced across the cancer continuum (Spector et al., 
2012). The core design of community-based programs is inherently formatted to address 
psychological / physical correlates of cancer-related fatigue, leading to a potential improvement 
in fatigue.     
 Second, these results suggest that participation in a community-based exercise program 
can have a positive impact in improving cancer-related fatigue in early breast cancer survivors 
who are within one year of completing primary anti-cancer therapy. The computed effect size of 
 147 
 
0.51 for the improvement of fatigue in response to community-based exercise would indicate this 
program being a viable treatment option for cancer-related fatigue. Comparatively, community-
based exercise appears to have no beneficial impact on fatigue for healthy-sedentary controls, 
likely due to the absence of mild to moderate fatigue at baseline. Fatigue in early breast cancer 
survivors also remained stable at six months post exercise while not actively participating in the 
community-based exercise program. These results supplement some of the initial investigations 
of a beneficial impact of community-based exercise on cancer-related fatigue (Battaglini et al., 
2006; Irwin et al., 2017; Leach et al., 2016; Wagoner et al., 2021). 
Interestingly, improvements in fatigue for early breast cancer survivors were not 
associated with aerobic / resistance exercise adherence and compliance. This finding provides 
valuable insight into the extended benefits of community-based exercise programs beyond 
maintenance of physical health and increased physical activity participation. For example, after 
exercise training cancer-related fatigue was shown to be associated with various psychosocial, 
functional, and even physiological outcomes (VO2peak) post intervention, highlighting its multi-
factorial characteristic once again. However, the improvements in fatigue were primarily shown 
be associated with improvements in psychosocial-related and functional outcomes (physical 
health, depression, self-efficacy, 6MWT, etc). Improvements in cancer-related fatigue driven by 
primarily psychosocial outcomes may stem from the communal aspect of the exercise program, 
rather than solely the physical exercise intervention by itself. This suggests that in this particular 
setting, communal exercise may provide physical health benefits and an additional benefit in 
improving mental health, which in turn plays a significant role in the observed alleviation of 
cancer-related fatigue and improved quality of life for early breast cancer survivors.    
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Overall, the present study was able to provide a more comprehensive understanding of 
cancer-related fatigue in early breast cancer survivors who wish to participate in a community-
based exercise program. It is apparent the current community-based program model may be 
missing cancer survivors that are experiencing severe fatigue. Reasons as to why this might be 
could not be addressed in the current study design but should be a focus of future research. 
Despite the mild levels of fatigue detected, the community-based program still appeared 
impactful in its ability to alleviate the side effect in early breast cancer survivors. Moreover, 
cancer-related fatigue was primarily associated with psychosocial outcomes in early breast 
cancer survivors whereas healthy-sedentary controls showed few associations. This indicates 
fatigue as being primarily driven by the cancer experience as well as psychological distress 
commonly observed across the cancer continuum. It is our hope that future exercise programs 
take these findings in to consideration for cancer-related fatigue management as they show a 
marked benefit from community-based exercise.  
 
Strengths and Limitations  
 The main limitation of the present study is the sample, both in size and selection. The 
sample of early breast cancer survivors was small and was comprised predominantly of white 
women able to consistently perform exercise three times a week for four months. This is not a 
true representation of the overall early breast cancer survivor population. However, in 
completing the study in this manner, this limitation provided valuable insight into the group of 
cancer survivors who are missing from community-based exercise programs; that being 
survivors experiencing more severe fatigue and/or racial minorities. We now know to anticipate 
and address this when expanding the outreach of community-based exercise programs for fatigue 
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management. Additionally, our ability to adequately capture exercise compliance was hindered 
to a certain degree due to subjectively assessing exercise intensity with rate of perceived 
exertion, particularly for resistance exercise.  
 The primary strength of the study was the well-established community-based exercise 
program that has continually been led by veteran staff and experienced cancer exercise trainers. 
This in itself assisted in creating a true communal setting for patients to participate in exercise 
and socialize with others who have undergone similar distressing experiences. Furthermore, 
every outcome measurement that was utilized has been deemed safe/feasible and validated in 
cancer populations, allowing for an accurate depiction of cancer-related fatigue in this particular 
context.   
 
Future Research  
 Future research should expand the analysis of impacts of community-based exercise 
programs. It was clear from the present study that patients experiencing higher fatigue severity 
were missed as well as racial/ethnic minorities. Future studies should strive to understand both 
the facilitators and barriers to community-based exercise participation. This may involve a more 
in depth understanding of the benefits of exercise on fatigue management from a patient 
perspective as well as racial and socio-economic determinants for exercise participation in this 
setting. Additionally, community-based exercise programs would benefit from implementing and 
understanding the expansion of different modes of exercise delivery. This could include both 
virtual or home-based exercise and may improve program outreach to those unable to currently 
participate in face to face exercise while still maintaining a communal and inclusive 
environment.   
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Future studies would also benefit from continuing to contextualize cancer-related fatigue 
as it relates to various outcomes in this setting. It is clear that more studies are needed to further 
determine factors associated with cancer-related fatigue that may either be driving its rise in 
severity or its improvement in response to exercise. The present study provided new insight 
regarding improvements in cancer-related fatigue in that it appears to be primarily driven by 
psychosocial outcomes in response to community-based exercise. Future research should also 
continue to explore physiological mechanisms that may be associated with cancer-related 
fatigue, as this will only assist in the development future exercise prescriptions targeted for 




APPENDIX 1: Tables of Univariate and Change Score Analyses  
 
Supplemental Table 1. Adherence/Compliance Univariate Analysis (Pre/Post) 
  EBCS CON 
Variable  Estimate (SE)  Adj. R2  Estimate (SE)  Adj. R2 
Exercise Adherence  
      
Aerobic Exercise  -0.057 (0.037) 0.046 -0.075 (0.070) 0.010 
Resistance Exercise  -0.055 (0.037) 0.042 -0.057 (-0.029) -0.029 
Exercise Compliance     
Aerobic Exercise  -0.036 (0.036) 0.0004 -0.080 (0.071) 0.021 
Resistance Exercise  -0.050 (0.070) -0.018 -0.096 (0.190) -0.067 






























Supplemental Table 2. Univariate analysis of associations with Cancer-Related Fatigue (Post) 
  EBCS  CON 
Variable  Estimate (SE)  Adj. R2  Estimate (SE)  Adj. R2 
Demographic Characteristics        
Age  0.139 (0.072) 0.097 0.001 (0.137) -0.100 
Body Mass Index (BMI) -0.004 (0.168) -0.037 -0.023 (0.212) -0.090 
Body Weight  0.090 (0.066) 0.030 0.028 (0.070) -0.075 
Psychosocial Outcomes    
PROMIS Global Health (Physical)  -2.085 (0.307) 0.617 -0.584 (0.604) -0.006 
PROMIS Global Health (Mental) -1.120 (0.290) 0.331 -0.067 (0.445) -0.089 
FACT- General -0.215 (0.052) 0.364 -- -- 
Physical  -0.818 (0.172) 0.436 -- -- 
Social/Family -0.383 (0.138) 0.194 -- -- 
Emotional  -0.403 (0.365) 0.008 -- -- 
Functional -0.583 (0.162) 0.298 -- -- 
Depression (MHI) 0.519 (0.173) 0.223 0.161 (0.236) -0.046 
Anxiety (MHI) 0.472 (0.283) 0.060 -0.258 (0.453) -0.060 
PROMIS-Pain  0.505 (0.169) 0.220 0.567 (0.289) 0.192 
Sleep Quality (ISI) 0.132 (0.203) -0.021 0.295 (0.339) -0.021 
Self-Efficacy for Fatigue Self-
Management 
-0.250 (0.053) 0.433 -0.130 (0.080) 0.139 
Physical Activity / Functionality Outcomes  
Self-Reported Physical Activity 
(min/week) 
    
Moderate Physical Activity  0.005 (0.003) 0.050 0.001 (0.008) -0.090 
Vigorous Physical Activity  -0.004 (0.006)  -0.016 -0.022 (0.022) -0.004 
Continuous Walking -0.002 (0.002) -0.012 0.001 (0.002) -0.070 
Outcome Expectations for Exercise 0.563 (0.186) 0.227 0.307 (0.213) 0.090 
Balance  -0.171 (0.074) 0.136 0.125 (0.195) -0.057 
6-Minute Walk  -0.025 (0.010) 0.163 -0.051 (0.028) 0.167 
Physiological Outcomes   
VO2peak  -0.315 (0.143) 0.121 -0.214 (0.239) -0.017 
Lower Body Strength      
Isokinetic Leg Extension (PT) -0.022 (0.035) -0.021 0.012 (0.047) -0.085 
Isometric Leg Extension 
(MVC)  
-0.023 (0.026) -0.007 -0.075 (0.048) 0.107 
Isometric Leg Extension (RTD) 0.002 (0.006) -0.033 0.008 (0.010) -0.030 
Upper Body Strength     
Isometric Row (MVC) -0.010 (0.044) -0.035 -0.065 (0.053) 0.040 
Isometric Row (RTD) -0.001 (0.005) -0.037 0.009 (0.013) -0.047 







Supplemental Table 3. Univariate analysis of Pre-Post Intervention Changes in Fatigue with 
Changes in Outcome Measures 
  EBCS  CON 
Variable  Estimate (SE) Adj. R2  Estimate (SE)  Adj. R2 
Demographic Characteristics        
Age -0.029 (0.060) -0.031 0.118 (0.126) -0.012 
Body Mass Index (BMI) 0.505 (1.068) -0.029 -0.103 (0.912) -0.090 
Body Weight 0.280 (0.381) -0.017 -0.020 (0.366) -0.091 
Psychosocial Outcomes 
PROMIS Global Health (Physical) -1.471 (0.329) 0.404 -0.153 (0.107) -0.086 
PROMIS Global Health (Mental) -0.353 (0.555) -0.022 -0.207 (0.393) -0.064 
FACT- General -0.129 (0.067) 0.087 -- -- 
Physical -0.355 (0.189) 0.083 -- -- 
Social/Family -0.094 (0.186) -0.027 -- -- 
Emotional -0.819 (0.229) 0.297 -- -- 
Functional -0.126 (0.206) -0.023 -- -- 
Depression (MHI) 0.475 (0.166) 0.205 0.316 (0.204) 0.105 
Anxiety (MHI) 0.355 (0.296) 0.010 -0.085 (0.396) -0.086 
PROMIS-Pain 0.229 (0.102) 0.125 0.275 (0.335) -0.028 
Sleep Quality (ISI) 0.287 (0.217) 0.026 0.638 (0.287) 0.246 
Self-Efficacy for Fatigue Self-
Management 
-0.091 (0.056) 0.055 -0.181 (0.101) 0.183 
Physical Activity / Functionality Outcomes 
Self-Reported Physical Activity 
(min/week) 
    
Moderate Physical Activity -0.001 (0.002) -0.031 0.001 (0.006) -0.005 
Vigorous Physical Activity 0.009 (0.005) 0.077 -0.034 (0.016) 0.221 
Continuous Walking 0.001 (0.001) -0.003 0.002 (0.002) -0.001 
Outcome Expectations for Exercise 0.472 (0.109) 0.398 0.058 (0.122) -0.076 
Instrumental Activities of Daily Living -1.850 (2.141) -0.009 -- 
Balance -0.093 (0.085) 0.006 0.360 (0.241) 0.100 
6-Minute Walk -0.033 (0.014) 0.141 0.010 (0.036) -0.083 
Physiological Outcomes  
VO2peak -0.122 (0.225) -0.026 0.011 (0.290) -0.091 
Lower Body Strength     
Isokinetic Leg Extension (PT) 0.006 (0.044) -0.036 0.039 (0.046) -0.024 
Isometric Leg Extension (MVC) 0.012 (0.044) -0.034 0.068 (0.042) 0.120 
Isometric Leg Extension (RTD) -0.007 (0.009) -0.010 0.003 (0.008) -0.072 
Upper Body Strength     
Isometric Row (MVC) -0.011 (0.044) -0.035 -0.028 (0.093) -0.082 
Isometric Row (RTD) -0.004 (0.005) -0.013 -0.011 (0.016) -0.047 
Note: Bold/italic print identifies p values < 0.05; ‘--' = not collected 
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Supplemental Table 4. Pre-Post Changes– Mean (SD) 
  EBCS  CON 
Variable  Baseline  Post  Baseline Post 
Demographic Characteristics        
Body Mass Index (BMI) 27.6 (5.2) 27.6 (5.2) 29.2 (5.0) 28.8 (5.5) 
Body Weight (kg) 76.9 (12.6) 76.9 (12.8) 75.1 (14.6) 74.4 (16.4) 
Psychosocial Outcomes    
PROMIS Global Health (Physical)  12.4 (2.4) 13.6 (1.7) *  14.2 (1.8) 14.5 (1.9) 
PROMIS Global Health (Mental) 10.8 (2.7) 11.7 (2.4) *  12.6 (2.3) 12.8 (2.6) 
FACT- General 82.6 (13.5) 87.8 (13.1) 
*  -- -- 
Physical  22.0 (4.7) 23.8 (3.7) 
* -- -- 
Social/Family 20.0 (4.8) 21.6 (5.6) 
* -- -- 
Emotional  20.4 (3.5) 20.7 (2.3)  -- -- 
Functional 20.2 (4.1) 21.8 (4.4) 
* -- -- 
Depression (MHI) 9.4 (7.1) 6.4 (4.3) *  4.5 (3.5) 6.2 (4.9) † 
Anxiety (MHI) 5.0 (4.0) 3.8 (2.9) *  4.7 (2.7) 4.5 (2.5) 
PROMIS-Pain  11.7 (6.9) 10.7 (4.5) 8.8 (1.5) 9.9 (3.5) 
Sleep Quality (ISI) 8.6 (5.3)  6.9 (4.2) *  6.5 (3.9) 4.4 (3.3) * 
Self-Efficacy for Fatigue Self-
Management 
40.9 (11.8) 46.8 (12.2) * 50.8 (11.6) 48.4 (11.0) † 
Physical Activity / Functionality Outcomes  
Self-Reported Physical Activity 
(min/week) 
    
Moderate Physical Activity  119.8 (195.8) 178.6 (267.1) 26.9 (83.2) 117.3 (155.2) 
Vigorous Physical Activity  43.4 (63.6) 182.6 (150.5) * 5.7 (14.9) 58.5 (50.8) *† 
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